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Glossary of terms 
 
Concentric contraction 
This refers to the muscle action leading to shortening of the structure with joint movement1. 
Compression garment 
This refers to a type of clothing/material designed to provide pressure to the body part it surrounds 
(i.e. compression applied to a segment of the body by a garment). Various different types of 
compression garments have been developed including: 
I. Below knee compression garment 
This refers to a compression garment that starts below the knee and encloses the foot 
(resembling a knee height stocking). 
II. Calf sleeve compression garment 
This refers to a compression garment that starts below the knee and ends above the ankle 
leaving the feet open. 
III. Compression shorts 
This refers to compression garments that starts at the pelvis and ends above the knees. 
IV. Full leg length compression  
This refers to a compression garment that starts at the pelvis and end above the ankles 
(resembling a pair of leggings/tights). 
V. Whole body compression garment 
This refers to a compression garment that covers the entire body i.e. arms, legs and trunk in 
one full body suite. 
VI. Upper limb sleeve compression garment 
This refers to a compression garment that starts below the armpit (axilla) and ends at the 
wrist. 
 
Delayed onset of muscle soreness 
This refers to the sensation of muscle pain and/or discomfort and/or stiffness that occurs several 
hours following unaccustomed exercise2. 
Eccentric contraction  
This refers to the muscle action leading to lengthening of the structure with joint movement1. 
Endurance running 
This is defined as the capability to utilise aerobic energy systems to run sustained distances3. 
Ergogenic aid 
Any procedure or method related to nutrition, psychology, pharmacology, mechanics or physical 
science that is utilised to improve physical performance and/or athletic capability1. 
Exercise induced muscle damage 
This refers to damage occurring to muscular structures following unaccustomed exercises with 
manifestations including a reduction in muscle force production, enhanced passive muscle tension, 
swelling/oedema, muscle pain, decreased range of motion and increased levels of blood proteins 
and inflammatory markers4,5  
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Isometric contraction 
This refers to the muscle action where muscle length remains unchanged and the joint angle static 
(i.e. force is exerted without any movement occurring)1. 
Muscle thickness 
This is defined as the space between the two aponeuroses ((i.e. connective tissue) of a muscle6. 
One Repetition Maximum 
This refers to the highest load that can be moved once through full range of motion of a joint with 
acceptable form and posture before fatigue1. 
Peak power output 
This refers to the maximum amount of power (i.e. the rate of performance of work) produced during 
exercise1. 
Pennation angle 
This refers to the angle formed between the muscle aponeurosis and an individual muscle fiber6. 
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Abstract 
Introduction: 
Compression garments utilisation is very popular among runners despite the relative lack of consensus 
in the literature regarding a beneficial impact. 
Methods: 
A randomised controlled experimental study was conducted in healthy, uninjured endurance runners 
(n=41) participating in the Old Mutual Two Oceans 56km race. The experimental group (n=20) trained 
for six weeks and participated in the race wearing below knee compression garments while the control 
group (n=21) did not. Participants were tested on four occasions for various markers of exercise 
induced muscle damage (EIMD) and running performance. Six weeks prior to the race, ultrasound 
scans of the medial gastrocnemius, mid-calf and figure-of-8 ankle circumference baseline 
measurements were performed. Shortly prior to the race, these measurements were repeated in 
addition to a countermovement jump (CMJ) test. Immediately following the race, circumference 
measurements and CMJ testing were repeated in addition to pain ratings on the visual analogue scale 
(VAS). Race performance times were also obtained. Two days following the race, the ultrasound scans, 
circumference measurements and VAS pain ratings were repeated. 
Results: 
Ankle circumferences measurements increased significantly less (p=0.01, Cohen’s d=0.9) in the 
experimental group from immediately after the race until two days post-race compared to the control 
group. There were no further statistically significant changes over time in any other objective outcome 
measure (i.e. mean mid-calf circumference, medial gastrocnemius mean muscle thickness and mean 
pennation angle, mean CMJ height and estimated peak power output nor in race performance) 
between the experimental and control groups. Selected pain ratings were statistically significantly 
worse in the experimental group. Muscle thickness and pennation angles were significantly greater in 
the control group compared to the experimental group two days following the race. 
Conclusion: 
There were limited indications of a beneficial impact of compression garments with minor 
improvements in ankle circumference measurements, but no further significant effects related to 
EIMD were detected. Furthermore, no ergogenic impact was detected. Based on the results of the 
study, there is limited evidence to support the continued utilisation of commercially available below 
knee compression garments during running. 
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CHAPTER 1: Introduction and scope of dissertation 
1.1 Introduction 
Endurance running is becoming increasingly popular among individuals across a broad spectrum of 
ages and capabilities3. This popularity coincided with an enhanced interest in finding a balance 
between the health benefits and injury risks associated with endurance running. In addition, methods 
of improving performance are equally significant due to the competitive nature of humankind. 
It is well-established that running, as a form of aerobic exercise, is associated with various health 
benefits. This includes improved cardiovascular fitness, weight loss or maintenance and enhanced 
psychological well-being7. In addition, regular exercise reduces the risk for the development of 
diabetes mellitus, obesity, hypertension, various rheumatic conditions, certain types of cancer and 
depression among others7.  
Conversely, long distance running may be associated with various acute and/or chronic 
neuromusculoskeletal conditions, with over-use injuries to the lower limb occurring most 
frequently8,9. Arguably, the most common ailment related to endurance running is exercise induced 
muscle damage (EIMD) which refers to damage occurring to muscular structures following 
unaccustomed exercise with various manifestations4,5,10,11. Signs and symptoms of EIMD include a 
reduction in muscle force production, enhanced passive muscle tension with decreased range of 
motion (ROM), swelling/oedema, muscle pain and increased levels of various blood proteins and 
inflammatory markers4,5,11. It is also associated with reduced endurance running performance in 
subsequent sessions if adequate recovery is not achieved12.  
To encourage continued participation in running and the associated health benefits, various methods 
have been suggested and investigated in an attempt to decrease the possible detrimental impact of 
EIMD and a subsequent reduction in performance. Warm-ups, cool-downs and stretching have been 
performed for several decades and remain common practice with the aim of decreasing injury risk13–
15. Other methods used in an attempt to counter-act EIMD and/or improve performance with varying 
success include nutritional strategies, electrotherapy, cryotherapy, non-steroidal anti-inflammatory 
drugs (NSAIDs), massage, foam rolling, light intensity exercise and, more recently, modalities providing 
compression5,16. 
Compression garments have become particularly prominent in runners in recent years with the two-
fold aim of reducing EIMD and promoting running performance17. In a review, it was suggested that 
compression used therapeutically to reduce muscle damage may be attributed to decreasing oedema, 
inflammation and pain sensitivity, while promoting circulatory cytokine dissipation post-exercise11. 
However, there is a lack of consensus in available research regarding its impact on both of these 
factors related to endurance runners18,19. Currently, it is unclear if compression garments have a 
beneficial impact over and above usual sporting attire to justify its popularity17,19,20. Further research 
is required to assess its impact both on performance and EIMD in the endurance running population. 
The aims and objectives of the current study were developed to shed light on this matter by means of 
a randomised controlled field experimental study. 
1.2 Aim & Objectives 
1.2.1 Aim 
The aim of this study was to determine the impact of below knee compression garments on running 
performance and exercise induced muscle damage of the lower legs in an ultramarathon road race in 
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endurance runners training and competing with below knee compression garments compared to 
runners competing and training without compression garments. 
1.2.2 Objectives 
The specific objectives of the study were: 
1) To determine if there were significant differences in finish times (in hours:min) of an
ultramarathon in runners who trained in the final six weeks and participated in the race
wearing below knee compression garments (experimental group); compared to runners who
neither trained nor participated in the race with compression garments (control group).
I. To determine if there were significant differences in average running pace (min/km) in
runners in the experimental and control groups during an ultramarathon.
II. To determine if there were significant differences in average running pace (min/km) in
the last 14km (final 25% of 56km) in runners in the experimental and control groups
during an ultramarathon.
2) To determine if there were significant differences in mid-calf and ankle circumferences (in cm)
six weeks before, shortly (from three days) prior to, at the finish line and two days after an
ultramarathon in runners in the experimental and control groups.
3) To determine if there were significant differences in pennation angles (in o) and thickness (in
cm) of the medial gastrocnemius muscle at 90o ankle plantarflexion six weeks before, shortly
(from three days) prior to and two days after an ultramarathon in runners in the experimental
and control groups.
4) To determine if there were significant differences in lower leg pain as recorded on the Visual
Analogue Scale (VAS) upon completion and two days following an ultramarathon in runners
in the experimental and control groups.
I. To determine if there were significant differences in VAS pain ratings at rest in the
anterior and posterior calf and anterior and posterior thigh between groups upon
completion of the race and two days following the race.
II. To determine if there were significant difference in VAS pain ratings with active non-
weight-bearing (NWB) plantarflexion, dorsiflexion, knee flexion and knee extension
between groups upon completion and two days following the race.
5) To determine if there were significant differences in countermovement jump (CMJ) heights
and estimated peak power output (PPO) between runners shortly (from three days) prior to,
upon completion and two days following an ultramarathon in runners in the experimental and
control groups.
1.3 Plan of Development 
To explore this topic further, a comprehensive review of the literature related to compression garment 
utilisation in sport, and specifically in endurance running, in relation to exercise induced muscle 
damage and running performance will be presented (Chapter 2). This sets the ground for the 
randomised controlled field experimental study conducted to investigate the impact of below knee 
compression garments in endurance runners during training and participation in an ultramarathon 
event (Chapter 3). Finally, the findings of the study will be summarised and concluding statements will 
be presented (Chapter 4). 
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Chapter 2: A review of the literature 
2.1 Introduction 
2.1.1 Overview 
The utilisation of compression garments is increasing exponentially, especially among runners, despite 
the relative lack of consensus in the literature regarding a beneficial impact18,19. This literature review 
aims to investigate available research regarding compression garments utilised in a sporting 
environment, with emphasis on endurance running. The impact of compression garments on the 
body’s physiology, with emphasis on intra- and post-exercise muscle damage and the influence 
thereof on the performance of athletes will be discussed. 
2.1.2 Methods 
An electronic search of the literature was performed using EBSCO Host (with Academic Search 
Premier, CINAHL, Health Source, MasterFile Premier and Medline selected), Web of Science and 
Google Scholar online databases. The key terms utilised to conduct the literature search included: 
“compression garments”, “compression socks”, “compression stockings”, “endurance”, “sport”, 
“exercise”, “run*”, “muscle damage”, “muscle response”, “delayed onset muscle soreness”, “exercise 
induced muscle damage”, “physiological response”, “performance” and “recovery” for the sections 
investigating the impact of compression garments in running and various other sports. Another search 
was performed for prior research at the targeted event using “Old Mutual Two Oceans Marathon” 
and “run*” as key terms. The instrumentation section included the key terms “validity”, “reliability” 
and various instrumentation (i.e. “ultrasound”, “pennation angle”, “muscle thickness”, “visual 
analogue scale”, “countermovement jump”, “figure-of-8 ankle measurement”, “mid-calf 
circumference”, “time trail” and  “time-to-exhaustion test”).  
Studies with randomisation were prioritised and only those studies where the full text could be 
retrieved were considered for inclusion. All of the studies were published in academic journals or as 
academic scripts (i.e. postgraduate dissertations). 
2.1.3 Background  
Compression garments were originally utilised in medical practice with the aim of promoting 
circulation for the prevention of venous thrombosis, oedema and the treatment of wounds, scars or 
venous ulcers17,21–24. Increased venous circulation may help to speed up removal of metabolic waste 
products while improving oxygen supply, enhancing arterial blood flow and decreasing space for 
swelling19,20.  Intermittent compression therapy systems have successfully been linked to a reduction 
in the incidence of deep vein thrombosis in post-operative and/or bedridden patients25. However, 
recent systematic reviews concluded that the use of compression garments in medical practice are 
not fully supported by available research26,27. 
Compression garments were introduced into the field of sports with the aim of promoting recovery 
and as a possible ergogenic aid11. It is hypothesised to function by counter-acting exercise-induced 
oedema, enhancing scar tissue pliability, promoting proprioception, maintaining force production and 
decreasing exercise related pain responses11. In theory, the creation of an external pressure gradient 
through compression decreases space for swelling and provides mechanical support to soft tissue 
structures11. Consequently, an ergogenic effect would theoretically be possible with improved 
performance during and/or following training and competition while wearing compression 
garments28. It is suggested that any beneficial effect may result from a combination of physical, 
physiological and psychological factors influenced by compression garments17. 
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However, a beneficial impact of compression garments on running related recovery and performance 
has not been consistently demonstrated by research studies suggesting that the increased popularity 
thereof may instead be due to anecdotal reports or marketing techniques. To ensure evidence based 
practice, further high quality research is required.  
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Findings in the literature: 
2.2 Endurance running  
2.2.1 Endurance running and the Old Mutual Two Oceans Ultramarathon 
Endurance running is becoming increasingly popular with participation in marathons and 
ultramarathons increasing significantly over time3. This increased participation rate naturally 
coincided with an enhanced interest in minimising any associated detrimental effects and maximising 
performance.  
One notable example is The Old Mutual Two Oceans Marathon (OMTOM) 56km event, hosted yearly 
in Cape Town, South Africa, over the Easter period. It was started in 1970, with merely 26 runners and 
has since increased dramatically with the limit of 11 000 entries reached for the year 201729. The route 
covers 56km on road with an elevation gain of 1501m and an average slope of 3.7%29. This race has 
served as a setting for many previous endurance running related studies30–33. For instance, a 
prospective study performed over a four year period, reported the incidence of medical complications 
at the event at a rate of 8 per 1000 individuals who started the 21km and 56km OMTOM races34. No 
fatalities occurred in the ultramarathon, compared to two in the half-marathon, although the over-all 
incidence of medical complications were higher in the prior34. The most race related complications 
were exercise-associated collapse, and various dermatological and musculoskeletal ailments34. The 
large number of runners and other parties involved implies that it is likely to remain a popular setting 
for future studies. 
2.2.2 Exercise-induced muscle damage (EIMD) 
2.2.2.1 The impact of EIMD on runners 
The health benefits of exercise such as running are well known, with associated reductions in all-cause 
morbidity and mortality7. Conversely, prolonged, novel and/or unaccustomed exercise, particularly 
with an eccentric (lengthening) component, such as endurance running with long downhill sections, 
may lead to muscle damage i.e. EIMD with various ramifications4,5. The OMTOM 56km sets the field 
for the development of EIMD due to its prolonged duration with various incline changes.  
In general, muscle damage occurs through an initial degenerative phase involving muscle fibre 
necrosis and increased calcium concentration due to enhanced membrane permeability and is 
followed by an inflammatory phase with neutrophils and macrophages invading affected areas35. The 
symptomatic manifestations of EIMD include a transient reduction in muscle force production, 
enhanced passive muscle tension, swelling/oedema, muscle pain – specifically delayed onset muscle 
soreness (DOMS), decreased range of motion (ROM) and increased concentrations of blood proteins 
and inflammatory markers4,5,11. EIMD signs and symptoms may linger from days to weeks4. Pain tends 
to peak after 2-48hrs and last several days, whereas swelling peaks at 48hrs and remains for up to 10 
days4. Muscle strength loss usually starts immeadiately and may last for 7-14 days following the 
precipitating event4. After EIMD induction, it has been reported that athletes had reduced 
performance in countermovement jump, squat jump and drop jump tests36,37. A significant decrement 
in running performance with increased ratings of perceived exertion (RPE) have been recorded in 
endurance runners12. Furthermore, reduced ankle and knee ROM have been reported in runners after 
induction of DOMS38.  
On a physiological level, Z-line streaming with ruptured myofilaments and sarcolemmas followed by 
disrupted intra-muscular calcium homeostasis and loss of membrane integrity may occur5. Elevated 
concentrations of myoglobin (Mb), creatine kinase (CK), myosin heavy chain fragment concentration, 
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lactate dehydrogenase, troponin and aspartate aminotransferase have been recorded following 
damage-inducing bouts of exercise4. Using these as markers of muscle damage may however be 
problematic due to the vast inter-individual variation in production and clearance rates4.  
In addition, it has been suggested that EIMD may be related to increased concentrations of reactive 
oxygen species (ROS) released with muscle contractions35. There is, however, minimal research to 
substantiate any lasting muscle damage related to increased ROS concentrations35. In healthy muscle 
tissue, the inflammatory phase is followed by a regeneration phase involving activation and 
proliferation of undifferentiated, mononuclear satellite cells to facilitate muscle tissue recovery35. 
Recovery methods generally aim to speed up or enhance these processes. 
Evidence of EIMD has been observed following numerous running events. Increased concentrations 
of Mb, CK and interleukin-6 (IL-6) has also been reported following eccentric downhill running39, a half 
marathon40 and an ultramarathon41. Increased CK-myoglobin concentrations have also been detected 
specifically in the gastrocnemius muscle of long distance runners both before and after a 
marathon42,43. Biopsies performed on the gastrocnemius of runners after completing a marathon 
revealed several ultrastructural signs of muscle damage42. This included intra- and extra-cellular 
oedema, myofibrillar lysis, disruption of T-tubules and focal mitochondrial degeneration to varying 
degrees42. Due to structural differences, the medial gastrocnemius also appears to be at increased risk 
of muscle damage compared to the lateral gastrocnemius and the soleus44. The focus of prior research 
on the gastrocnemius muscle may also be on account of this muscle being the greatest contributor to 
force production during the propulsion phase of gait, which is critical during running45. 
2.2.3 Gender and age related differences in EIMD and running performance 
Some controversies exist in terms of the difference in muscle responses to exercise between men and 
women4. In animal studies, females seem to have a less pronounced muscle damage response to 
eccentric exercise compared to males4. Human studies indicate that females tend to be more resistant 
to fatigue with similar intensity isometric contractions46. These changes may be attributed to altered 
gene expression among genders47 and may also relate to the anti-oxidant protective effect of estrogen 
in females48. In general, a review found that females tend to have lower resting CK concentrations, 
but the difference in response to exercise in terms of this and other muscle damage markers is less 
clear between the genders4. Based on available research it appears that contrary to animal studies, 
human females may portray an aggravated initial EIMD response compared to males, but this effect 
remains minor4. 
It is well-known that average running performance times tend to differ among genders49. This may be 
partly due to the impact of the menstrual cycle on the performance of females50. Slightly improved 
absolute maximum oxygen consumption values have been recorded during the follicular phase 
compared to the luteal phase50. This may be related to increased female steroid hormones during the 
latter phase50. In general, studies have found that females report better athletic performance in the 
days following menstruation and worse performance in the days preceding menstruation51. 
Furthermore, utilisation of contraceptive medication may further decrease athletic performance51. In 
contrast, it appears that females may have less musculoskeletal injuries when utilising oral 
contraceptives51. 
Age related changes to muscle recovery mechanisms have been widely described between the elderly 
and the very young35,52, hence muscle responses following exercises is likely to differ. With age, 
muscles tend to become smaller in cross-sectional area with associated reductions in force 
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production35.  Muscle fibre degeneration tends to start at approximately 50 years of age and 
progresses gradually with older age53. Muscle atrophy occurs particularly in the type 2 fast glycolytic 
muscle fibres, with the relative proportion of type 1 slow oxidative fibres being maintained better35. 
Performance decrements appear to be inevitable even in trained marathon athletes where running 
performance decreases at approximately 40 years of age53. Animal studies have also demonstrated a 
prolonged duration of EIMD in older individuals compared to their younger counter-parts35. Human 
studies are limited due to ethical concerns, but it is anticipated that damage may be more severe and 
recovery extended in older adults35. This may be partly due to a reduction in the number of satellite 
cells in muscle tissue35.  
2.2.4 Methods to reduce EIMD 
EIMD may cause difficulty in subsequent exercise performance and may impact on the compliance to 
exercise programmes5, which may have repercussions through loss of health benefits as well as 
decreasing performance in competitions. Some of the methods, other than compression, used in an 
attempt to reduce EIMD and therefore counter-act these possible repercussions include antioxidant 
supplementation, β-Hydroxy-β-Methylbutyrate, electrotherapy, cryotherapy, ample carbohydrate 
and adequate protein intake, non-steroidal anti-inflammatory drugs (NSAID), analgesics, massage, 
stretching and low intensity exercise prescription5,10. Nutritional supplements such as protein, anti-
oxidants and β-Hydroxy-β-Methylbutyrate may help to prevent or reduce EIMD if taken long-term5. 
However, there is limited evidence to support the use of these supplements if a well-balanced diet is 
followed1. NSAID’s and analgesics may help reduce symptoms short-term but NSAID’s may also inhibit 
recovery long-term5,10. Massage seems to decrease subjective pain ratings, but evidence is limited for 
any impact on subsequent performance measures5. Similarly, stretching has been found to have very 
limited or no impact on the incidence of DOMS54. There is also very limited support for the continued 
utilisation of cryotherapy, electrotherapy and high carbohydrate supplementation in the management 
of EIMD at present5,55. Gentle exercise has been suggested as a valuable method to reduce EIMD 
related pain, but it appears to have a limited impact long term5,55. More recently, the use of foam 
rollers after exercise has become popular. In one study, foam rolling was associated with reductions 
in lower limb pain and performance decrements following exercise compared to a control group and 
may therefore be promising as a recovery modality16. 
2.2.5 Methods to maximise performance 
There is considerable overlap between recovery aids and performance enhancement methods, as 
improved recovery may enable improved subsequent performance as well as more rapid return to 
training following prolonged, intensive training sessions or competitions. 
Other than compression, possible legal ergogenic aids utilised during running include caffeine, 
carbohydrate loading techniques, certain nutritional supplements and anti-oxidants56. Banned 
substances include anabolic steroids, erythropoietin, human growth hormones and insulin-like growth 
factor 1 (ILF-1) among others56,57. This review focused on those aids that can be used reasonably safely 
and are permitted in running competitions. Caffeine was prohibited in the past, but is now permitted 
and may enhance aerobic exercise performance, whereas creatine and pyruvate have no clear impact 
on activities such as endurance running58. Carbohydrate supplementation during running appears to 
enhance endurance capacity and performance59. This may relate to the maintenance of increased 
carbohydrate oxidation and inhibition of the development of hypoglycaemia59. Furthermore, runners 
who mouth-rinsed with a 6.4% carbohydrate-electrolyte solution significantly increased the distance 
covered in one hour of running compared to placebo mouth-rinsing, which may relate to a centrally 
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governed mechanism influencing the perception of exertion60. A well-balanced, nutritious diet is 
required for health and performance purposes, however additional anti-oxidants, amino acids or 
protein supplementation do not appear to have an additive impact on performance58. Stretching, also 
sometimes suggested as ergogenic aid, has not been linked to improved performance and may even 
reduce running economy54. 
Compression garments were introduced into the field of running related recovery and performance 
more recently than many other methods and its impact remains contentious. Studies investigating 
these factors will be discussed in more depth in the sections that follow. 
2.2.6 Summary of the literature: Endurance running  
Endurance running participation is increasing over time. Although the health benefits are numerous 
and commendable, endurance runners are at increased risk of injuries and exercise induced muscle 
damage. EIMD is associated with pain, swelling, reduced ROM, altered biochemical parameters and 
performance decrements among others. It appears to be prominent among long distance runners. 
Many attempts have been made to counter-act these possible detrimental effects and optimise 
running performance with varying success rates. Compression garments has become prominent 
among these methods in recent years. The following sections will investigate available literature 
regarding their impact on exercise induced muscle damage and sports performance. 
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2.3 Compression Garments in Runners  
The lack of consensus in available studies currently confound interpretation17,20. Other confounding 
factors include the vast array of compression garments made by different manufacturers, varying 
pressure levels, anatomical areas of application, duration and timing of utilisation17,19. In addition, a 
diverse range of subjects with different age groups, genders and training statuses,  as well as various 
sports and outcomes measures have been used for assessments17,19. Based on available systematic 
reviews, it appears there may be some beneficial effect of compression garments as a recovery 
method, although many studies have found no effects on recovery and a marginal impact on sporting 
performance11,17,19. Studies specific to endurance running are also inconclusive and are often of 
inadequate quality20. 
2.3.1 Compression garments worn during running 
Twenty-four randomised controlled studies that assessed the impact of lower limb compression 
garments (CG) worn during exercise on various parameters in runners were identified. Significant 
improvements in one or more outcome measures were reported in the majority of these 
studies18,28,41,61–71, with five studies finding no differences in any parameters72–76 and three reporting 
some significant differences that may be undesirable71,77,78. Incongruence among results makes 
informed decision making difficult regarding the value of compression garments in running. 
Below knee CG worn during running have been associated with significant (p<0.05) improvements in 
post-race subjective ratings of pain in some studies41,61,63,69. In addition, lower limb CG worn during 
running was associated with improved RPE values65,66. In contrast, it was associated with more 
discomfort24 and increased69 or unchanged pain63,66 and RPE values61,63,64,68,70,79 compared to controls 
in other studies. In one study conducted in nineteen recreationally active females, the findings of 
lowered pain ratings and increased RPE values69 appear to be contradictory, seeing as one would 
expect lower perceived pain ratings to coincide with decreased RPE values. In addition, the lowered 
pain ratings were not associated with any significant changes in running performance during 5km time 
trials with CG compared to usual attire69. When different degrees of compression were compared, it 
was found that low grade compression represented the most comfortable rated running experience 
with high compression gradient levels rated as more uncomfortable than control condition24,62. 
Even less consensus in results were found regarding objective outcome measures. In terms of physical 
performance tests, improvements were found with the utilisation of below knee CG compared to 
control (none or placebo) with improved time-to-exhaustion treadmill tests (p=0.01; p<0.05 
respectively)70,80 and greater total work and duration of stepwise treadmill tests (p<0.05; 0.3 and 0.4 
effect sizes respectively)28. Similarly, significant improvements (p<0.05) were found with full leg length 
CG compared to controls in terms of lower energy costs at 12km/hr pace on a treadmill64 as well as 
improved sprint performance, altered running techniques with enhanced electromyography (EMG) 
activity of muscles and increased step lengths65.  
However, there were no significant differences in the time trial performances in the same participants 
wearing no, low, medium or high pressure below knee CG respectively62. Many studies found no 
improvements in running performance when CG were utilised. For example, no significant changes 
were found with below knee CG compared to controls in a 10km road run or shuttle running test 
performance61; muscle function determined through countermovement jump tests24,63; average 
marathon and ultramarathon running pace and over-all time41,63; treadmill VO2max values28,71,74,81; time-
to-exhaustion treadmill testing67,74; 5km running performance69; 15.6km trail running performance76; 
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nor in running economy measures70. Furthermore, no significant changes were found with full leg 
length CG compared to controls in terms of 4km and 400m indoor track running performance78. One 
study even reported a performance decrement with lower time-to-exhaustion treadmill test results 
with CG utilisation compared to a control trial68. Another study found reduced running economy with 
full leg length CG conditions compared to control conditions71. In addition, no significant changes were 
found in any running kinematic measures with calf compression sleeves compared to control 
conditions75. Based on these over-all findings, there seems to be mild support for improvements in 
treadmill running performance with compression garments compared to controls in some studies. 
However, there is currently no support for improvements in any field testing measures (from 400m 
track running78 to ultramarathon races41). 
When considering measures of muscle power, when low and medium pressure CG were used during 
a 10km track time trial, a less pronounced reduction (p<0.05) in CMJ performance were reported 
compared to control trials in 12 highly trained athletes62. However, other studies found no change in 
CMJ measures performed when CG were used compared to control conditions63,76. In addition, no 
significant changes were detected in maximal voluntary contraction (MVC) measures76. 
Regarding physiological measures, the majority of results appear to be non-significant. In terms of 
cardiopulmonary measures, below knee CG compared to control conditions was not associated with 
any significant changes compared to control in heart rate (HR) values24,61,62,68,72–74,76; cardiac output73; 
stroke volume73; minute ventilation72,76; oxygen uptake24,68,73–75,82; nor blood oxygen saturation63,73. 
Likewise, full leg length CG compared to control was not associated with significant differences in HR, 
blood pressure (BP)78 or  tissue oxygenation concentration65. One study, however, found increased 
VO2max, lower HR measures and decreased tissue oxygenation index measures with full leg length CG 
compared to control conditions during progressive maximal and time-to-exhaustion treadmill 
testing71. In addition, significantly increased local blood flow was reported with CG compared to 
control conditions71. Only one study reported significantly improved (p<0.05) tissue oxygenation at 
rest and during recovery after a treadmill running test when utilising below knee CG compared to a 
control trial without CG67. Still, this did not translate to improved performance and it is unclear if it 
aided recovery as no markers of muscle damage were included.  Based on these findings, there is very 
limited support for any beneficial or other impact of compression garments on any cardiopulmonary 
measures considered, except one isolated study with  improvements in blood flow, decreased HR and 
increased oxygen consumption71. 
Besides the lack of perceived benefits to the cardiopulmonary system, below knee CG did not cause 
significant changes compared to control in various markers of possible muscle damage including blood 
lactate24,62,73,83; lactate threshold (LT)68; lactate dehydrogenase63; serum sodium, chloride or 
potassium63; CK41,63; or Mb concentrations63. From current literature it appears that CG have minimal 
measurable impact on biochemical processes in the neuromuscular system with only a few exceptions.  
Some significant (p<0.05) improvements were found in a study performed at the OMTOM 56km 
among 40 male athletes in those wearing below knee compression socks with lower concentrations 
of Mb and decreased blood lactate concentrations reported in addition to improved Visual Analogue 
Scale pain ratings of the calf, hamstrings and quadriceps compared to a placebo control group41. 
Experimental participants in this study utilised CG during the race as well as during the subsequent 
72hours. The results of the study are promising for those promoting CG utilisation, seeing that this 
was one of the largest studies (in terms of sample size) performed to date. However, these beneficial 
results were not accompanied by altered CK concentrations and it did not translate to improved 
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performance times41. Welman and others have suggested that future studies should focus on the 
utilisation of compression garments during training as opposed to only during an event as an 
adaptation period may be required for measurable improvements to occur41,70. Another study also 
reported lower blood lactate concentration at 1 and 5 minutes respectively, during a maximal 
treadmill test when below knee CG were utilised compared to a control trial without CG, although the 
lactate thresholds were unchanged68. This also did not translate to improved performance with poorer 
time-to-exhaustion test results with CG compared to controls and no alteration in cardiopulmonary 
outcome measures68. Another study performed in 14 untrained females found that full leg length CG 
were associated with significantly higher (p<0.05) venous emptying rates 30 minutes after running 
compared to control trials without CG78. Yet, similarly, this did not translate to improved performance 
or altered cardiopulmonary outcome measures78 and the impact on exercise induced muscle damage 
was not tested physiologically.  
Significantly decreased (p<0.05) swelling determined with circumference measures were detected in 
thirteen runners performing a 10km cross country track run with below knee CG on one leg compared 
to the opposite leg without CG18. In addition, decreased lower limb circumference measures were 
reported following the OMTOM ultramarathon in runners using CG compared to placebo socks41. In 
contrast, no significant differences in circumference measures were reported in thirty-four runners 
performing a marathon either with or without CG63. These conflicting results require further research 
into the topic. In addition, there is no correlation between decreased circumference measurements 
and other outcomes i.e. reduced inflammation and this may simply be due to the pressure reducing 
interstitial fluid localised to the calves. 
Significantly higher (p<0.05) skin temperatures with full leg length CG were detected in two 
studies66,78. For this reason, CG may need to be used with caution in very hot conditions. However, 
neither of these studies reported temperature values high enough to cause serious concerns and 
compression garments are still considered reasonably safe in any weather conditions66,78. In addition, 
no impact on running performance was reported under any simulated temperature tested66. 
Nevertheless, seeing as these tests were of limited duration, there may not have been adequate time 
to properly assess the use of compression garments on heat stress66. 
Other measures that were not significantly different with the use of CG compared to controls include 
sweating, subjective thermal and comfort sensations64; blood glucose63; as well as red blood cell 
deformability74. 
It is clear that a variety of outcome measures have been considered in search of a possible explanation 
for the anecdotal popularity of compression garments. Although some significant improvements were 
detected, the impact of compression garments remains unclear. In addition, due to heterogeneity of 
the field and studies performed, results from isolated outcome measures in particular should be 
considered with caution. 
2.3.2 Compression garments worn during recovery from running 
Only two randomised controlled studies assessing the utilisation of CG during recovery from running 
were identified. The first study assessed the impact of below knee CG utilised for 48 hours during 
recovery from a marathon race compared to placebo in thirty-three trained men and women, 
randomly allocated to either group80. Significantly improved (p=0.009)  time-to-exhaustion treadmill 
results were obtained two weeks after the marathon in those wearing CG compared to the control 
group80. The second study was conducted in forty-one men and women randomly allocated to wear 
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full leg length CG or receive sham ultrasound during the 72hrs of recovery following a marathon84. 
Some significant improvements (p<0.05) were also detected by means of subjectively lower ratings of 
muscle soreness in the CG group compared to the placebo recovery group. However, no significant 
changes were detected in any of the objective measures included with no difference in maximal 
voluntary isometric contraction of knee extensors, CK or C-reactive protein concentrations between 
groups84. The study was performed in experienced marathon runners who had completed several 
previous endurance events, thus training status is suggested as a possible reason for the lack of 
difference in objective markers compared to improved subjective pain measures in this study84. 
Trained runners tend to produce lower CK concentrations following exercise, therefore the exercise 
stress may have been inadequate to produce a measurable effect in blood markers84. Alternatively, 
the subjectively improved pain recordings may be due to a psychological belief that CG should be 
superior to therapeutic ultrasound. These findings are similar to some of the studies utilising CG during 
running (not recovery) with improvements in subjective measures not necessarily translating to any 
alterations in objective measures61,63,66. 
2.3.3 Problematic trends 
The heterogeneity of study designs has made comparisons and drawing conclusions challenging19,20. 
Several problematic trends in the available studies have been identified.   
Considering participant selection, males constitute the vast majority of total research participants (302 
males compared to 101 females). In addition, the previous study testing compression garments at the 
OMTOM 56km race excluded females41. Future research should include females when testing the 
efficacy of compression garments in running.  
Another problematic trend relates to blinding. Most of the studies did not utilise any form of 
blinding28,61,64,65,67–70,72–74,78,84,85 or only used blinding for baseline measures63,66 due to practical 
constraints. Furthermore, in the few selected studies where double blinded approaches (participants 
and examiners blinded) were utilised, participants still accurately assumed their allocation due to the 
feeling of the degree of tightness of garments24,62,80. Therefore, even when utilised, the efficacy of 
blinding drastically diminished. Practically, effective blinding may not be possible seeing as even 
“placebo” CG were easily distinguished from actual CG24. In addition, the most beneficial degree of 
compression has not been established19 so any degree of compression in garments may have an 
impact and establishing a “placebo” level may not be possible at present. Conversely, if the garments 
were too loose, it may also confound results by inhibiting performance due to reduced aerodynamics 
with increased wind resistance86. 
One study compared CG to an apparently different intervention (placebo ultrasound), which may have 
been useful84. However, pre-conceived ideas of either of these interventions could still impact on 
participants’ perceptions and therefore results are at risk of being biased based on participants’ 
expectations for each intervention. 
In addition, large discrepancies exist in terms of the different degrees of compression applied with 
some studies providing no information regarding the specifics of the CG products making 
interpretation difficult. However, a systematic review replicating previous studies to evaluate the 
impact of different degrees of compression concluded that there is no clear relationship between the 
amount of pressure applied and the impact of compression garments19.  
The relatively small samples sizes in most of these studies further limits generalisability to the rest of 
the running population. In addition it means that results may not truly reflect the impact of 
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compression garments. Practically it may be difficult to obtain large sample sizes as it requires 
dedication, compliance and often extensive time commitment on the part of participants.  
None of the studies recruited a random sample from the population for inclusion in the study. 
Therefore, there may be pre-existing differences in the sample compared to the general population. 
The large variety of pressure garments, outcome measures and participant groups tested limits 
comparability among studies. The conflicting results further complicates drawing conclusions with 
certainty. Clearly, the role of compression garments still remains controversial.  
Table 2.1 presents a summary of randomised controlled trials in runners considered in this review 
section, with relevant details regarding the participants, compression garment specifications, 
methodology and outcome measures highlighted. This illustrates some of the problematic trends 
related to relatively small sample sizes and the heterogeneity of study designs among trials. 
2.3.4 Summary of Literature: Compression Garments in Runners 
Currently available literature regarding compression garments in runners is inconclusive and/or of 
insufficient quality to support related findings. There seems to be mild to moderate support for 
improved subjective measures when compression garments were worn during running compared to 
controls with associated decreased pain and exertion ratings detected in most studies, but opposed 
in others. There is also some support for reduced swelling measures (associated with reductions in 
circumference measurements), and enhanced time-to-exhaustion and running performance tests, 
although many studies found no impact on various performance measures and one even reported a 
decrement in performance with CG use compared to controls. Minimal improvements in physiological 
measures were detected with associated reductions in Mb and blood lactate in two studies, but with 
no effect detected in the majority of studies. No improvements were found in cardiopulmonary 
measures in the vast majority of studies. 
There appears to be slightly more support for CG worn during recovery from running with 
improvement in subjective measures and subsequent running performance, but no impact on other 
physiological measures tested. In addition, the number of studies were limited and further research 
is required. 
Some of the problematic trends in available research methodology include the exclusion of female 
participants, the inability to provide sufficient blinding due to practical constraints, small sample sizes 
and the heterogeneity among studies.
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Table 2.1: Lower Limb Compression Garments in Running  
Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
Ali, et al., 
200761 
RCT 
CG vs control 
repeated in 
same 
participants 
Trial A: 14 M 
Trial B: 14 M 
Recreational 
runners 
Below knee CG 
(18 – 22 mmHg) 
 
CG worn 
during 
exercise 
A: two multi-
stage 
intermittent 
shuttle running 
tests 
B: 10km road run 
A: No significant difference 
in exercise performance; 
HR; or RPE (A); 10km times; 
RPE (B) 
Significantly reduced pain 
ratings in CG trial at 24hrs; 
more ratings of pain 
located in calf for control 
trial. 
CG appears to assist 
with decreased DOMS 
related pain in lower 
limbs –based on 
subjective ratings, but 
no ergogenic effect 
was detected. 
 
Ali, et al., 
201077 
RCT 
CG compared to 
light and high 
CG in counter-
balanced order 
in same 
participants 
 
9 M & 1 F 
Competitive 
runners 
A: No compression 
B: Light below knee 
CG 
(12-15mHg) 
C: High below knee 
CG (23-32 mmHg) 
 
CG worn 
during 
exercise 
3 X 40min 
treadmill runs 
with A, B, C 
conditions 
 
No significant differences in 
oxygen uptake; HR; blood 
lactate;  counter-
movement jump test and 
PPO between trials 
C perceived as tighter and 
more painful to wear than 
A & B.  
No physiological 
benefits detected; 
more comfortable 
with low grade CG. 
Ali, et al., 
201162 
RCT 
None, low, 
medium and 
high CG 
conditions in 
randomised 
order in same 
participants 
9M & 3F 
Highly trained, 
competitive 
runners 
 
A: no compression 
B: low below knee 
CG (12–15 mm Hg; 
C: medium below 
knee CG (18–21 mm 
Hg) 
D: high below knee 
CG (23–32 mm Hg) 
CG worn 
during 
exercise 
10km time trial 
With CMJ test 
pre- and post-run 
No compression and low 
compression was rated as 
more comfortable than 
medium and high 
compression conditions, 
whereas high compression 
was rated as the most 
painful. 
Significantly lower change 
from pre- to post-CMJ was 
Minor improvement 
in CMJ measures, 
with no improvement 
in running 
performance, cardio-
pulmonary or lactate 
levels. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
reported in low and 
medium CG trials. 
No significant change in 
running performance 
times; blood lactate; or 
mean HR between trials. 
Armstrong, 
et al., 201580 
RCT 
CG vs placebo 
socks groups 
 
23 M & 10 F 
Moderately 
trained runners 
Below knee CG 
compared to 
placebo socks 
(ankle: 
30–40 mm Hg calf: 
21–28 mm Hg) 
CG worn for 
48 hours 
during 
recovery 
period  
Graded treadmill 
running test to 
exhaustion 2 
weeks  before 
and following 
actual marathons  
 
Treadmill times increased 
significantly (2.7%) in CG 
group and decreased 
(3.4%) in control group. 
CG appears to aid 
functional recovery 
when worn following 
a marathon. 
Areces, et 
al., 201563 
RCT 
CG vs control 
group 
30 M & 4 F 
Experienced 
endurance 
runners 
 
 
Below knee CG 
(lowest at 25 to 20 
mmHg) compared to 
control 
CG worn 
during 
exercise 
Marathon 
running 
performance 
and various blood 
markers 
No difference in average 
running times or pace; RPE; 
blood oxygen saturation; 
serum sodium, chloride; 
potassium; blood lactate; 
blood glucose; Mb; CK; 
lactate dehydrogenase; 
lower leg volume 
measures; CMJ 
between groups. 
Significantly lower pain 
rating 24hrs (but not at 48 
hrs) following marathon in 
CG group compared to 
control group 
Limited 
improvements in pain 
measures, but not in 
performance or any 
other objective 
markers 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
Bringard et 
al., 200664 
Repeated 
measures RCT  
Three garment 
conditions in 
each subject 
over 2 months  
 
A: 6 M 
B: 6 M 
Trained runners 
 
 
 
Compression tights 
compared to classic 
elastic tights and 
conventional shorts 
(pressure not 
available) 
CG worn 
during 
exercise 
A: Incremental 
exercise test to 
voluntary 
exhaustion at 10, 
12, 14, and 16 
km/h on 3 
different days  
B:  Constant 
running exercise 
at 80% of VO2max 
of 15 min 
duration on three 
different day 
A: Significantly lower 
energy cost at 12 km/h 
with CG and elastic tights 
compared to conventional 
shorts. 
B: Significantly lower VO2 
slow component in CG 
compared to other 
garment conditions.  
No differences in sweating, 
thermal and comfort 
sensations; or RPE between 
clothing conditions in A or 
B. 
Limited 
improvements in 
running economy 
measures. 
Born, et al., 
201465 
RCT 
CG vs control 
(without CG) in 
same subjects 
24 F 
Track and female 
club members 
Full leg length 
compression 
garment with 
adhesive silicone 
stripes (18.3-
21.7mmHg) 
CG worn 
during 
exercise 
2 sets of 30 X 
30m sprints 
Significant difference in 
sprint times in the final 
third segment in the CG 
trial compared to control 
trial. 
RPE and running technique 
changed with increased 
EMG activity of rectus 
femoris and increased step 
length in CG trial compared 
to control. 
No significant difference in 
cardiorespiratory or 
metabolic parameters, 
tissue oxygenation and 
haemoglobin, and skin 
It was suggested that 
the altered running 
style may result in 
performance and 
comfort 
improvements with 
CG. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
temperatures between 
trials. 
Bovenschen, 
et al., 201385 
Cross sectional 
experimental 
control study 
with CG on one 
leg only of each 
subject 
 
8 M & 7 F 
Trained 
recreational 
runners 
Below knee CG (25–
35 mm Hg) 
CG worn 
during 
exercise 
10km track run 
& stepwise, 
speed-
incremented 
maximum 
treadmill test 
until voluntary 
termination 
Decreased lower leg 
volume after 10km and 
maximal treadmill test 
measured with perometer 
in CG leg compared to 
opposite. 
No difference in leg 
complaints between sides. 
Leg volumes were 
improved but was not 
accompanied by 
subjective 
improvements. 
Goh, et al., 
201166 
RCT 
With CG 
compared to 
control (none) in 
same subjects in 
randomised 
counter-
balanced order 
10 M 
Recreational 
runners 
 
SkinsTM long tights 
CG 
(13.6 ± 3.4 mmHg at 
the calf and 8.6 ± 
1.9 mmHg at the 
thigh) 
CG worn 
during 
exercise 
4 X 20 min 
treadmill running 
trials with and 
without CG 
performed in 
10oC  and 32oC 
respectively 
Lower limb 
skin temperature was 1.5oC 
higher at 10oC with CG 
compared to control. 
RPE decreased 
during submaximal running 
at 32oC with CG compared 
with control. 
No significant differences in 
other physiological 
variables, including rectal 
temperature 
between garment 
conditions. 
CG are not contra-
indicated in the heat. 
Dascombe, 
et al., 201171 
Randomized 
crossover design 
In same subjects 
With two CG 
conditions 
11 M 
Well trained 
middle distance 
runners 
Full length CG 
classified as 
“undersized” (15.9 
±2.6 mmHg at the 
thigh and 21.7 ±4.3 
CG worn 
during 
exercise 
Progressive 
maximal test and 
Time to 
exhaustion test 
performed on 
During the progressive 
maximal test: 
Both CG conditions 
resulted in significantly 
increased oxygen 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
compared to 
control (none) 
mmHg at the calf); 
Full length CG 
classified as 
appropriate by the 
manufacturer (13.7 ± 
2.3 mmHg at thigh 
and 19.2 ±3.2 at calf) 
 
treadmill in each 
CG condition and 
without CG 
consumption, oxygen pulse 
and decreased running 
economy, oxyhemoglobin 
and tissue oxygenation 
index at low intensity 
speeds compared to 
control conditions.  
At higher speeds, CG 
conditions significantly 
increased local blood flow 
and decreased HR and 
tissue oxygenation index 
compared to controls. 
During the time to 
exhaustion tests: 
Both CG conditions 
significantly increased 
deoxyhemoglobin 
concentration; undersized 
CG increased regional 
blood flow significantly.  
No significant changes 
were reported in 
endurance performance; 
VO2max, nor LT. 
Hill,  et al., 
201484 
RCT 
CG compared to 
placebo 
ultrasound 
groups 
17 M & 7 F 
Recreational 
runners 
(approximately 
9.9 mmHg at 
Lower limb 
compression tights 
 
CG worn for 
72hr during 
recovery  
After running a 
self-paced 
marathon 
distance, blood 
markers and 
Significantly lower muscle 
soreness at 24hrs in CG 
group compared to control 
No significant differences in 
maximal voluntary isometric 
Subjective markers 
improved but no 
objective markers 
significantly different 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
thigh and2 
19.3mmHg at 
calf) 
subjective ratings 
collected at 
24hrs, 48hrs and 
72hrs 
contraction of knee 
extensors; CK, and C-
reactive protein between 
groups. 
Kemmler, et 
al., 200928 
RCT randomised 
cross-over 
design 
CG compared to 
control (none) in 
same subject 
 
21 M 
Moderately 
trained runners 
Below knee CG (24 
mm Hg at ankle) 
CG worn 
during 
exercise 
Stepwise 
treadmill test 
up to a voluntary 
maximum, 2 
trials, 10 days 
apart 
Significantly increased the 
total work and duration 
achieved voluntarily; as 
well as anaerobic and 
aerobic thresholds in CG 
compared to the control 
trial  
No significant differences in 
VO2max values 
 
Ménétrier, 
et al., 201167 
RCT 
CG compared to 
none in same 
subjects in 
randomised 
order 
14 M 
moderately 
trained athlete 
Calf compression 
sleeves (15-
27mmHg) 
 
CG worn 
throughout 
sessions 
2 treadmill 
running tests 7 
days apart with 
and without CG 
Significantly increased 
tissue oxygenation at rest 
and during recovery from 
exercise with CG compared 
to control 
No difference in time to 
exhaustion – no ergogenic 
effect on running 
performance 
 
Priego, et al., 
201572 
RCT 
CG vs control 
(placebo 
stocking) in 
same subjects in 
randomised 
order 
13 M & 7 F 
Recreation 
runners 
Below knee CG (21-
24mmHg)  
CG worn 
during 
exercise and 
two groups 
randomly 
allocated to 
train with CG 
2 X fatigue 
running test of 30 
minutes at 80% 
of their maximal 
aerobic speed 
with or without 
CG 
No difference in 
cardiorespiratory 
parameters considered i.e. 
VE, HR, VE/O2 and VE/VCO2 
between trials 
This study does not 
support the notion 
that venous 
circulation is 
improved. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
or placebo for 
3 weeks 
Sperlich, et 
al., 201173 
RCT 
With 5 different 
CG conditions 
with each 
subject 
15 M 
Well trained 
runners  
Below knee CG at 0, 
10, 20, 30 and 40 
mmHg respectively 
 
CG worn 
during 
exercise 
 
Five periods of 
submaximal 
running on 
treadmill with 5 
CG conditions 
No significant changes in 
cardiac output and index; 
SV; arteriovenous 
difference in oxygen 
saturation; oxygen uptake; 
arterial oxygen saturation; 
HR and arterial lactate 
concentration between CG 
conditions 
 
Stickford, et 
al., 201575 
Randomized 
cross-over 
design 
CG compared to 
control (none) in 
same subjects 
16 M 
Well trained 
runners 
Graduated calf 
compression sleeves 
(15-20 mmHg) 
 
 
CG worn 
during 
exercise 
Running economy 
tests on a 
treadmill 
No significant changes in 
VO2, running economy, 
ground contact time, swing 
time, step length or step 
frequency. 
 
Rider, et al., 
201468 
Randomised 
cross-over 
design 
Experimental 
control with CG 
compared to 
control (none) in 
same participant 
7 M & 3 F 
Collegiate cross-
country runners 
Below knee CG (with 
a minimum of 15 
mm Hg exerted) 
CG worn 
during 
exercise 
Tests: Maximal 
treadmill test, X2, 
7 days apart 
Lower blood lactate levels 
at 1 and 5 minutes 
respectively with CG 
compared to control.  
Lower time to exhaustion 
in CG compared to control 
trial. 
No other significant 
differences in HR, 
Respiratory exchange 
ratio,VO2, RPE and LT 
between trials. 
CG may decrease 
performance 
- authors suggest it 
may be useful to ask 
how participants feel 
about CG e.g. if 
uncomfortable may 
deter performance 
Possibly aids muscle 
recovery with 
lowered blood lactate 
levels. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
Treseler, et 
al., 201669 
Randomised 
cross-over 
design 
CG vs control 
(none) in same 
participant 
 
19 F 
Recreational 
runners 
Below knee CG (18–
21 mm Hg at ankles 
to 12.6–14.7 mm Hg 
below the knee) 
CG worn 
during 
exercise 
2 X 5km run time 
trials on outdoor 
course, 7 days 
apart 
 
Significantly increased RPE 
and decreased lower limb 
muscle pain (not localised 
to calf) in CG compared to 
control. 
No significant difference in 
5km running times. 
 
No impact on 
performance. May 
worsen subjective 
perception of effort. 
May decrease muscle 
pain in lower limb 
with subjective pain 
ratings, but not 
specific to region of 
CG. 
Varela-Sanz, 
et al., 201170 
RCT 
CG vs control 
group 
A: 
Randomised 
repeated 
measures 
design. 
B: Randomised 
non-cross-over 
design. 
 
A: 13 M & 3F 
endurance 
trained runners 
B: 12 of the 
above 
participants 
Below knee CG (15–
22 mm Hg at the 
ankle) 
CG worn 
during 
exercise 
A:  
4 bouts of 6 
minutes at 
a recent half-
marathon pace 
on a treadmill in 
random order 
B:  
Time limit test on 
a treadmill at 
105% of a recent 
10-km 
pace 
Performed over a 
period of 2 weeks 
Lower HRmax in CG group 
compared to control in B. 
Improved time to fatigue 
and lower VO2peak in CG 
compared to control in B. 
No difference in running 
economy or RPE in A or B. 
 
Authors suggest that 
accommodation 
period may be 
required for a true 
effect to be observed. 
 
Venckunas, 
et al., 201478 
RCT 
Cross over 
design with CG 
compared to 
13 F 
Non-athletic 
subjects 
Breech CG (17 at 
upper calf and 
18mmHg at thigh) 
CG worn 
during 
exercise 
 
4km indoor track 
running in 30 
minutes followed 
by 400m sprint 
No significant difference in 
running performance; HR & 
BP dynamics; or RPE during 
test between two trials. 
No clear positive or 
negative impact on 
physiology or 
performance. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
control (loose fit 
breeches) in 
randomised 
order in same 
participant 
 
Non-significant increased 
oxygenation with CG 
compared to control. 
Venous emptying rate 
slightly increased 30min 
after exercise in CG trial 
compared to control. 
Significant increase in skin 
tempareture in CG 
compared to control. 
Increased 
temperature, but not 
enough to cause 
clinical concerns 
related to exercising 
in hot temperatures. 
Vercruyssen, 
et al., 201476 
Randomised 
cross-over 
design 
With CG 
compared to 
control (none) 
11 M 
Trained trail 
runners 
Calf compression 
sleeves 
(18mmHg) 
CG worn 
during 
exercise 
15.6km trail run 
CMJ and MVC 
were performed 
pre- and post-
run. 
No significant changes in 
running times, HR, minute 
ventilation, blood lactate 
concentrations, RPE, MVC 
nor CMJ. 
No significant 
changes in any 
variables considered. 
Welman, 
201141 
RCT 
CG compared to 
placebo socks 
group 
40 M 
Competitive 
runners 
Below knee 
compression 
(20-30mmHg) 
CG worn 
during 
exercise and 
72hrs of 
recovery 
 
OMTOM 56km No statistically significant 
differences were reported 
in race finish times nor in 
CK levels. Significantly 
decreased levels of Mb, 
blood lactate, improved 
VAS pain ratings of the calf, 
hamstrings and quadriceps 
and smaller calf and ankle 
circumferences in CG 
compared to a placebo. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
Wahl, et al., 
201174 
Randomised 
cross-over 
repeated 
measures study. 
Different CG 
conditions in 
randomised 
order in same 
subject. 
9 M 
Well trained 
athletes 
Knee high CG 
compared to control 
in different trials 
 (0, 10, 20, 40mmHg 
respectively) 
CG worn 
during 
exercise 
. 
Four trials of sub-
maximal running 
at 70% of peak 
oxygen uptake for 
30 min followed 
by a ramp test 
until exhaustion 
with different 
degrees of CG. 
No significant differences in 
oxygen uptake, blood 
lactate, HR and time-to-
exhaustion determined by 
a ramp test between the 
levels of compression 
All levels of compression 
had no impact on RBC 
deformability during 
exercise. 
 
RCT – randomised controlled trial 
CG – compression garments 
M – males 
F – females  
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2.4 Compression garments in other sports 
The utilisation of compression garments is not isolated to runners and can be used in a variety of 
different sports and activity settings. Many of these studies in other sporting disciplines also found 
limited or no differences in exercise performance and recovery with compression garments 
compared to usual sporting attire17,19,87.  
2.4.1 Compression garments worn during exercise 
Similar to results in runners, five randomised controlled studies assessing the use of compression 
garments worn during other forms of exercise reported mixed results with no significant results 
reported in half of these83,88,89 and selected significant changes in the rest90,91.  
No significant differences were reported between an experimental group utilising below knee CG 
compared to a control group during an Ironman 70.3 triathlon (i.e. 1.9km swim, 90km bike ride and 
21.1km run) in terms of RPE and muscle soreness, total race time, jump height and leg power following 
the race, nor in Mb and CK blood test results83. Furthermore, no significant differences were reported 
with full leg length CG compared to placebo CG worn during single leg hopping in spatiotemporal and 
kinetic characteristics, or in total duration until volitional fatigue88; nor were any significant differences 
reported with these CG compared to usual sporting attire in handball players in jump and sprint 
performance, rate of force development of knee extensors and plantar flexors or pain pressure 
thresholds of the soleus90. Likewise, upper limb compression sleeves had no effect on subjects’ 
isometric peak torques, muscle activation, ultrasound echo intensity, CK concentrations or perceived 
muscle soreness ratings of the arm compared to those utilising placebo sleeves89. Furthermore, no 
significant changes were found in blood lactate concentration, insulin like growth factor-1, free 
testosterone, Mb, CK, IL-6, interleukin-1 (IL-1) or receptor antagonists with full body CG compared to 
controls in resistance trained men92. The lack of significant changes may show that compression 
garments did not have any impact on EIMD or performance measures considered. However, it is also 
possible that the relatively small sample sizes were insufficient to detect differences between groups 
and/or inter-individual changes. 
In contrast, a few studies have detected significant changes in certain outcome measures. One study 
detected significant improvements (p<0.05) in one-repetition maximum (1RM) recovery rates for 
chest presses and knee extensions as well as lower subjective ratings of muscle soreness and fatigue 
when full body CG were utilised during exercise and recovery as opposed to the control group92. 
Unfortunately the small sample size (n=9) limits the value of generalising the findings to the wider 
population. Likewise, improved MVC of knee extensors were reported for full leg length CG utilised 
during exercise compared to controls in a slightly larger, but still limited sample size of 18 handball 
players90. Another study found significantly decreased blood flow in the quadriceps femoris (p<0.001; 
effect size= 1.55) in six cyclists wearing compression shorts compared to their usual attire, which is 
contrary to the theory of increased circulation to the compressed area and is in contrast to previous 
research17,91,93. Further studies with larger sample sizes would be required to assess the impact on 
blood flow further. 
2.4.2 Compression garments worn during recovery from sport 
Compression garments used during recovery (as opposed to during exercise) in these studies have 
also shown a positive trend in improved outcome measures similar to running related studies. Full leg 
length CG resulted in non-significant improvements in sprint (p=0.22; effect size=0.03) and 3km time 
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trial (p=0.12; effect size=0.23) performance as well as better fatigue ratings (p=0.08; effect size=0.51) 
compared to placebo CG in male rugby players94. Another study in resistance trained individuals 
showed significant improvements (p<0.05) in subjective ratings of vitality, fatigue and pain as well as 
in ultrasound measured swelling, CK concentrations and bench press power in whole body CG 
compared to usual sporting attire95. The same trial found no significant differences in counter-
movement vertical jump performance or circumference measures between groups95. The third study 
found significantly improved (p<0.02) MVC and contractile properties as well as lower pain ratings at 
72hrs (p<0.05) in legs with CGs compared to the opposite legs without CGs96. 
2.4.3 Problematic trends 
Problematic trends in the research relating CG to various other sports is similar to those discussed 
previously. As with running, the majority of sports related studies included predominantly or only male 
subjects (164 men across studies compared to only 17 females), reflecting the paucity of research 
relating to CG utilisation in females in sport. Blinding was also problematic in these studies with only 
one using a single-blind approach (participants blinded)66, and none with double-blinding. This limits 
the validity of results obtained particularly with subjective ratings of pain and fatigue as it may be 
influenced by expectations for CG compared to no intervention. Due to practical constraints previously 
discussed it may not be feasible to include blinding without creating other possible confounding 
variables. Sample sizes of most studies were also all relatively small, which limits the ability to 
generalise results to a wider sports population.  
Table 2.2 presents a summary of randomised controlled studies testing compression garments in 
sports other than running. This illustrates similar problematic trends with sample sizes and 
heterogeneous methodology compared to running related studies. 
2.4.4 Summary of the literature: Compression garments in sport 
Compression garments are commonly used in various sports and modes of activity, despite 
inconsistencies in the literature as to their effectiveness. A common trend in the results of studies 
performed to test compression garments’ impact in various sports other than running were improved 
subjective ratings of RPE and muscle soreness and some improved physical performances measures 
with only isolated improvements in physiological tests and specific sporting performance.  In addition, 
improvements were more common when compression garments were worn during recovery from 
exercise as opposed to only during exercise, which represents the most common timing of utilisation 
for CG. The discrepancies in the literature necessitates further research utilising objective measures 
to assess the true impact of compression garments in sport. 
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Table 2.2: Compression garments in various other sports 
Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
Del Coso, et 
al., 201483 
RCT 
CG vs control 
(regular socks) 
group 
30 M & 4 F 
Triathletes 
Ankle to knee CG 
(60% polyamide, 
25% elastane and 
15% polyester; 
pressure not 
provided) 
Worn 
during 
exercise 
Half ironman 
triathlon 
No significant differences in total 
race time; jump height; leg 
muscle power; RPE; muscle 
soreness; Mb or CK between 
groups. 
No impact of 
compression garments 
on physiology or 
performance. 
Goto 
& Morishima, 
201492 
RCT 
CG vs control 
(regular attire) 
in randomised 
order 
9 M 
Resistance 
rained  
 
Full body CG 
(pressure not 
provided) 
Worn 
during 
recovery 
for 24hrs 
 
Resistance 
exercises; 
1 month apart 
Significantly improved 1RM 
recovery rate in CG group for 
chest press and knee extension; 
lower muscle soreness and 
subjective fatigue scores with CG 
compared to control. 
No significant differences in 
blood lactate, insulin like growth 
factor-1, free testosterone, Mb, 
CK, IL-6, and IL-1 receptor 
antagonist concentration. 
Muscle strength 
recovery improved with 
CG. 
Gupta, et al., 
201588 
RCT 
CG vs placebo 
CG vs no CG in 
same 
participants 
38 M 
Recreational 
activity 
Full leg length CG 
(SkinsTM, pressure 
not provided) 
Worn 
during 
exercise 
Single leg hopping 
to volitional 
fatigue 
No significant difference in total 
duration of tests and between 
conditions for  
spatiotemporal or kinetic 
characteristics between trials. 
No impact detected. 
Hamlin, et al., 
201294 
Randomized 
single-blind 
crossover study 
with CG vs 
placebo CG 
 
22 M  
Well-trained 
rugby union 
Players 
Full leg length CG 
(8.6±2.6 mmHg at 
ankle) 
Worn 
during 
recovery  
3km and sprint 
performance 
Non-significant improvements in 
sprint and 3km time trail 
performance times, fatigue and 
pain ratings in CG compared to 
placebo. 
Improved performance 
and subjective ratings, 
but no change in 
objective blood 
measures. 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
No difference in CK 
concentration. 
Kraemer, et 
al., 201095 
RCT 
CG vs control 
(usual attire) 
11 M & 9 F 
Resistance 
trained 
Whole body CG 
(pressure not 
provided) 
Worn 
during 
recovery 
for 24hrs 
Heavy resistance 
training 
Significant improvements in 
vitality ratings, resting fatigue 
ratings, muscle soreness, bench 
press power and ultrasound 
measured swelling and lower CK 
concentration in CG group 
compared to control. 
No significant differences in 
countermovement vertical jump 
performance or circumference 
measures 
between trials. 
Moderate 
improvements found in 
subjective ratings and 
come physiological and 
physical markers. 
Perrey, et al., 
200896 
RCT 
CG on one leg 
only, opposite 
as control 
8 M 
Healthy, 
recreational 
activity 
Calf CG 
(SupportivTM, 
pressure not 
provided) 
Worn 
during 
recovery 
5hrs per 
day for 3 
days 
Eccentric 
backwards 
downhill walking 
MVT and contractile properties 
of CG leg improved quicker than 
control leg. 
Lower pain ratings in CG leg. 
Improved recovery and 
subjective ratings. 
Pereira, et al., 
201489 
RCT 
CG vs placebo 
control 
22 M 
Resistance 
trained 
Upper limb 
compression 
sleeves 
Worn 
during 
exercise 
Isokinetic 
eccentric/ 
concentric elbow 
flexion repetitions 
No significant differences 
In isometric peak torque, muscle 
activation, ultrasound echo 
intensity, perceived muscle 
soreness or CK concentration. 
No impact detected. 
Ravier, et al., 
201690 
RCT 
cross-over 
design 
18 M 
Handball 
players 
Full-leg length CG Worn 
during 
exercise 
Handball specific 
circuit 
Significantly improved MVC of 
knee extensors.  
No significant difference in jump 
and sprint performance; rate of 
force development of knee 
Improvement in 
isolated measure of 
muscle power only, 
with no improvement 
in other performance 
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Article Study Type Sample Compression 
garments 
Timing Protocol Findings Additional information 
CG vs control 
(usual attire) in 
random order 
 
extension and ankle 
plantarflexion; or pain pressure 
threshold for soleus between 
trials. 
measures or subjective 
ratings. 
Sperlich, et 
al., 201391 
Experimental 
control trial 
with 
 
6 M 
Healthy  
Compression shorts 
(applying 37 
mmHg) on one leg 
only compared to 
usual clothing on 
opposite leg 
 
Worn 
during 
exercise 
Blood flow 
measured in 
hamstrings and 
quadriceps during 
a cycling ramp test 
to exhaustion 
Decreased blood flow was 
detected with CG condition 
during recovery from exercise. 
 
 
 
Contrary to theory of 
enhanced blood flow 
with CG. 
RCT – randomised controlled trial 
CG – compression garments 
M – males 
F – females 
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2.5.1 Review Studies of Compression Garments 
Four systematic reviews over the past decade relating to compression garments in sport were 
identified in the literature. It was unanimously concluded that the impact of compression garments in 
sport remain controversial due to the large heterogeneity between study designs, compression 
garment types, outcome measures, participants and results17,19,20. This is apparent in the studies 
discussed above. 
The findings of the earliest review were that any ergogenic impact of CG worn during exercise is very 
limited, except perhaps with certain explosive activities such as jumping17.  This is in contrast to most 
of the above studies that found no significant differences in jump height or performance83,90 nor in 
counter movement jump tests24,63. One study discussed above did, however, find a reduced 
performance decrement in CMJ when low and medium pressure below knee CG were utilised 
compared to control conditions62. Most of these studies were only performed after this initial review 
was conducted. One out-dated study (1998) considered by MacRae and colleagues17 found 
improvements in mean jumping power output in men and women utilising compression shorts97. In 
addition, the study detected improvements in proprioception and a reduction in muscle oscillations 
on landing with CG compared to control conditions97. Unfortunately, these results have not been 
reproduced in more recent times and these isolated outcomes should be considered with caution.  
The use of CG during recovery showed some promising results in power and torque related outcome 
measures17. The earliest review also mentioned some evidence for enhanced blood flow17, although 
this appears to be limited to one study that detected increased forearm perfusion with upper limb 
compression sleeves compared to controls considered above93. More recently, a reduction in blood 
flow has been detected in cyclists wearing compression shorts91. As increased circulation is one of the 
major theoretical considerations in promoting CG, further research is critical.   
Similar to the studies previously discussed testing compression garments in running and other sports, 
muscle soreness ratings were generally improved, but not in all studies17. Most physiological blood 
markers and swelling measures showed limited or no improvements with compression garments 
compared to controls17. Likewise, the latest meta-analysis of randomised controlled trails for CG in 
sport, reported that blood markers such as CK were not associated with any significant differences 
between experimental and control groups, whereas lactate dehydrogenase may be reduced with CG 
compared to controls20. This is similar to studies discussed above. Blood lactate was also reportedly 
reduced in males utilising CG in the OMTOM 56km previously discussed41. However, even so, the high 
inter- and intra-individual differences among these blood markers brings into question the validity of 
utilising these measures to assess impact20.  
Compression garments have been associated with reduced swelling with the greatest effect seen after 
the second and third days following exercise respectively20. Similarly, the above studies reported 
decreased circumference and swelling measures with lower limb CG18,41. Still, others contradicted 
these findings with no significant reductions in circumference measurements reported63,95. 
In general, there appears to be more support for CG worn during recovery than during running19. This 
is similar to the findings in the studies discussed previously with a trend for more improvements with 
CG used during recovery. However, in practice, athletes appear to utilise these garments more 
commonly during exercise, necessitating further research of this mode of utilisation. 
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One of the systematic reviews included only studies performed in runners98. Similar to the results 
discussed above, a trend for minor improvements in endurance performance was detected with better 
time-to-exhaustion tests, although it was not replicated in all studies98. In contrast, running time trial 
performance across a vast range of running distances from 400m sprints to marathons, did not change 
significantly with utilisation of compression garments compared to control groups98. This echoes the 
results discussed above with the same studies considered with no significant changes in short sprint 
distances78, middle to long distances61–63,69,78, nor in the ultra-endurance event referred to above41.  
The exception was limited improvement reported in a repeated very short sprint distance of 30m65. 
The lack of improvements in cardiopulmonary measures and various physiological and blood marker 
measures mentioned in the review98 also echoes the findings discussed above. As with all of the other 
reviews and the currently discussed studies, psychological improvements were reported with better 
subjective ratings of pain and fatigue17,19,20,98. The mean sample sizes of included studies were 
relatively small with an average of 15 participants (with a range of 6 to 36 participants) per study98, 
therefore results should be interpreted with caution until it is reproduced by studies with larger 
sample sizes. 
One of the issues identified in available research was the large heterogeneity among pressure gradient 
levels applied17,19,20,98. One review assessed this specifically and found that there were no significant 
differences between low and high pressures and the results obtained19.  Beneficial alterations to 
predominantly subjective measures were reported across a wide range of compression gradient levels 
applied, although the underlying mechanism is unclear19. This is similar to findings above with 
subjective improvements often not translating to alterations in objective physiological or performance 
measures, with only isolated or mixed results. Further investigations should aim to identify if there 
are truly benefits related to CG, and if so, establish the underlying mechanisms. 
2.5.2 Summary of review studies of compression garments 
Systematic reviews performed to date to assess the utilisation of CG in various forms of exercise 
concluded that the impact thereof remains controversial as is evident in the studies discussed. The 
same conclusion was drawn from a fourth systematic review considering only runners. A trend for 
improvements in subjective measures such as pain ratings have been observed with limited 
improvements in objective measures with more benefits detected when worn during recovery than 
during exercise alone. 
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2.6 Instrumentation 
2.6.1 Instrumentation for exercise induced muscle damage 
2.6.1.1 Circumference measurements 
Circumference measurements are commonly used to determine the presence of swelling or oedema 
in various body segments. Using a tape measure is a quick, easy and affordable method of determining 
circumferences. 
Tape measurements has specifically been used with high reliability in mid-calf circumference99,100 and 
high validity and reliability in upper limb circumference measures101. The figure-of-8 ankle tape 
measurements has also been used with high validity in detecting oedema with high inter- and intra-
reliability of measurement102–105. A standard error of measurement (SEM) of 0.5cm has been reported 
for mid-calf circumferences106,107. SEM values of 0.47cm105  and 0.44102 have been reported for the 
figure-of-8 ankle circumference measurement method. 
2.6.1.2 Ultrasound and other radiographic imaging 
Ultrasound can be used to obtain a representation of muscle damage following a precipitating event. 
For instance, ultrasound imaging has previously been used to assess muscle damage in male runners 
after inducing delayed onset muscle soreness108. Researchers have investigated changes over time in 
the medial gastrocnemius muscles of the non-dominant legs of participants108. Significantly increased 
(p<0.05) muscle thickness was detected at 48hrs compared to baseline and started to decrease by 
72hrs following DOMS-induction108. Likewise, pennation angles also increased significantly (p<0.05) 
until 48hrs and decreased by 72hrs108. Based on these findings, the peak changes compared to 
baseline should be observed by 48hrs following a race. 
Ultrasound has been included in two previous studies identified in the literature as an alternative 
method to measure muscle echo intensity89 and lower limb swelling95 which may also relate to muscle 
damage. No significant changes were detected in terms of the prior when utilising upper limb 
compression sleeves89. However, the latter study, found significant improvements (p<0.05) in 
ultrasound measured swelling when whole body CG were worn during recovery from resistance 
training compared to usual clothing95. It has not previously been included as an outcome measure in 
research on CG utilisation in runners. However, the results with resistance training individuals 
reported previously indicates its potential for inclusion in future research.  
Diagnostic ultrasound has acceptable validity for assessing trunk muscle size109 and has high inter- and 
intra-reliability for measuring pennation angle and muscle thickness in the medial gastrocnemius 
muscle6,110. Another study found no statistically significant changes in intramuscular swelling after 
repeated eccentric biceps contractions to induce DOMS using diagnostic ultrasound2. 
Other radiographic imaging that may be used to analyse musculoskeletal systems include computed 
tomography (CT) and Magnetic Resonance Imaging (MRI) scans. However, both of these 
measurements tend to be expensive and subjects participants to radiation and enclosed spaces. In 
addition, CT scans may not be able to detect changes in soft tissue structures. Furthermore, muscle 
thickness measurements were similar between ultrasonography, MRI and CT scans111. Ultrasound is 
therefore the most affordable, convenient and suitable alternative measure to obtain a 
representation of possible muscle damage following a precipitating event. 
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2.6.1.2A Pennation angle 
Pennation angle is defined as the angle created between the deep aponeurosis and the muscle 
fascicles’ attachment6. Ultrasound imaging can be utilised to visualise muscle architecture and 
consequently calculate the degrees of angulation between the deep aponeurosis and the muscle 
fascicles6. Values of pennation angles have been obtained from cadaver dissection with values 
obtained for prominent leg musculature112. Based on this study, the average pennation angle is 17o 
for medial gastrocnemius; 8o for lateral gastrocnemius; 25 o for the soleus; 5 o for rectus femoris, vastus 
lateralis and vastus medialis; 15 o for semimembranosus; 5 o for semitendinosis and 23 o for biceps 
femoris long head112. In distance runners, values of 23o for the medial gastrocnemius and 16 o for the 
lateral gastrocnemius have been reported113. A further study reported pennation angle values of 33 o 
(in males) and 32 o (in females) for the right medial gastrocnemius muscle in runners114.  
Pennation angles may be related to muscle strength as greater pennation angles allows for larger 
quantities of contractile muscle tissue to be contained within a certain volume with a consequent 
enhancement of force production115,116. Pennation angles also tend to decrease with age117,118. 
However, endurance runners represent a special population as pennation angles have been reported 
to be greater in certain muscles such as the medial gastrocnemius in endurance runners compared to 
sprinters113. This may be due to shorter fascicle lengths observed in endurance runners and the 
associated lower average velocities during long distance running113. A longer fascicle length may limit 
the alteration in pennation angle usually associated with hypertrophy, which may explain the above 
phenomenon113. This also highlights the complex nature of muscle architecture and adaptation. For 
example, after inducing DOMS, pennation angles have been found to increase transiently for 48hrs 
before starting to return to normal108. Theoretically, this may relate to EIMD related swelling, exerting 
pressure on muscle fibres which may cause an increase in angulation. Furthermore, it has been found 
that pennation angles tend to increase as muscles shorten119. Thus considering that temporary muscle 
shortening may occur with EIMD, pennation angles may increase with the associated reduction in 
ROM. 
The measurement of pennation angle with ultrasound imaging is considered reliable (r>0.8) if 
performed by the same investigator under the same conditions120. Ultrasound imaging has been used 
with high inter- and intra-reliability to measure pennation angles in the medial gastrocnemius 
muscle6,110. Standard error of measurement values of 0.1-1.2o have been reported for pennation 
angles determined by ultrasonography121. 
2.6.1.2B Muscle thickness 
Muscle thickness is defined as the space between the superficial and deep aponeuroses6,118. 
Ultrasound imaging can be utilised to visualise muscle architecture and subsequently calculated by 
measuring the distance between the superficial and deep aponeuroses, usually at the midpoint 
between the proximal and distal musculotendinous junctions6. Previous ultrasound imaging studies 
reported muscle thickness values of 1.97cm and 1.59cm for the medial and lateral gastrocnemius 
respectively in controls compared to 2.10cm and 1.69cm respectively in distance runners113. Another 
study reported right medial gastrocnemius thickness values of 1.8cm and 1.7cm in male and female 
runners respectively114. 
Muscle thickness is also an important factor in predicting muscle strength and greater muscle 
thickness generally related to enhanced force production6,116. Similar to pennation angles, muscle 
thickness tends to decrease with aging115,118. In endurance runners, muscle thickness may increase 
45 | P a g e  
 
slightly compared to controls, but tends to be smaller than in sprinters113. After inducing DOMS, 
muscle thickness has been found to increase compared to baseline108, which may be due to swelling 
related to EIMD. 
The measurement of muscle thickness with ultrasound imaging has been found to be highly reliable 
(r>0.88) when performed on the same day by the same investigator and same conditions120. 
Ultrasound imaging has been used with high inter- and intra-reliability in measuring muscle thickness 
in the medial gastrocnemius muscle6,110. Standard error of measurement values of 0.1-0.4cm have 
been reported for medial gastrocnemius muscle thickness with ultrasonography122. 
2.6.1.3 Subjective ratings 
The Visual Analogue Scale represents a commonly used numerical tool to assess pain among other 
subjective ratings. Generally, a scale of 0-10 is used with 0 representing no pain and 10 representing 
the worst pain imaginable. Participants are instructed to rate their pain with a number based on this 
scale. Visual representations of facial emotions are also sometimes used to visually enhance testing. 
Numerical VAS questionnaires have been used to assess pain with high reliability and validity in many 
research settings123–126. However, it will always remain a subjective rating and is therefore susceptible 
to various internal and external factors. Pain is a biopsychosocial concept influenced by personal 
experience, mood and the external environment127. For example, if someone anticipates that a 
modality will work, is in an amiable mood and have not had any negative experiences related to the 
situation, (s)he may be more likely to give a low VAS rating compared to opposite conditions.  
2.6.1.4 Blood/Serum testing 
Various skeletal muscle enzymes, cytokines and proteins are frequently utilised as markers of the 
physiological and/or pathological state of muscle tissue128. An increase in some of these enzymes is 
typically related to the degree of EIMD and/or other injuries. 
Prominent among these markers of muscle damage, is creatine kinase, an enzyme which transfers to 
interstitial fluid with excess exercise40,128. CK concentrations tend to be most elevated following 
endurance events and remains high for 24 hours before starting to return to resting concentrations129. 
However, there may be vast differences in CK levels amongst individuals as it may be altered by many 
factors including the individual’s age, sex, lean muscle mass and the weather conditions129–131. Other 
commonly used measures include IL-6, as the greatest proportion of this cytokine is produced during 
physical activity132. 
These measure have been used in several previous studies related to compression garment 
use17,39,41,63,133–135. Unfortunately, due to its heterogeneity, studies comparing CK and other blood 
markers may not be the most accurate representation of muscle damage across the spectrum. In 
addition, interpretation of blood tests may be expensive and the invasive nature of testing may lead 
to anxiety and/or associated discomfort in some individuals136.  
2.6.1.5 Summary of instrumentation for exercise induced muscle damage 
Various types of instrumentation has been utilised to assess muscle damage related to exercise and 
running performance. Blood markers of muscle damage include increased concentrations of CK, IL-6, 
IL-1 and Mb following unaccustomed or prolonged exercise; however its value for comparison is 
decreased due to vast inter-individual variations. Ultrasound represents an affordable, safe and 
convenient imaging technique to assess soft tissue and is valid and reliable in detecting muscle 
characteristics such as pennation angles and thickness. Circumference measurements may be used to 
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indicate the degree of swelling of limbs and has been used with high reliability and validity in the lower 
leg. Subjective pain measures are commonly assessed by the VAS rating system and is considered valid 
and reliable, although it is not necessarily indicative of alterations in objective measures. 
2.6.2 Instrumentation for running performance 
2.6.2.1 Time trials and time-to-exhaustion tests  
Assessing performance is an important aspect in the field of sports and physiology and should aim to 
simulate specific skills or capacities required for particular sports or activity types137. Time trials and 
time-to-exhaustion tests are commonly used methods of assessing performance in endurance sports 
such as running or cycling138. Time trials consists of running or cycling until a predetermined endpoint 
such as a distance (i.e. participants aim to reach this in the shortest possible time) or set time (i.e. 
participants aim to cover the greatest work load within this time limit)137,138. Due to the known 
distance or duration, participants are able to pace intensity accordingly138. Time-to-exhaustion tests 
involve performing an activity such as running at a set intensity until volitional fatigue137,138. This test 
may be particularly useful to assess the impact of certain interventions on performance as other 
factors are standardised137.  However, time trials may be a closer simulation of race conditions and 
are therefore considered a more valid predictive performance measure for running or cycling 
competitions137. In addition, a study performed in male runners, found higher reliability rates for 
running time trials compared to time-to-exhaustion tests138. All performance tests should aim to be a 
close replication of actual exercise conditions for more accurate results137.  Fortunately, activities such 
as running may be easier to simulate in laboratory conditions compared to others incorporating a vast 
range of techniques and skills such as tennis or rugby. However, treadmill conditions likely to be 
utilised in a laboratory setting is still different to road running, cross country or trial running 
respectively. Whenever possible, athletes should be assessed within conditions that most closely 
simulate actual competitions. Using a running competition to assess the impact of an intervention on 
performance has the advantage of representing a time trial of actual race conditions. Conversely, it is 
not possible to control other factors such as weather conditions, making comparisons among such 
trials difficult. During races, timing chips such as RaceTecTM are utilised to provide time to 
predetermined points and time to completion for each participant. RaceTecTM is the official timing 
device for the OMTOM event and is internationally accepted as a valid and reliable timing system139. 
2.6.2.2 Other running performance tests 
Numerous other methods have also been utilised in an attempt to measure running performance or 
aspects thereof such as cardiorespiratory fitness, muscle power and endurance. A device to measure 
the rate of oxygen consumption can be utilised in conjunction with an exercise test on a treadmill (for 
running) to determine VO2max or VO2peak values28,64,68,74. Higher values are indicative of 
cardiorespiratory performance and aerobic capacity140. However, lower values are paradoxically 
associated with improved running economy141. Heart rate monitoring devices can also be used as 
indicators of the relative intensity of exercise24,61,70,72,91. If the same absolute intensity is associated 
with a lower HR, it may be indicative of improved training status142.  Other cardiopulmonary measures 
such as minute ventilation, carbon dioxide flow and oxygen saturation may also be utilised, although 
it was not associated with any significant changes related to compression garments in past 
studies63,72,73. 
Muscle power can be determined in various ways depending on the muscle group. 1RM measures are 
commonly used and represents the maximum value an individual can lift once with proper form and 
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technique before fatigue143. It has been utilised with high validity in detecting leg strength143. Maximal 
voluntary contraction tests are also commonly used to test a muscle group such as the knee 
extensors84,90,96 and can be determined through incorporation of electromyography144. Peak torque 
tests can also be performed through isokinetic strength testing89. Other functional tests include bench 
presses, chest presses and squats among others. 
Unfortunately, isolating aspects related to running does not necessarily provide a direct indication of 
running performance145. Therefore, running specific performance testing remains the preferred 
option145. Nonetheless, it may be useful in adjunct to other measures. 
2.6.2.3 Countermovement Jump testing 
Various functional jump tests such as single leg hopping and countermovement jump (CMJ) tests may 
provide insight into spatiotemporal characteristics, muscle power and endurance. The CMJ test 
activates the stretch-shortening cycle146, which may provide insight into muscle power related 
changes for instance following a muscle damage inducing bout of running. CMJ testing has previously 
been performed by runners utilising low and medium pressure CG with improved performance of CMJ 
after a 10km run compared to control conditions reported62. In addition, the CMJ can be performed 
as indication of the degree of loss of muscle power in the lower limb related to EIMD36.  
This test requires participants to start in a static position with their hands on their waist with the hips 
and knees extended to a neutral position. This is followed by a countermovement self-selected squat 
to approximately 90° of knee flexion immediately followed by jumping to maximal capacity while 
keeping the legs extended, and landing with both feet simultaneously147,148. It incorporates the 
stretch-shortening cycle through the downward countermovement36. 
Countermovement jump tests have been used with high reliability and validity in determining 
explosive power measurements in the lower limb when performed on a force place148. A SEM value of 
0.79cm has been reported for CMJ height measurments149. It has also been performed with high 
reliability in determining peak power144, peak force147,150 and peak velocity measures in the lower 
limb147. Furthermore, a relatively recently developed application named MyJump has been found to 
be valid and reliable in CMJ variables compared to CMJ tests performed on a force plate151. Power-, 
force- and velocity-time curves derived from CMJ testing on force plates have been used to provide 
insight into training status between two groups of trained and untrained individuals respectively152.  
In the absence of a force plate, for instance during field experiments, the peak power output (PPO) 
can be estimated with validated formulas. Johnson & Bahamonde (1996) validated the estimation of 
PPO calculated as follows:  
‘Ppeak=(78.6XCMJheight)+(60.6Xmass)-(15.3Xheight)-1308’ 
where Ppeak is PPO (in Watt), CMJheight is the vertical jump height (cm), mass is the body mass (kg) and 
height is stature (cm)153. The standard error for PPO using this formula is 462W153. 
2.6.2.4 Summary of Literature: Instrumentation 
Running time trials and time-to-exhaustion tests are commonly used as it closely simulates actual 
running conditions, with time trials preferred. CMJ tests may be used to estimate lower limb muscular 
power and incorporates the stretch-shortening cycle. Various other measures of cardiorespiratory 
fitness and muscle power may be included in adjunct to this.  
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2.7 Summary of the literature review 
Compression garments, initially utilised in medical practice, was introduced into sporting activities 
such as running with the aim of aiding muscle recovery and improving performance. Its utilisation has 
been tested in various activity modes, with different types of CG and using a variety of outcome 
measures with conflicting results. The heterogeneity among studies has made comparisons difficult 
and its utilisation remains controversial.  
A trend has been found for improvement in subjective measures such as ratings of pain, RPE and 
comfort in the majority, but not all, of the studies identified. Objective measures showed limited 
improvements in measures of swelling, blood/serum testing and almost no changes in 
cardiopulmonary measures.  
Performance benefits were limited with some improvements in time-to-exhaustion, energy cost, 
workload and other variables during treadmill testing in certain studies. There were no significant 
changes in the majority of performance outcome measures. It appears that there is slightly more 
support for wearing CG during recovery as opposed to during exercise based on current literature.  
Various types of instrumentation have been utilised in an attempt to determine the impact of CG on 
EIMD and performance with variable success. Blood/serum markers are commonly used as indicators 
of muscle damage, but the vast inter-individual variability limits the value of comparisons. Ultrasound 
imaging may be a suitable, safe, affordable alternative to assess muscle damage. Time trials and time-
to-exhaustion tests may be used to assess running performance by simulating race conditions either 
in a controlled environment or field conditions. CMJ testing may be used to test lower limb muscle 
power. The advantages and disadvantages of various types of instrumentation should be considered 
carefully before selecting the appropriate measurements for research studies assessing the efficacy 
of compression garments. 
Based on available literature, the efficacy of compression garments are yet to be established. Due to 
the high rate of utilisation in endurance runners, research studies conducted in an attempt to establish 
the impact of compression garments on running performance and muscle recovery rates in this 
population is of utmost importance.  
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CHAPTER 3: Investigation of the impact of below knee compression 
garments on exercise induced muscle damage and performance in 
endurance runners 
Study Procedure 
3.1 Introduction 
The anecdotal popularity of the utilisation of compression garments amongst endurance runners and 
the controversy in the literature regarding its impact as discussed necessitates further research with 
high methodological quality specific to the field of running. This should help to guide the 
appropriateness of their continued use. 
In general, the large heterogeneity between study designs, compression garment types, outcome 
measures, participants, sports and results limit the comparison value among studies currently 
available in the literature17,19,20. The impact of compression garments on exercise induced muscle 
damage and performance in various exercise forms such as running remains controversial17,19,20. 
A vast range of participant characteristics are among the identified issues in the objective assessment 
of the usefulness of CG. For example, gender differences were not accounted for in many of the 
previous studies considered although muscle recovery may differ in men and women for example 
following MVC’s154 or resistance training155. In addition, it is well known that performance times differ 
among the sexes, which may relate to different aerobic capacities and muscle power49. Matching 
groups for gender may help to minimise the effect of these changes. In addition, as discussed in the 
literature review, the research basis has consisted predominantly of males, indicating the need for 
inclusion of females in research studies. Similarly, age related changes to muscle recovery mechanisms 
have also been widely described between the elderly and the very young52,156 and hence accounting 
for age could also impact on results.  
Furthermore, selecting appropriate, valid and reliable outcome measures and instrumentation is 
challenging. Creatine kinase, myoglobin, interleukin-1 and -6 among other blood and serum markers 
are commonly used indicators of muscle damage, yet researchers have mostly failed to detect any 
changes when compression garments have been used compared to controls83,89,92,94. It is unclear if this 
is due to a lack of impact on physiological responses or due to the vast inter-individual variation among 
these measures4. Ultrasound represents an affordable, convenient, suitable alternative measure to 
obtain a representation of possible muscle damage following a precipitating event108. For instance, 
ultrasound imaging has previously been used to assess muscle damage in male runners after inducing 
delayed onset muscle soreness and detected significant increases in pennation angles and muscle 
thickness of the medial gastrocnemius108. 
No previous study has included a significant training period with compression garments, and none 
have allowed familiarisation with compression garments for longer than two weeks. It has been 
suggested that future studies should focus on the utilisation of compression garments during training 
to analyse any additive effect on performance during a race and recovery responses thereafter41,70. 
Previous research including a six week period have proven to be adequate in detecting significant 
changes in parameters of muscle adaptation157,158. Furthermore, following a muscular injury, a period 
of 4-6 weeks is generally recommended for sufficient tissue adaptation for return to activity, 
depending on the severity159. In addition, many programmes for endurance running includes peak 
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distances around 3-6 weeks prior to the race and a tapering period in the final 2-3 weeks160, thus a 6 
week training period will generally include some longer and heavier sessions in training in addition to 
the anticipated tapering period. 
Research of the utilisation of compression garments in runners is still inconclusive98. The current study 
aimed to address the paucity in research by conducting a randomised controlled field experimental 
study.  Previously identified issues in the literature were considered in the design in an attempt to 
shed light on the true impact of compression garments worn during running. 
It was anticipated that the chosen methodology would substantially impact on results obtained to 
provide a more accurate depiction of the effect of below knee compression garments on performance 
and muscle responses during training and participation in endurance running events. The information 
obtained may help to guide decision making for sports health professionals, coaches and athletes 
alike. Since this study was performed as a mini-dissertation, the long term impact of compression 
garments was not determined. However, it may set the grounds for further research in the field.  
3.2 Methodology 
3.2.1 Research design and recruitment 
A randomised controlled field experimental research study was conducted in healthy endurance 
runners participating in the Old Mutual Two Oceans ultramarathon. Prior to initiating the study, ethical 
approval was obtained from the University of Cape Town (UCT)’s Human Research Ethics Committee 
and from the OMTOM event organisers (Appendix A).  
Participants were recruited from the OMTOM data-basis of entrants. The OMTOM organisers 
provided a list of 1685 individuals between the ages of 20-45, residing in the Western Cape (for 
logistical data collection purposes) who entered the 56km race and indicated an interest in 
participating in research studies during the entry process. Each individual provided on the list was 
contacted by means of a bulk e-mail distributing electronic information sheets (Appendix B). 
3.2.1.1 Inclusion criteria 
Long distance runners between the ages of 20 and 45 who were entered for the OMTOM 56km race 
in 2017 were recruited for inclusion in the study. In addition, participants needed to have a minimum 
average training distance of 50km per week and have completed one or more marathons or 
ultramarathons in the 18 months preceding the start of data collection. 
3.2.1.2 Exclusion criteria 
Participants with pre-existing musculoskeletal injuries to the lower limb in the past 3 months and/or 
with any unresolved symptoms from past injuries (based on the screening tool and verified by Nordic 
Musculoskeletal Questionnaire) (Appendix C) were excluded from the study. Furthermore, 
participants with a history of underlying chronic or acute neurological, musculoskeletal, orthopaedic, 
cardiac, endocrine or other medical diseases or complications that may have impacted on safety of 
participation and/or performance (based on screening by the Physical Activity Readiness 
Questionnaire+/PAR-Q+) (Appendix D) were also excluded. In addition, participants who were 
routinely using compression garments and/or were unwilling to train and/or compete with or without 
compression garments based on potential group allocation were excluded. 
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3.2.2 Sampling 
3.2.2.1 Sampling and recruitment 
A sample of convenience was obtained during the recruitment process. Ninety-eight people 
responded to the advertisements sent out per bulk email to OMTOM 56km race entrants between the 
age group specified. Eighty-eight of these individuals showed an initial interest in the study. After 
sending further information and answering any questions or concerns raised, 53 individuals remained 
interested in participating. Reasons for losing interest involved living too far away from the site for 
data collection, lack of monetary reward, or undisclosed (i.e. lack of subsequent response).  
All interested participants (n=53) were screened with a preparatory self-developed online screening 
tool (Appendix E) for a preliminary indication of inclusion and exclusion criteria for eligibility to 
participate. Five participants were excluded from the study due to self-reported lower limb injuries. 
Two further participants were excluded - one indicated that he operated as pacer at the OMTOM 
making it impractical to measure performance, whereas another participant was excluded as she did 
not qualify to participate in the race. Participants were encouraged to ask questions and be satisfied 
with responses electronically (per email), telephonically and/or in person prior to obtaining written 
informed consent (Appendix F) from 46 potentially eligible and willing participants. One participant 
withdrew after being informed of his random allocation to the experimental group due to personal 
preferences (therefore he also did not meet exclusion criteria regarding compression garment use). 
3.2.2.2 Sample size calculation 
With a selected confidence level of 95%, a power of detectability of 80%, a hypothesised difference of 
1.8, and a variance of 4 (based on data from a previous study by Welman, 201141), the required sample 
size was calculated as 19 participants per group. Standard programmes using variants in effect size 
were used for the power calculation. This is similar to the calculations in a prior doctoral dissertation 
for a study performed to test compression garments during the OMTOM 56km race in which some 
significant differences were reported41.  
A minimum of 38 participants (i.e. 19 per group) were required to ensure adequate statistical power. 
Twenty-three participants were initially included for each group in this study. 
3.2.2.3 Random allocation 
The participants were matched based on sex, age and personal best (PB) marathon times (converted 
to pace per kilometre) before being randomly allocated to the experimental or control group (using 
Microsoft excel, 2013 simple randomisation). The experimental group consisted of 22 participants 
who were instructed to train as usual in the final six weeks and participate in the race while wearing 
below knee compression garments (the 23rd participant withdrew at the start of the study). 
Compression garments were thus only worn during running and not during the recovery period. The 
control group consisted of 23 participants who were instructed to neither train nor participate in the 
race with compression garments. Participants were informed regarding allocation and group 
expectations throughout the study prior to the start of data collection. 
3.2.3 Completion of study 
Following baseline screening and data-collection for the initial participants, four did not complete the 
study, with equal numbers from each group. During the training period, one experimental group 
participant withdrew due to thermal discomfort while using the compression garments. A further two 
participants withdrew, one for personal reasons (too busy to attend follow up sessions) and the other 
due to falling ill and consequently being unable to compete in the OMTOM 56km race. At the final 
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visit, one participant did not arrive for his appointment and confirmed telephonically that due to other 
obligations, he would no longer be able to attend.  In addition, for logistical reasons, three participants 
were unable to access the medical tent and missed out on circumference measurements, however 
they were not excluded from the study seeing as data on all other variables were collected. Only the 
data of those participants who completed the study were included in the final report of findings.  
3.3 Measurement instruments 
3.3.1 Screening tools and consent 
3.3.1.1 Informed consent 
Prior to participating in the study, each individual was required to sign written informed consent forms 
to confirm willingness to comply to study procedure, with an emphasis on his/her right to withdraw 
at any point for whatever reason with no detrimental impact on his/her well-being. The informed 
consent form provided information regarding the study purposes, procedure, risks, benefits and 
institution affiliation and participants were encouraged to ask questions if anything was unclear. This 
was to ensure participants were well-informed prior to providing written consent.  
3.3.1.2 Self-developed screening tool 
A screening tool was developed to assess participants’ preliminary eligibility to participate in the study 
based on the inclusion and exclusion criteria. The form was sent to participants electronically to 
complete prior to commencement of further testing. Further screening was performed by means of 
the Nordic Musculoskeletal Questionnaire and the Physical Activity Readiness Questionnaire (PAR-Q+) 
at the first data collection session.  
3.3.1.3 Nordic Musculoskeletal Questionnaire 
Participants were required to complete a revised Nordic Musculoskeletal Questionnaire to screen for 
musculoskeletal conditions specifically in the lower limb that may have impacted on safety of 
participation and performance. If conditions were identified, appropriate referrals would be made for 
further assessment by an appropriate health professional. 
3.3.1.4 Physical Activity Readiness tool 
Participants were required to complete the PAR-Q+ to screen for any medical conditions that may 
have impacted on safety of participation and performance. If conditions were identified, appropriate 
referrals were made for further medical assessment. 
3.3.2 Study instrumentation  
3.3.2.1 Anthropometric measurements 
For group descriptive purposes, the body mass index (BMI) was calculated based on body mass and 
stature measurements. Body mass (kg) was measured with a calibrated digital scale (UWE, BW-150, 
no. 1).   Stature was measured using a mechanical stadiometer (Detecto, UWE-BW-150). The standard 
formula: ‘mass(kg)/stature(m2)’ was used to calculate BMI161. 
3.3.2.2 Time trial with RaceTec timing chips 
The first objective was assessed with RaceTec timing chips as utilised by all runners according to 
OMTOM regulations during the 56km race. Time durations to 42km and 56km respectively was 
obtained online following completion of the race. This information was used to calculate the average 
running pace (min:sec/km) over-all as well as during the first 75% and the final 25% of the race. 
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RaceTec is the official timing device for the OMTOM event. It is considered internationally as a valid 
and reliable timing system and is utilised at many other running events139.  
3.3.2.3 Ultrasound imaging 
The second objective was assessed by measuring the pennation angle and muscle thickness of the 
medial gastrocnemius using ultrasound imaging. A Siemens ACUSON X150 diagnostic ultrasound 
machine was utilised. Brightness mode (B-mode) with musculoskeletal (MSK) setting selected was 
utilised during imaging114. The right leg of participants were tested with the participant in the prone 
position with the ankle positioned in 900 plantarflexion maintained by a firm footplate. Participants 
were instructed to relax the muscle while ultrasound imaging was performed. The mid-point between 
the proximal and distal musculotendinous junctions of the medial gastrocnemius was utilised to obtain 
the scans114. Each measurement was performed at least twice and average values used (Appendix G). 
The same data collector performed all measurements. 
3.3.2.3A Pennation angle 
Pennation angle was calculated as the angle formed between the muscle fascicles and the deep 
aponeurosis6,114. The scan was performed at the midpoint between the proximal and distal 
musculotendinous junctions of the medial gastrocnemius muscle. For each scan, two angles were 
calculated and average values were utilised. 
3.3.2.3B Muscle thickness 
The thickness was calculated as the “distance between the superficial and deep aponeuroses”6,114. The 
scan was performed at the midpoint between the proximal and distal musculotendinous junctions of 
the medial gastrocnemius muscle. For each scan, measurements were taken perpendicularly at the 
middle of each image and the average of two muscle thickness values were utilised. 
An example of pennation angles (PA) and muscle thickness (MT) measurements can be seen in Figure 
2.1 below. 
Figure 2.1: Ultrasound measurements 
 
Original photo by investigator 
 
MT 
PA 
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3.3.2.4 Circumferences with tape measurement 
The third objective was assessed by measuring mid-calf and figure-of-8 ankle circumferences with 
standardised anatomical landmarks with a tape measure (in cm). Participants were positioned in 
sitting with feet extending over the edge of the plinth and instructed to relax the muscles while the 
measurements were taken. The same data collector performed all measurements. 
3.3.2.4A Ankle measurement: 
The ankle circumference was taken with the right ankle in a relaxed neutral position with a 
standardised figure-of-8 method103. Each measurement was performed twice and average values 
used.  
3.3.24B Mid-calf measurement: 
The mid-calf measurement was taken at the widest girth section (standardised protocol162) between 
the ankle malleoli and the fibular head. Each measurement was performed twice and average values 
used.  
3.3.2.5 Visual Analogue Scale for pain ratings 
The fourth objective was assessed with the administration of the VAS questionnaire with subjective 
pain ratings on a scale of 0-10 with 0 representing no pain and 10 representing the worst pain 
imaginable. The numerical VAS scale was adapted and applied to evaluate pain at rest and during 
active NWB lower limb movements. (Appendix H and I.) 
3.3.2.6 Countermovement jump 
The fifth objective was assessed by video recording a CMJ test and analysing data using the MyJump 
application in the three days prior to, upon completion and two days following the race. Peak power 
output was subsequently estimated using the Johnson & Bahamonde (1996)153 formula utilising body 
mass, stature and MyJump App derived CMJ vertical height values. 
An iPhone 6s (Apple Inc., Cupertino, California) sampling at 240 Hz was used to analyse three CMJ trials 
in the right sagittal plane. The camera was secured and positioned in a steady position, level with the 
ground in line with the lateral malleolus, which was used as marker, for each participant.  
The CMJ test was performed based on standardised procedures147,148,151. Participants started in a static 
position with their hands on their waist with the hips and knees extended to a neutral position. 
Participants were then instructed to squat to approximately 90° of knee flexion immediately followed 
by jumping as high and as fast as possible while keeping the legs extended, and landing with both feet 
simultaneously147. Participants were instructed to perform the test to their maximal capability147,148,151. 
After two practice jumps for familiarisation purposes150, three CMJ tests were performed with 30 
seconds of passive rest separating attempts. Average values were calculated. 
3.3.2.7 Self developed questionnaire 
A self-developed questionnaire was utilised to assess records of compression garment utilisation and 
training details during the six week training period. Further self-developed questionnaires were 
utilised to provide a record of fluid and nutrition during the race as well as any muscle recovery 
modalities utilised in the week prior, during or two days following the race5,16. Females were also 
requested to provide information regarding their menstrual cycle and utilisation of the contraceptive 
pill. In addition, participants were questioned regarding any issues that may have occurred during the 
race. This was to provide a qualitative component to account for any possible confounding variables 
such as being ill or cramping during the race. Participants were instructed to refrain from any muscle 
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recovery techniques if possible from one week prior to the race until the final data collection. 
However, if recovery modalities were utilised, participants were asked to report on frequency and 
timing of utilisation. These records served to provide descriptive data on possible confounding factors 
and is reported alongside results. 
3.3.3 Training with instrumentation 
3.3.3.1 Ultrasound training 
The data collector was trained in utilising the Siemens Diagnostic Ultrasound equipment for imaging 
the gastrocnemius muscle by an experienced instructor. A total of four hours under supervision and 
12 hours of independent practice was performed. The pennation angle and muscle thickness of the 
medial gastrocnemius muscle measurements (as described in Section 3.3.2) were performed on seven 
voluntary participants, who were recreationally active. Two of these were also assessed on separate 
days and at different times of the day to establish reliability (r=0.95 for pennation angle and r=0.99 
for muscle thickness obtained). The results of these participants were not included in the research 
study.  
3.3.3.2 Circumference measure training 
The measurements were practiced according to precise specifications (as described in Section 3.3.2) 
on seven voluntary participants. Two subjects were also tested on separate days and at different times 
of the day to establish reliability of the data collector (r=0.98 for figure-of-8 ankle measurement and 
r=0.99 for mid-calf circumference were obtained). The results of these participants were not included 
in the study.  
3.3.4. Compression Garments 
3.3.4.1 Composition 
Commercially available below knee compression garments produced locally were utilised in the study. 
The composition of these garments are 68% polyamide, 30% Drynamix (containing predominantly 
polyester) and 2% elastane fabric. The manufacturers were not financially involved in the study to 
avoid introducing any bias to produce desirable outcomes. The garments utilised were within a price 
range that should be accessible to the majority of South African endurance runners, across the socio-
economic range.  
3.3.4.2 Pressure level 
Due to financial limitations it was not viable to establish the pressure level exerted by the garments 
on each participant. However, the product is advertised to provide light to moderate levels of 
compression. Previous studies have defined light to moderate compression in below knee garments 
as those exerting pressures ranging from 15-21mmHg at the ankle19 and gradually decreasing towards 
the calf. Another classification system categorises light CG as below 20mmHg, medium as between 
20-30mmHG and high as greater than 30mmHg163. No significant change in impact was detected when 
utilising low, medium or high level compression garments19 and considering that low and medium 
level compression has been rated as more comfortable62 this should be the preferred choice. 
3.4 Procedure 
3.4.1 Data collection  
Data collection was performed on four occasions. The initial data collection (Visit 1) was performed 
six weeks prior to the race at UCT’s Division of Exercise Science & Sports Medicine (ESSM) of the 
Department of Human Biology at the Sport Science Institute of South Africa (SSISA). After obtaining 
written informed consent, the Nordic Musculoskeletal Questionnaire164 was administered to verify 
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that participants had been injury-free for 3 months; and the PAR-Q+ questionnaire was administered 
to verify that participants were without any medical condition that could have inhibited safety of 
participation. Each participant’s stature and body mass was measured to calculate BMI for group 
descriptive purposes. Ultrasound imaging was used to determine pennation angles and muscle 
thickness of the medial gastrocnemius muscle and mid-calf and figure-of-8 ankle circumferences were 
recorded with a tape measure. Participants were instructed to refrain from analgesics, NSAIDs, 
excessive alcohol consumption, sports massage, foam rolling, extensive stretching5,16,165 and any other 
muscle recovery strategies from one week prior to OMTOM until completing the final data collection 
visit as far as possible. If utilised, they were requested to keep a record of utilisation. In the three days 
prior to the race (Visit 2), these measurements were repeated. An optional CMJ test recorded using 
the MyJump app was completed by willing participants. In addition, each participant received a 
questionnaire regarding compression garment utilisation and training schedule over the six week 
training period (Appendix J). At the finish line of the OMTOM (Visit 3), circumference measurements 
and VAS pain ratings were repeated in an allocated area of the medical tent facilities. The additional 
CMJ test was completed by the same participants. In addition, reports of nutrition and fluid intake as 
well as possible recovery strategies were obtained (Appendix I). Two days following the event (Visit 
4), the circumference measurements, ultrasound imaging and the optional CMJ tests were repeated 
as above at ESSM, SSISA. VAS pain ratings and records of recovery strategies were obtained (Appendix 
I). Electronic appraisal of results based on RaceTec timing values were obtained for each participant’s 
finish time and 42km split times. This was used to calculate the average race pace to 42km, overall (to 
56km) and during the final 14km. 
(Appendix K). 
3.4.2 Data management 
Autonomy and confidentiality is maintained with representation of data. Hard copies of data are 
stored in a secure, locked cabinet. It was and will only be appraised by the researchers concerned. 
Data is recorded electronically on a password protected personal laptop and secure online Dropbox 
folder (www.dropbox.com). This data is also stored on a removable hard-drive, and stored in a secure, 
locked cabinet along with the hard copies. Electronic records of RaceTec times are available on the 
OMTOM event website (http://www.twooceansmarathon.org.za). However, participants’ identities 
were not linked to the research study on this public accessible site.  
3.4.3 Statistical Analysis 
All statistical analysis was performed with Statisitica software (Statistica13; 2017) and Microsoft Excel 
(2013). Statistical significance was accepted as p < 0.05. 
The Shapiro-Wilk tests for normality were conducted to determine if data were normally distributed. 
The data were considered normally distributed if p > 0.05. All descriptive data (i.e. age, PB marathon 
race pace, weight and height) except BMI were normally distributed. Means and standard deviations 
(SD) were calculated and a t-test for independent samples was performed to determine if there were 
any statistically significant (p<0.05) differences between groups. The median and interquartile range 
was calculated for the BMI. 
The race pace data were normally distributed, therefore means and SD of the average race pace were 
calculated and compared between groups for over-all race pace and during the first 75% and the last 
25% respectively. A repeated measures ANOVA test was performed to assess if there were statistically 
significant (p<0.05) differences among the groups.  
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Muscle architecture values, circumference measurements and CMJ variables were normally 
distributed. Therefore the mean and SD of medial gastrocnemius pennation angles and muscle 
thicknesses, ankle and mid-calf circumferences as well as CMJ height and PPO’s were calculated for 
each period of data collection (Visit 1 to 4).  This data was analysed with Repeated-measures-ANOVA 
tests to compare values between groups at each visit to assess for statistical significance (p<0.05). T-
tests for independent samples were also used to assess if there were significant differences (p<0.05) 
between groups at any point in time. In addition, proportional changes over time were calculated for 
circumference measurements and muscle architecture values over different time frames (i.e. Visit 1 
to 2; Visit 2 to 3; Visit 3 to 4; and Visit 2 to 4) and presented as percentages. Effect sizes of absolute 
and proportional changes over time and between variables at each visit were calculated using Cohen’s 
formula: ‘(mean1-mean2)/SDpooled’166. Values of >0.2 is considered a “small” effect size, >0.5 a 
“medium” effect size and >0.8 a “large” effect size167. Values smaller than 0.2 were considered trivial. 
The smallest worthwhile change (SWC) was determined as: ‘(SD)(0.2)’. These values were compared 
to Standard Error of Measurement values to assess its relative relevance.  Values considered of 
practical significance refers to a large difference (in effect size) which exceeds SWC and therefore may 
be considered to have practical significance regardless of statistical significance. 
The frequency and medians of VAS scores were calculated. In addition, the relative change in VAS 
ratings over time (from visit 3 and visit 4) was determined. As it was not normally distributed, a Mann-
Whitney-U test was performed to assess for statistically significant (p<0.05) differences from Visit 3 
until Visit 4. 
The frequencies (converted to percentages) of responses were recorded for each self-developed 
questionnaire and a Mann-Whitney-U test was performed to determine if there were any statistically 
significant differences between the two groups.  
3.4.5 Ethical considerations 
The study adheres to the principles of the Declaration of Helsinki (2013). It was submitted and 
approved by the University of Cape Town’s, Faculty of Health Sciences, Human Research Ethics 
Committee (HREC REF: 872/2016) (Appendix A). Informed consent was obtained from each participant 
to determine willingness to comply to the study procedure, with emphasis on their right to withdraw 
at any point for whatever reason with no detrimental impact on their well-being. Study participants 
were well-informed of study purposes, procedure, risks and benefits and institution affiliations. All 
data obtained were and will continue to be kept in a secure, locked (hard copies) or password 
protected (electronic copies) location. No personal information was divulged during the study 
procedure and presentation thereof.  
3.4.5.1 Risks and benefits 
No financial remuneration was provided. However, at different phases of the study conduction, all 
participants received cost-free compression garments. In addition, a report of personal results and 
findings have been provided to study participants (Appendix M). Each participant will also receive a 
copy of the over-all study results once it is finalised. Furthermore, the value of the study in a field with 
relative paucity in research was explained to participants with implications regarding the utilisation of 
compression garments in endurance running.  
Anthropometric measures of height and weight, lower limb circumference tape measurements and 
VAS ratings pose no/minimal known risks to participants. Ultrasound as utilised in this study poses 
minimal risks in the assessment of human tissue114,168. The CMJ test also poses minimal risks to 
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participants. None of these measures, including ultrasound, is associated with any discomfort to 
participants. 
3.4.5.2 Significance and Justification 
This investigation differed to previous studies in several ways. Firstly, the study was conducted at an 
actual ultramarathon event. Laboratory conditions may not be an accurate depiction of the natural 
running conditions in which compression garments are mostly utilised. Secondly, the groups were 
matched for sex, age and performance times to account for gender, age and performance related 
differences in running pace and muscle recovery. Thirdly, ultrasound imaging was used to analyse 
objective changes to the medial gastrocnemius muscle between a group training and competing with 
compression garments compared to controls not utilising compression garments. This is the first 
study, to our knowledge, to investigate compression garments in runners by means of ultrasound 
imaging to analyse exercise induced muscle damage.  Only the medial gastrocnemius was used for 
comparison purposes, due to time-constraints (relatively large sample to be tested in short space of 
time with only one ultrasound device available for testing) and, importantly, due to prior research to 
confirm reliability and validity of ultrasound imaging to detect changes in this muscle6,169. Fourthly, 
this study assessed the impact of routine utilisation of compression garments in the final training and 
tapering period to no utilisation at any stage. To our knowledge, no previous study has included such 
a long training component to investigate the impact of routine utilisation of compression garments on 
performance in a long distance running event. Finally, this study investigated performance in the final 
25% of the race in addition to over-all performance. It was anticipated that if compression garments 
decreased muscle damage, changes may only have become apparent following a prolonged period of 
exercise (i.e. following 42km of running). Past studies performed at marathon distances did not find 
statistically significant results in performance63,84.   
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Results 
3.6 Participant flow 
Forty-six eligible and willing participants were recruited for the study of which forty-one remained at 
the final data collection session. The process of recruitment, screening and the four respective data 
collection sessions are summarised in Figure 3.1 below. 
Figure 3.1: Participant flow 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruitment 
Bulk email to OMTOM entrants 
from 20-45 years of age 
(n=1685) 
98 responses received with 53 
possibly eligible and willing to 
participate 
 
Excluded (n=7) 
 Musculoskeletal injuries (n=5) 
 Other: unrelated to inclusion 
and exclusion criteria (n=2) 
Randomized (n=46) 
Allocation & 6 week pre-race 
baseline 
 Allocated to experimental 
group (n=23) 
 Withdrew after allocation 
(n=1) 
 
 
 Allocated to control 
group (n=23) 
 
 
Screening 
Height & weight 
Circumferences 
Ultrasound 
Tapering pre-race baseline 
 Completed data collection 
(n=21) 
 Withdrew (n=1) – thermal 
discomfort 
 
 
 Completed data 
collection (n=21) 
 Withdrew (n=2) – time 
commitment and illness 
 
Circumferences 
Ultrasound 
CMJ test 
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Immediately post-race 
 Completed data 
collection (n=21) 
 Missed data collection 
due to logistics (n=1) 
 
 
 
 
 Completed data collection 
(n=21) 
 Missed data collection due 
to logistics (n=2) 
 
 
 
 
Circumferences 
CMJ test 
VAS pain ratings 
Race times and pace 
Two days post-race 
 Completed data 
collection (n=20) 
 Withdrew (n=1) 
 
 
 
 
Circumferences 
Ultrasound 
VAS pain ratings 
CMJ 
 Completed data 
collection (n=21) 
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3.7 Baseline Data 
3.7.1 Visit 1 
3.7.1.1 Descriptive characteristics 
After matching, random allocation and screening, the experimental group originally consisted of six 
females and sixteen males, whereas the control group consisted of six females and seventeen males. 
At baseline, the average pace calculated from the best marathon times reported in the 18 months 
preceding the study was 06:03 min:sec/km for the experimental group and 06:02 min:sec/km for the 
control group. The average age for the experimental group at the start of the study was 34 years for 
each group respectively. When considering only those who completed the study, the group averages 
remained similar with no statistically significant differences between the groups at any stage. More 
specifically, group descriptive measures of participants who completed the study were not 
significantly different between groups in terms of average age (p=0.57), body mass (p=0.17), height 
(p=0.18), BMI (p=0.78) or reported PB marathon pace times (p=0.98) at baseline. Furthermore, 
analysis of covariance (ANCOVA) revealed no significant differences in descriptive characteristics of 
males and females between the two groups.  
Group descriptive measures of the forty-one participants who completed the study are presented in 
Table 3.1. Only the data of these participants have been considered in further analysis.  
Table 3.1: Descriptive data of participants at completion of study 
 Experimental Group Control Group  
Total 20  21  
Males 14 15  
Females 6 6  
Average pace in PB marathon in  
past 18 months ± SD 
06:04 ± 00:37 min:sec/km  
 
06:04 ± 00:45 min:sec/km  
 
 
Average age ± SD 34 ± 4.8 years 34 ± 6.4 years   
Average body mass ± SD 72.1 ± 10.5kg  76.6 ± 9.9kg  
Average height ± SD 1.7 ± 0.9m  1.8 ± 0.09m   
Median BMI 
(interquartile range) 
24.3kg/m2 
(18.0-28.8 kg/m2) 
 23.8kg/m2   
(20.8-29.0 kg/m2) 
 
SD=standard deviation  
  
3.7.1.2 Baseline circumference measures 
At the initial data collection, six weeks prior to the OMTOM 56km race, circumference measurements 
were similar for the experimental and control groups with figure-of-8 ankle mean measurements of 
54.6 ± 3.9cm and 55.3 ± 3.1cm and mid-calf circumference means of 38.8 ± 3.2cm and 39.4 ± 2.3cm 
respectively. These measurements were normally distributed in both groups as determined by 
Shapiro-Wilk testing (p>0.05). Although the control group circumferences were both somewhat higher 
than the experimental group at the onset of the study, there were no significant differences between 
mean ankle circumferences (p=0.56) or mid-calf circumferences (p=0.39) as determined by t-test for 
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independent groups. Small effect sizes were detected in mean ankle circumference (Cohen’s d=0.2) 
and mean mid-calf circumference (Cohen’s d=0.3) at baseline. 
Baseline circumference measures are presented in Table 3.2 below. 
Table 3.2 Baseline circumference measures 6 weeks prior to the race  
6 week baseline pre-race: Experimental group Control Group Difference between 
groups 
Mean ankle circumference  
measures ± SD  
(n=38) 
54.6 ± 3.9cm 
 (n=19) 
55.3 ± 3.1cm  
 (n=19) 
p=0.56 
Cohen’s d=0.2 
“small” effect size 
Difference in means:  
-0.7cm 
Mean mid-calf circumference 
measures ± SD 
(n=38) 
38.8 ± 3.2cm 
 (n=19) 
39.4 ± 2.3cm 
 (n=19) 
p=0.39 
Cohen’s d=0.3 
“small” effect size 
Difference in means: 
-0.6cm 
n=number of participants 
SD=standard deviation 
  
3.7.1.3 Baseline muscle architecture 
The muscle architecture measurements at baseline were similar for the medial gastrocnemius muscles 
with a normal distribution of data (p>0.05). The pennation angle mean for the experimental group 
was slightly lower at 18.6 ± 1.3o compared to 19.8 ± 2.4o for the control group. Similarly the muscle 
thickness mean of 1.7 ± 0.2cm for the medial gastrocnemius was slightly lower for the experimental 
group than the mean of 1.82 ± 0.2cm for the control group. However, there were no significant 
differences between the two groups, albeit with a tendency towards statistical significance in both 
pennation angles (p=0.06) and muscle thickness (p=0.05). There were medium effect sizes in average 
pennation angles (Cohen’s d=0.6) and muscle thickness (Cohen’s d=0.6) of the medial gastrocnemius 
in the two groups at baseline.  
The baseline muscle architecture measurements for both groups are summarised in Table 3.3 below. 
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Table 3.3 Baseline muscle architecture 6 week prior to the race 
6 week baseline pre-race: Experimental group Control Group Difference between 
groups 
Mean medial gastrocnemius 
pennation angles ± SD  
(n=41) 
18.6 ± 1.3o 
 (n=20) 
19.8 ± 2.4o   
(n=21) 
p=0.06 
Cohen’s d=0.6 
“medium” effect size 
Difference in means:  
-1.2o 
Mean medial gastrocnemius 
thickness ± SD  
(n=41) 
1.70 ± 0.2cm 
 (n=20) 
1.82 ± 0.2cm  
 (n=21) 
p=0.05 
Cohen’s d=0.6 
“medium” effect size 
Difference in means:  
-0.12cm 
n=number of participants 
SD=standard deviation 
3.8 Follow up data 
3.8.1 Visit 2 
In the three days preceding the OMTOM race, when it was anticipated that the runners would be in 
their tapering phase, the circumference measurements and diagnostic ultrasound scans of the medial 
gastrocnemius muscle were repeated. Furthermore, those participants who were willing performed 
an additional countermovement jump test analysed by the MyJump Application.  
3.8.1.1 Tapering baseline circumference measures 
The circumference means remained very similar compared to baseline for ankle and mid-calf 
measurements in both groups. There were still no significant differences and small effect sizes 
detected in the experimental and control groups’ ankle circumference means (p=0.44; Cohen’s d=0.2) 
and mid-calf circumference means (p=0.44; Cohen’s d=0.3). No significant changes over time for ankle 
(p=0.95) or mid-calf (p=0.37) measurements were detected.  
The results of the tapering baseline circumference measurements are summarised in Table 3.4 below. 
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Table 3.4: Tapering baseline circumference measurements 
Tapering baseline pre-race: Experimental 
group 
Control Group Difference between 
groups 
Mean ankle circumference measures 
± SD 
(n=38) 
54.3 ± 3.7cm  
 (n=19) 
54.9 ± 3.2cm 
(n=19) 
p=0.44 
Cohen’s d=0.2 
“small” effect size 
Difference in means: 
 -0.6cm 
Mean mid-calf circumference 
measures ± SD  
(n=38) 
38.8 ± 2.0cm  
 (n=19) 
39.3 ± 2.1cm  
 (n=19) 
p=0.44 
Cohen’s d=0.3 
“small” effect size 
Difference in means:  
-0.5cm 
n=number of participants 
SD=standard deviation 
3.8.1.2 Tapering baseline muscle architecture 
Muscle architecture values changed only by small margins in both groups and data remained within a 
normal distribution (p>0.05). Medial gastrocnemius pennation angle means increased minimally to 
18.7 ± 1.4o in the experimental group and slightly more to 20.5 ± 2.2o in the control group (i.e. less 
than 1o increase in each group). The muscle thickness values also increased to 1.79 ± 0.2cm and 1.90 
± 0.2cm for the experimental and control groups respectively (i.e. an 8mm increase in each group). At 
this point in time, the muscle thickness values were significantly higher (p=0.03) in the control group. 
A medium effect size was detected in muscle thickness at the same point in time, whereas a large 
effect size was detected in mean pennation angles between the two groups at tapering baseline. 
However, there were no significant changes (p=0.70) over the 6 week training period between the two 
groups. The pennation angles were neither statistically significantly different at the tapering baseline 
(p=0.06) nor over time from 6 weeks pre-race to shortly pre-race (p=0.27) between the two groups. 
The results of the tapering baseline muscle architecture of the medial gastrocnemius are summarised 
in Table 3.5 below. 
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Table 3.5: Tapering baseline muscle architecture measurements  
Tapering baseline pre-race: Experimental group Control Group Difference between 
groups 
Average medial gastrocnemius 
pennation angles ± SD  
(n=41) 
18.7 ± 1.4o  
 (n=20) 
20.5 ± 2.2o  
 (n=21) 
p=0.06 
Cohen’s d= 0.9 
“large” effect size 
Difference in means: 
-1.8 o 
Average medial gastrocnemius 
thickness ± SD  
(n=41) 
1.79 ± 0.2cm   
 (n=20) 
1.90 ± 0.2cm  
(n=21) 
p=0.03 
Cohen’s d= 0.6 
“medium” effect size 
Difference in means: 
-0.11cm 
n=number of participants 
SD=standard deviation 
 
3.8.1.3 Tapering baseline countermovement jump measures 
Thirty-five participants agreed to perform the optional CMJ test with eighteen from the experimental 
group and seventeen from the control group. The control group, in accordance with the higher muscle 
architecture values, had a slightly higher average jumping height of 23.1 ± 6.2cm with estimated PPO 
of 2684 ± 1156W compared to 22.5 ± 5.3cm and estimated PPO of 2400 ± 694W in the experimental 
group. The data were normally distributed (p>0.05). Despite the slightly higher mean jump height in 
the control group, there were no statistically significant differences between the groups at this point 
in time in terms of CMJ height (p=0.74) or PPO (p=0.39). A trivial effect size was detected in CMJ height 
(Cohen’s d=0.1) and a small effect size was detected for estimated CMJ PPO (Cohen’s d=0.3) at tapering 
baseline between the two groups. 
The results of the tapering baseline CMJ testing are summarised in Table 3.6 below. 
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Table 3.6: Tapering baseline Countermovement jump measurements 
Tapering baseline: Experimental group Control Group Difference between groups 
Mean CMJ height ± SD 
 (n=35) 
  
22.5 ± 5.3cm  
 (n=18) 
23.1 ± 6.2cm  
 (n=17) 
p=0.74 
Cohen’s d=0.1 
“trivial” effect size 
Difference in means: 
-0.6cm 
Mean calculated PPO ± SD 
 (n=34)* 
2400 ± 694W 
(n=17) 
2684 ± 1156W  
 (n=17) 
p=0.39 
Cohen’s d=0.3 
“small” effect size 
Difference in means: 
-284W 
n=number of participants 
SD=standard deviation 
*missing body mass data for one participant 
3.8.1.4 Additional information 
3.8.1.4A Compression garment utilisation over the 6 week training period 
The majority (65%) of experimental group participants reported utilising the below knee compression 
garments provided for most of their runs, with 30% reporting utilising the compression garments 
during all of their runs. A small percentage reported using compression garments during long runs 
only. The majority of participants (75%) reported that compression garments were utilised 
approximately three to four times per week. The control group confirmed that no compression 
garments were utilised during the six week training period. 
3.8.1.4B Training history over the 6 week period 
The largest percentage (40%) of participants in the experimental group reported running on average 
five times per week, compared to four runs per week over the six week period for the largest 
percentage (33%) of the control group. In general, the average number of runs per week over the six 
week period was quite varied for both groups ranging from three to more than eight in both groups. 
The total distance of running performed per week was 50-59km for 30%, 60-69km for 25% and 70-
79km for a further 30% of the experimental group with the remaining participants reporting above 
and below these distances. The largest percentage (43%) of the control group reported an average 
weekly distance of 50-59km with the vast majority of the remaining participants reporting values 
between the categories of 60-69km, 70-79km and 80-89km per week. A small percentage reported 
values above and below these. This also shows that although all participants reported a minimum of 
50km per week at the start of the study, three of these (two in the experimental group and one in the 
control group) did not maintain the minimum distance of running required to enter the study. 
Furthermore, the majority of individuals from both groups performed other types of training in 
addition to running. The largest percentage of each group reported performing strength training on a 
weekly basis (40% of the experimental group and 48% of the control group). This was followed by 
flexibility, swimming and cycling in both groups. Smaller percentages also reported performing team 
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sports and surfing (classified as “other”) in the experimental group and skill specific training in the 
control group. There were no statistically significant differences detected (p>0.05) between groups 
for any aspect related to the training history.  
The training history of both groups over the 6 week period considered is summarised in Figures 3.2-
3.4 below. 
Figure 3.2: Average number of runs per week 
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Figure 3.3: Average distance per week: 
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Figure 3.4: Additional training types 
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3.8.2 Visit 3 
The circumference measurements and CMJ tests were repeated immediately following the race at the 
medical tent facility adjacent to the finish line. In addition, RaceTec timing frames were obtained once 
results were finalised on the public accessible OMTOM-website  
(http:// www. twooceansmarathon.org.za/events/info/results). 
3.8.2.1 Immediately post-race circumference measures 
The ankle and mid-calf circumference measurements decreased slightly in both groups. There were 
no significant differences between the two groups immediately following the race in terms of average 
ankle circumferences (p=0.67) or mid-calf circumference (p=0.26) measurements.  A trivial effect size 
(Cohen’s d=0.1) in average ankle circumference measurements was detected immediately post-race. 
However, there was a medium effect size (Cohen’s d=0.4) between the two groups in average mid-calf 
circumferences. No significant difference over time in comparison to tapering baseline measurements 
for the ankle (p=0.66) and mid-calf (p=0.27) were detected. 
Circumference measurements obtained shortly following the race are summarised in Table 3.7 below. 
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Table 3.7: Post-race circumference measurements immediately post -race 
Immediately post-race Experimental 
group 
Control Group Difference between 
groups 
Average ankle circumference 
measures ± SD 
 (n=38) 
54.1 ± 3.6cm 
(n=19) 
54.6 ± 3.1cm   
(n=19) 
p=0.67 
Cohen’s d= 0.1 
“trivial” effect size 
Difference in means: 
-0.5 
Average mid-calf circumference 
measures ± SD 
 (n=38) 
38.2 ± 1.9cm  
 (n=19) 
39.0 ± 2.2cm 
(n=19) 
p=0.26 
Cohen’s d= 0.4 
“small” effect size 
Difference in means: 
-0.8cm 
n=number of participants 
SD=standard deviation 
 
3.8.2.2 Immediately post-race countermovement jump measures 
As expected following an ultra-endurance race, the CMJ heights decreased in both groups with mean 
maximum heights of 17.4 ± 7.2cm with estimated PPO of 1874 ± 870W in the experimental group 
compared to 18.9 ± 7.5cm with estimated PPO of 2204 ± 1199W for the control group. This means 
that the experimental group maintained approximately 77% of the original mean height and PPO, 
whereas the control group maintained approximately 81% of the original mean height and PPO. 
However, there were no statistically significant differences between the two groups in terms of CMJ 
height (p=0.54) and estimated PPO (p=0.37) immediately following the race. Small effect sizes in mean 
CMJ height (Cohen’s d= 0.2) and CMJ PPO (Cohen’s d= 0.3) were detected immediately post-race. No 
statistically significant change over time for CMJ height (p=0.68) and PPO (p=0.8) in comparison to 
pre-race values were detected. 
CMJ test characteristics immediately post-race is presented in Table 3.8 below. 
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Table 3.8: Countermovement Jump heights immediately post-race 
Immediately post-race Experimental group Control Group Difference between groups 
CMJ height ± SD 
 (n=35) 
17.4 ± 7.2cm 
 (n=18) 
18.9 ± 7.5cm 
 (n=17) 
p=0.54 
Cohen’s d= 0.2 
“small” effect size 
Difference in means: 
-1.5cm 
Mean calculated PPO ± SD 
 (n=34) 
1874 ± 870W  
 (n=17) 
2204 ± 1199W  
 (n=17) 
p=0.37 
Cohen’s d= 0.3 
“small” effect size 
Difference in means: 
-357W 
n=number of participants 
SD=standard deviation 
 
3.8.2.3 Race performance 
Race pace was calculated from the start until 42km (approximately marathon distance), during the 
final 14km and over-all for the 56km race. The experimental group had an average race pace of 06:23 
± 00.39 min:sec/km up until 42km compared to 06:16 ± 00.52 min:sec/km for the control group with 
a normal distribution of data (p>0.05). During the final 25% of the race, both groups’ race pace 
deteriorated as anticipated with the experimental group averaging 07:16 ± 01.17 min:sec/km 
compared to 07:05 ± 01.19 min:sec/km in the control group. This indicates that both groups’ pace 
deteriorated on average 13% during the final 14km’s of the race compared to the average pace to the 
42km mark (i.e. 87% of the race pace from 0-42km maintained in the final 42-56km of OMTOM). The 
over-all race pace was similar for both groups. There were no significant differences in the pace from 
0-42km (p=0.59), the final 14km (p=0.68) or in the over-all (p=0.60) race pace. A small effect size 
(Cohen’s d=0.3) was detected in average race pace from 42-56km between the two groups. Effect sizes 
were negligible in pace from 0-42km and overall (0-56km). 
Average race pace during different sections of the 56km OMTOM race are summarised in Table 3.9 
below. 
 
 
 
 
 
 
 
71 | P a g e  
 
Table 3.9: Average race pace during 56km OMTOM event  
 Experimental group Control Group Difference between 
groups 
Average pace from 0-
42km ± SD 
 (n=41) 
06:23 ± 00.39 
min:sec/km  
(n=20) 
06:16 ± 00.52 
min:sec/km  
(n=21) 
p=0.59 
Cohen’s d=0.1 
“trivial” effect size 
Difference in means: 
00:07 min:sec/km 
Average pace from 42-
56km ± SD  
(n=41) 
07:16 ± 01.17 
min:sec/km  
(n=20) 
07:05 ± 01.19 
min:sec/km  
(n=21) 
p=0.68 
Cohen’s d=0.3 
“small” effect size 
Difference in means: 
00:11 min:sec/km 
Average pace from 0-
56km ± SD 
 (n=41) 
06:36 ± 00.48 
min:sec/km  
(n=20) 
06:27 ± 00.54 
min:sec/km  
(n=21) 
p=0.6 
Cohen’s d=0.1 
“trivial” effect size 
Difference in means: 
00:09 min:sec/km 
n=number of participants 
SD=standard deviation 
 
3.8.2.4 Subjective pain ratings 
Immediately following the race, the median VAS ratings were slightly lower for the posterior lower 
leg, anterior and posterior upper leg at rest as well as during dorsiflexion, knee extension and knee 
flexion in the experimental group compared to the control group. In contrast, the experimental 
group had slightly higher pain ratings for the anterior lower leg and during plantarflexion compared 
to the control group. The only statistically significant result was detected in the anterior lower leg at 
rest on the right (p=0.03) and left (p=0.04), with the control group reporting a median of 0 compared 
to 2 in the experimental group.  
Pain ratings on VAS scale immediately following the race are presented in Table 3.10 below. 
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Table 3.10: Pain ratings immediately post -race 
Immediately post-race: Experimental 
group 
Control 
Group 
Difference 
between groups  
Difference 
between groups  
Right/Left lower limb: Right Left Right Left Right Left 
Median VAS rating of 
anterior lower leg at rest 
(range) [IQR] 
2                 
(0-8) 
[0.5-5] 
2
(0-80 
 [0.5-
5] 
0 
(0-5) 
[0-2] 
0 
(0-8) 
[0-2] 
p=0.02 
Difference in 
medians: 2 
p=0.04 
Difference in 
medians: 2 
Median VAS rating of 
posterior lower leg at rest 
(range) [IQR] 
1.5 
(0-7) 
[0-3.5]  
1.5 
(0-7) 
[0-
3.5] 
3 
(0-8) 
[0-5] 
3 
(0-8) 
[0-5] 
p=0.53 
Difference in 
medians: -1.5 
p=0.3 
Difference in 
medians: -1.5 
Median VAS rating of 
anterior upper leg at rest 
(range) [IQR] 
1.5 
(0-8) 
[0-5.5] 
1.5 
(0-8)  
[0-
5.5] 
2 
(0-9) 
[0-4] 
2 
(0-9)  
[0-4] 
p=0.42 
Difference in 
medians: -0.5 
p=0.42 
Difference in 
medians: -1.5 
Median VAS rating of 
posterior upper leg at rest 
(range) [IQR] 
2 
(0-9)  
[0-5] 
1.5 
(0-9)  
[0-
4.5] 
2 
(0-8)  
[0-3] 
2 
(0-8)  
[0-3] 
p=0.98 
Difference in 
medians: 0 
p=0.72 
Difference in 
medians: -0.5 
Median VAS rating with 
plantarflexion  
(range) [IQR] 
4 
(0-8)  
[0-7] 
4 
(0-8) 
[0-7] 
3 
(0-8)  
[0-5] 
3 
(0-6) 
[0-5] 
p=0.73 
Difference in 
medians: 1 
p=0.73 
Difference in 
medians: 1 
Median VAS rating with 
dorsiflexion 
(range) [IQR] 
1.5 
(0-7) 
 [0-4] 
1.5 
(0-7) 
[0-4] 
3 
(0-7)  
[0-4] 
2 
(0-7)  
[0-4] 
p=0.6 
Difference in 
medians: -1.5 
p=0.95 
Difference in 
medians: -0.5 
Median VAS rating with 
knee extension 
(range) [IQR] 
2 
(0-9) 
[0-5.5] 
2 
(0-9) 
[0-
5.5] 
4 
(0-9) 
 [0-
6] 
4 
(0-9) 
[0-6] 
p=0.48 
Difference in 
medians: -2 
p=0.47 
Difference in 
medians: -2 
Median VAS rating with 
knee flexion 
(range) [IQR] 
1.5 
(0-8) 
[0-2.5] 
1.5 
(0-8) 
[0-
2.5] 
2 
(0-
9), 
[0-3] 
1.5 
(0-8) 
[0-
2.5] 
p=0.87 
Difference in 
medians: -0.5 
p=0.93 
Difference in 
medians: 0 
*IQR: interquartile range   
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3.8.2.5A Additional information: Nutrition and Fluid during race 
The majority of participants in both groups reported drinking between 3-4 and 5-6 sachets 
(approximately 200ml) of water on average per hour during the race (72% of the experimental group 
and 74% of the control group). In addition, both groups most frequently reported drinking 1-2 or 3-4 
sachets of other fluids per hour during the race (89% of the experimental group and 79% of the control 
group). 
Energy gel intakes were most frequently reported followed by energy bars, potatoes and bananas in 
both groups. Other food types reported included various sweets, biscuits and biltong. There were no 
statistically significant differences detected (p>0.05) between groups in terms of fluid or nutritional 
intake. 
Fluid and nutritional details are captured in Figure 3.5-3.6 below. 
Figure 3.5: Fluid utilisation during OMTOM 56km 
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Figure 3.6: Nutrition during OMTOM 56km 
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3.8.2.5B Muscle recovery strategies pre-race and during race 
Although participants were requested to refrain from using other muscle recovery strategies as much 
as possible from the week prior to until the final data collection, some recovery modalities were 
utilised in both groups. In the week prior to the race, a few participants from each group reported 
utilising stretching, cryotherapy, massage, foam rolling, nutritional supplements and electrical therapy 
modalities. The frequencies were similar between the two groups with no statistically significant 
differences detected between groups for any modality (p>0.05). 
On race-day small percentages from each group reported using analgesics and anti-inflammatory 
medication, with a slightly higher percentage of utilisation reported in the experimental group. In 
addition, some participants from both groups reported utilising taping, nutritional supplements, post-
race massage and stretching with similar values reported between groups. There were no statistically 
significant differences detected between groups for any modality (p>0.05). 
Recovery modalities utilised in race week and on race day are summarised in Figure 3.7-3.8 below. 
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Figure 3.7: Race week modalities 
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Figure 3.8: Race-day modalities 
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3.8.2.5C Additional information: Menstruation history in female participants 
80% (n=4) of the females in the experimental group reported abnormal menstruation, with the 
majority reporting contraceptive use. In contrast, 80% (n=4) of the females in the control group 
reported normal menstruation with slightly less reporting contraceptive use. These differences were 
not statistically significant (p>0.05) and due to the small female sample size, it should be interpreted 
with caution. 
3.8.3 Visit 4 
The final data collection occurred two days following the completion of the race. Circumference 
measurements, diagnostic ultrasound scans, CMJ heights and VAS pain ratings were repeated.  
3.8.3.1 Two days post-race circumference measures 
The ankle circumference measurements were very similar in both groups compared to immediately 
post-race with a mild increase in the control group only. Mid-calf circumference measurements 
increased marginally on average to 38.8 ± 1.9cm for the experimental group and 39.7 ± 2.2cm for the 
control group. There were no significant differences in ankle measurements (p=0.39) or calf 
measurements (p=0.37) between the groups two days following the race. Small effect sizes were 
detected in average mid-calf (Cohen’s d=0.4) and ankle circumference (Cohen’s d=0.4) measurements 
two days post-race. There were also no significant changes from race day to two days post-race 
between groups for mid-calf circumference means (p=0.39). However, the ankle figure-of-8 
circumference means changed significantly from immediately post-race to two day post-race (p=0.01). 
The latter implies that the control group values increased statistically significantly more than the 
experimental group over the two day period.  
The circumference measurements are summarised in Table 3.11 below. 
Table 3.11: Circumference measurements two days post -race 
Two days post-race: Experimental group Control Group Difference between groups 
Average ankle 
circumference measures 
± SD 
 (n=38) 
54.1 ± 3.7cm 
 (n=19) 
55.1 ± 3.2cm  
 (n=19) 
p=0.39 
Cohen’s d=0.4 
“small” effect size 
Difference in means: 
-1cm 
Average mid-calf 
circumference measures 
± SD 
 (n=38) 
38.8 ± 1.9cm 
  (n=19) 
39.7 ± 2.2cm  
 (n=19) 
p=0.37 
Cohen’s d=0.4 
“small” effect size 
Difference in means: 
-0.9cm 
n=number or participants 
SD=standard deviation 
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3.8.3.2 Two days post-race ultrasound measures 
Ultrasound scans of the medial gastrocnemius muscle revealed that mean pennation angles increased 
slightly (less than 1o) in both groups to 19.2 ± 1.4oand 20.9 ± 2.3o in the experimental and control 
groups respectively, whereas muscle thickness values were very similar compared to tapering baseline 
values. Pennation angles (p=0.01) and muscle thickness (p=0.02) were significantly higher in the 
control group compared to the experimental group. A large effect size (Cohen’s d=0.9) was detected 
in mean pennation angles two days post-race, whereas a medium effect size (Cohen’s d=0.7) was 
detected in mean muscle thickness of the medial gastrocnemius. However, there were no significant 
changes in pennation angle means (p=0.92) or muscle thickness (p=0.93) over time from tapering 
baseline to post-race values. 
The muscle architecture values are summarised in Table 3.12 below. 
Table 3.12: Muscle architecture values two days post-race 
Two days post-race: Experimental group Control Group Difference between 
groups 
 
Average medial gastrocnemius 
pennation angles ± SD 
 (n=41) 
19.2 ± 1.4o 
 (n=20) 
20.9 ± 2.3o   
 (n=21) 
p=0.01 
Cohen’s d=0.9 
“large” effect size 
Difference in 
means: 
-1.7 o 
 
Average medial gastrocnemius 
thickness ± SD 
 (n=41) 
1.78 ± 1.7cm   
 (n=20) 
1.91 ± 2.0cm  
 (n=21) 
p=0.02 
Cohen’s d=0.7 
“medium” effect 
size 
Difference in 
means: 
-0.13cm 
 
n=number or participants 
SD=standard deviation 
 
3.6.5.3 Two days post-race CMJ measures 
CMJ performance improved by two days post-race compared to immediately post-race for both 
groups but still remained lower than pre-race values with jump heights of 19.9 ± 6.0cm  (PPO: 2242 ± 
808W) in the experimental group and 21.2 ± 6.8cm (2532 ± 1173W) in the control group. However, 
these differences were not statistically significant between groups at two days post-race in terms of 
CMJ heights (p=0.57) or PPO (p=0.41). Small effect sizes in mean CMJ height (Cohen’s d=0.2) and mean 
estimated PPO (Cohen’s d=0.3) were detected two days post-race. No significant changes were 
detected over time from immediately post-race until two days post-race in CMJ height (p=0.84) or 
CMJ PPO (p=0.77). 
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The CMJ heights two days following the race are summarised in Table 3.13 below. 
Table 3.13: Countermovement jump 2 days post-race 
 Experimental group Control Group Difference between groups 
CMJ height ± SD 
 (n=35) 
  
19.9 ± 6.0cm 
(n=18) 
21.2 ± 6.8cm 
(n=17) 
p=0.57 
Cohen’s d=0.2 
“small” effect size 
Difference in means: 
-1.3cm 
Mean calculated PPO ± SD 
 (n=34) 
2242 ± 808W 
(n=17) 
2532 ± 1173W 
(n=17) 
p=0.41 
Cohen’s d=0.3 
“small” effect size 
Difference in means: 
-290W 
n=number of participants 
SD=standard deviation 
 
3.8.3.3 Two days post-race subjective pain ratings 
Two days following the race, VAS pain ratings were very similar at rest and with non-weight bearing 
movements for both groups. There were no significant changes between groups at this point in time 
(see Table 3.14). However, the control group reported significantly reduced pain ratings from 
immediately post-race until two days post-race compared to the experimental group while performing 
dorsiflexion and knee extension with the right leg (but not the left leg), respectively. No further 
significant changes over time were detected. 
The VAS pain ratings obtained two days following the race are summarised in Table 3.14 below. 
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Table 3.14: Pain ratings 2 days post-race 
Two days post-race: Experimental 
group 
Control 
Group 
Difference 
between groups 
Difference 
between groups 
 Right Left: Right Left: Right: Left: 
Median VAS rating of 
anterior lower leg at rest 
(range) [IQR] 
0.5 
(0-6) 
[0-2] 
0.5 
(0-6) 
 [0-2] 
0 
(0-2) 
[0-0] 
0 
(0-2) 
[0-0] 
p=0.1 
Difference in 
medians: 0.5 
p=0.1 
Difference in 
medians: 0.5 
Median VAS rating of 
posterior lower leg at rest 
(range) [IQR] 
 1 
(0-3) 
 [0-1] 
1 
(0-3) 
[0-1] 
0 
(0-3) 
[0-1] 
1 
(0-3) 
[0-1] 
p=0.58 
Difference in 
medians: 1 
p=0.58 
Difference in 
medians: 0 
Median VAS rating of 
anterior upper leg at rest 
(range) [IQR] 
1 
(0-5) 
[0-2.5] 
1.5  
(0-5) 
[0-
2.5] 
1 
(0-8) 
 [0-2] 
1 
(0-7) 
[0-2] 
p=1 
Difference in 
medians: 0 
p=0.8 
Difference in 
medians: 0.5  
Median VAS rating of 
posterior upper leg at rest 
(range) [IQR] 
0.5 
(0-8) 
[0-2] 
0.5 
(0-8) 
[0-2] 
1 
(0-8) 
[0-1] 
1 
(0-8) 
[0-1] 
p=0.76 
Difference in 
medians: -0.5 
p=0.76 
Difference in 
medians: -0.5 
Median VAS rating with 
plantarflexion 
(range) [IQR]  
1.5 
(0-8) 
[0.5-3] 
1.5 
(0-8) 
[0.5-
3] 
1 
(0-6); 
[0-2] 
1 
(0-6) 
[0-2] 
p=0.53 
Difference in 
medians: 0.5 
p=0.53 
Difference in 
medians: 0.5 
Median VAS rating with 
dorsiflexion 
(range) [IQR] 
1.5 
(0-8) 
[0.5-2] 
1.5 
(0-8) 
[0.5-
2] 
1 
(0-3) 
[0-1] 
1 
(0-3) 
[0-1] 
p=0.12 
Difference in 
medians: 0.5 
p=0.12 
Difference in 
medians: 0.5 
Median VAS rating with 
knee extension 
(range) [IQR] 
2.5 
(0-6) 
[1-4] 
2.5 
(0-7) 
[1.5-
4] 
2 
(0-6) 
 [1-4] 
2 
(0-6) 
 [1-
4] 
p=0.47 
Difference in 
medians: 0.5 
p=0.47 
Difference in 
medians: 0.5 
Median VAS rating with 
knee flexion 
(range) [IQR] 
2 
(0-8) 
[0.5-3] 
2 
(0-8) 
 [0.5-
3] 
1 
(0-8) 
[0-2] 
1 
(0-8) 
[0-2] 
p=0.2 
Difference in 
medians: 1 
p=0.2 
Difference in 
medians: 1 
*IQR: interquartile range   
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3.8.3.4A Additional information: Muscle recovery strategies post-race 
Both groups reported using nutritional supplements, stretching, analgesics and anti-inflammatory 
medication since completing the race. Other recovery strategies utilised included massage 
(experimental group only), foam rolling and “other” (mostly alcohol consumption reported). The 
utilisation of recovery modalities was varied in both groups with no statistically significant difference 
(p>0.05) between the groups. 
The recovery modalities reportedly utilised in each group in the two days following the race is 
summarised in Figure 3.9 below. 
 
Figure 3.9: Post-race modalities 
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3.8.3.4B Additional information: Other issues 
Additional issues were reported for both groups. In the experimental group, complaints during the 
race included dizziness (two participants), stomach cramps (one participant), quadriceps cramps (one 
participant) and other musculoskeletal complaints i.e. lower back pain and knee pain (two 
participants). Another experimental group participant reported having flu in the week prior to the 
race, whereas another said he ran slower than usual for personal reasons. It seems unlikely that any 
of these issues are related to compression garment utilisation. 
In the control group, three participants reported falling and one reported calf cramps. None of these 
issues are likely to be related to not wearing compression garments. Over-all, additional, unrelated 
complaints were lower in the control group than the experimental group.  
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3.9 Changes over time of main outcomes 
3.9.1 Circumference measurements 
Over the period from six weeks pre-race until two days post-race, there were no significant changes 
over time in mid-calf (p=0.75) or figure-of-8 ankle (p=0.34) mean measurements in the experimental 
compared to the control group. In both groups, mid-calf circumferences remained similar during the 
two pre-race visits, with a decrease immediately post-race followed by an increase by two days 
following the race.  
The mid-calf measurements remained virtually unchanged over the training period with a 0.05 ± 1.5% 
average increase in the experimental group compared to a 0.3 ± 1.8% decrease in the control group. 
Following the race, values decreased on average 1.4 ± 1.3% in the experimental group compared to 
0.9 ± 1.7% in the control group. By two days following the race, these values increased on average 1.8 
± 1.2% in the experimental group compared to 1.5 ± 1.2% in the control group. There were no 
statistically significant differences between the two groups in terms of proportional changes in mid-
calf measurements during the training period (p=0.54); from shortly pre-race until immediately post-
race (p=0.26) or two days post-race (p=0.64); nor from immediately post-race until two days post-race 
(p=0.35). None of these relative percentage changes to mid-calf measurements were statistically 
significant over time between the two groups (p>0.05). Furthermore, there were small effect sizes 
from six weeks pre-race until shortly pre-race in proportional (Cohen’s d=0.3) and absolute values 
(Cohen’s d=0.2; SWC=-0.1cm); from shortly pre-race until immediately post-race in proportional 
(Cohen’s d=0.4) and absolute values (Cohen’s d=0.4; SWC=-0.1cm); from immediately post-race until 
two days post-race in proportional (Cohen’s d=0.3) and absolute (Cohen’s d=0.4; SWC=0.06cm) 
change; as well as in proportional (Cohen’s d=0.2) and absolute (Cohen’s d=0.4, SWC=0.1cm) change 
from shortly pre-race until two days post-race. The smallest worthwhile changes and differences in 
means were smaller than the standard error of measurement of 0.5cm106,107 hence it is unlikely to be 
significant. The effect size of the absolute change in mid-calf measurements from tapering baseline 
until two days post-race was trivial (Cohen’s d=0.1). 
The figure-of-8 ankle measurements remained virtually unchanged over time in the experimental 
group with an average reduction of 0.6 ± 1.2% over the training period, a further minimal decrease of 
0.2 ± 1.9% until immediately post-race and 0.3 ± 1.2% until two days post-race. The control group also 
remained virtually unchanged over the training period with a 0.2 ± 2.2% decrease over the six week 
period. These values decreased a further 1 ± 2.6% until immediately post-race and increased 0.8 ± 
1.5% by two days following the race. There were no significant differences in proportional changes of 
ankle measurements over the training period (p=0.48); from tapering baseline to immediately post-
race (p=0.31) or two days post-race (p=0.5). However, from immediately post-race until two days post-
race, the absolute ankle measurements (p=0.01) and the proportional difference (p=0.01) changed 
significantly over time in the two groups, with higher values in the control group. There were small 
effect sizes from six weeks until shortly pre-race in proportional (Cohen’s d=0.2) and absolute (Cohen’s 
d=0.3; SWC=0.2cm) change; from shortly pre-race until immediately post-race in proportional 
(Cohen’s d=0.3) and absolute (Cohen’s d=0.4; SWC=0.2cm) change; as well as from shortly pre-race 
until two days post-race in proportional (Cohen’s d=0.4) and absolute (Cohen’s d=0.2; SWC=0.2cm) 
change. These small effect sizes are unlikely to be significant since the changes in the means and SWC 
are smaller than the standard error of measurement of 0.4cm102. However, there was a large effect 
size from immediately post-race until two days post-race in proportional (Cohen’s d=0.9) and absolute 
(Cohen’s d=1.1; SWC=0.1cm) change, with the change in means (-0.7cm) exceeding the SEM.  
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The absolute circumferences measurement changes over time are presented in Figure 3.10-3.11 
below. 
Figure 3.10: Ankle circumference means over time 
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Figure 3.11: Mid-calf circumference means over time 
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3.9.2 Muscle architecture values 
Both groups showed an increase in pennation angles and muscle thickness from the start until the 
completion of the study. Muscle thickness of the medial gastrocnemius increased on average 4.3 ± 
7.9% in the experimental group and 4.8 ± 7.7% in the control group from six week pre-race until shortly 
pre-race. There was no statistically significant changes between the two groups (p=0.83) as 
determined by t-test for the normally distributed proportional (%) changes in muscle thickness over 
the six week period. A further increase was detected in both groups from shortly pre-race until two 
days post-race, with an average increase of 1.1 ± 4.6% in the experimental group and 0.8 ± 5.9% in the 
control group. This proportional (%) change was not statistically significant (p=0.86) between groups 
from shortly pre-race until two days post-race. In addition, there were no statistically significant 
changes between the two groups over time in absolute values of muscle thickness (p=0.91) 
throughout the study. Effect sizes were trivial for average muscle thickness proportional (Cohen’s d= 
-0.06) and absolute (Cohen’s d=0.1) change from six weeks pre-race until shortly pre-race; as well as 
from shortly pre-race until two days post-race in proportional (Cohen’s d=0.05) and absolute (Cohen’s 
d=0.03) values.  
Pennation angles increased from the first until the final data collection in both groups. The 
experimental group’s pennation angles increased slightly with an average of 0.5 ± 8.8% from 6 weeks 
until tapering baseline, whereas the control group increased 4 ± 10.7% on average over the training 
period. There were no significant proportional changes between the two groups over the training 
period (p=0.25). A further average increase of 3 ± 7.6% was observed from tapering baseline until two 
days following the race in the experimental group compared to an average of 2.6 ± 9.4% increase in 
the control group.  This change from tapering baseline to two days post-race was also not statistically 
significant between groups (p=0.89). There were no statistically significant changes over time between 
the two groups in absolute values for pennation angles (p=0.46) throughout the study. There was a 
small effect size in average proportional (Cohen’s d=0.3) and absolute (Cohen’s d=0.4; SWC=0.4o) 
pennation angle changes from six weeks pre-race until shortly pre-race. However, this is unlikely to 
be of significance since the change in the means was smaller than the standard error of measurement 
of 0.1-1.2o121. Effect sizes from shortly pre-race until two days post was trivial in proportional (Cohen’s 
d=0.04) and absolute (Cohen’s d=0.04; SWC=0.2o) pennation angle changes. 
The absolute muscle architecture measurements over time are presented in Figure 3.12-3.13 below. 
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Figure 3.12: Medial gastrocnemius muscle thickness changes over time 
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Figure 3.13: Medial gastrocnemius muscle pennation angle changes over time 
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3.9.3 CMJ heights 
Both groups decreased from pre-race to immediately post-race and regained most of the original 
jumping height and estimated PPO by two days following the race. However, there were no 
statistically significant differences between the groups over time in CMJ height (p=0.87) nor in 
estimated PPO (p=0.94).  
The CMJ height reduced on average 24 ± 23% in the experimental group and 17 ± 26% in the control 
from the tapering baseline pre-race until immediately post-race, with a small effect size in 
proportional change (Cohen’s d=0.3) detected. The absolute change in CMJ height had a trivial effect 
size (Cohen’s d=0.01; SWC=1.3cm). The estimated CMJ PPO reduced on average 31 ± 35% in the 
experimental group and 17 ± 25% over the same period, with a medium effect size in proportional 
change (Cohen’s d=0.5) and trivial effect size in absolute change (Cohen’s d=0.08; SWC=104W) 
detected. The average CMJ height increased on average 14 ± 20% in the experimental group and 9 ± 
25% in the control group from immediately post-race until two days post-race, with a small effect size 
in proportional change (Cohen’s d=0.2) and a trivial effect size for absolute change (Cohen’s d=0.05; 
SWC=1.1cm) detected. The average estimated CMJ PPO increased by 32 ± 56% in the experimental 
group and 13 ± 21% in the control group over the same period, with a medium effect size in 
proportional change (Cohen’s d=0.5) and trivial effect size in absolute change (Cohen’s d=0.1; 
SWC=64W) detected. The small effect sizes in CMJ heights may be of significance since the SWC 
exceeds the standard error of measurement of 0.8cm149. In contrast, the medium effect sizes in PPO 
are unlikely to be of significance, since the changes in the means and SWC are smaller than the SEM 
of 464W153 reported. 
The absolute CMJ jump heights and PPO changes over time are presented in Figure 3.14-3.15 below. 
Figure 3.14: CMJ heights changes over time 
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Figure 3.15: Average peak power output changes over time 
 
3.9.4 Race performance 
Both groups had a slower running pace per kilometre during the final 25% of the race compared to 
the first 75%; however there were no significant changes between groups at any point in time, nor 
over-all (p=0.97). Effect sizes were trivial in both proportional (Cohen’s d=0.02) and absolute (Cohen’s 
d=0.04) changes in pace from 0-42km compared to 42-56km pace between the groups. 
The race pace to 42km and during the final 14km are presented in Figure 3.16 below. 
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Figure 3.16: Average race pace during different stages of the 56km OMTOM race 
P
a
c
e
 f
ro
m
 0
-4
2
k
m
P
a
c
e
 f
ro
m
 4
2
-5
6
k
m
5
6
7
8
9
M e a n  p a c e  d u rin g  5 6 k m  O M T O M  ra c e  o v e r s e g m e n ts
R
a
c
e
 p
a
c
e
 (
m
in
:s
e
c
/k
m
)
E x p e r im e n ta l g ro u p
C o n tro l g ro u p
 
3.9.5 Subjective pain ratings 
The control group had a significantly greater improvement in median VAS pain rating during 
dorsiflexion (p=0.03) and during knee flexion (p=0.04) of the right leg, but interesting this was not 
reciprocated in the left leg. There was a trend for decreased pain rating by two days following the 
race, yet no other statistically significant changes were detected over time.  
The relative change in rating from immediately post-race until two days post-race are presented in 
Figure 3.17 below.
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Figure 3.17: Difference in pain ratings from immediately until two days post-race
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3.10 Summary of significant main outcomes 
No statistically significant changes were detected between the two groups from six weeks prior to the 
race until two days following the race for any of the main objective outcome measures i.e. 
circumferences, medial gastrocnemius muscle thickness and pennation angles, CMJ heights and race 
performance.  
There was, however, a statistically significantly (p<0.05) increase in absolute and proportional ankle 
circumference measurements from immediately post-race until two days post-race in the control 
group compared to the experimental group. In addition, a large effect size in proportional (Cohen’s d= 
-0.9) and absolute change (Cohen’s d=1.1) for ankle circumference measurements was detected. The 
difference in absolute change in means (-0.7cm) exceeds the SEM (0.44cm102), hence this finding is 
significant. 
Small effect sizes were detected in mean proportional and absolute ankle circumference 
measurements changes respectively from 6 weeks baseline until tapering baseline (Cohen’s d=0.2 and 
d=-0.3; SWC=0.2cm; difference in means:0.25cm); from tapering baseline until immediately post-race 
(Cohen’s d=0.3 and d=0.4; SWC=0.2cm; difference in means:0.25cm); as well as from tapering baseline 
until two days post-race (Cohen’s d=0.4 and d=-0.4; SWC=0.2cm; difference in means:0.2cm). Since the 
SWC and difference in means are smaller than the SEM (0.44cm102), these findings are unlikely to be 
of significance.  
Small effect sizes were also detected in mean proportional and absolute calf circumference changes 
from 6 weeks baseline pre-race until tapering baseline (Cohen’s d=0.3 and d=0.2; SWC=-0.1cm; 
difference in means=0.1cm); from tapering baseline until immediately post-race (Cohen’s d=-0.4; 
SWC=-0.4cm; difference in means=0.2cm); from immediately post-race until two days post-race 
(Cohen’s d=0.3; SWC=0.1cm; difference in means=0.1cm); as well as from tapering baseline until two 
days post-race (Cohen’s d=0.2; SWC=0.1cm; difference in means=-0.1cm). The SWC and difference in 
means is smaller than the SEM (0.5cm106,107) hence these findings are once again unlikely to be of 
significance. 
Small effect sizes were detected in mean proportional change in CMJ height from tapering baseline 
until immediately post-race (Cohen’s d=03); and from immediately post-race until two days post-race 
(Cohen’s d=0.2). Medium effect sizes were detected in CMJ PPO over the same time periods (Cohen’s 
d=-0.5 and d=0.5 respectively). The absolute changes in CMJ height and PPO over time had trivial effect 
sizes. The small effect sizes in CMJ heights may be of significance since the SWC (1.3cm; 1.1cm) 
exceeds the SEM (0.8cm149).  In contrast, the medium effect sizes in PPO are unlikely to be of 
significance, since the changes in the means (-41W; 64W) are smaller than the SEM (462W153) .  
Small effect sizes were detected in mean proportional (Cohen’s d=0.3) and absolute (Cohen’s d=0.4) 
pennation angle changes from 6 weeks baseline pre-race to tapering baseline pre-race. However, the 
effect size was trivial from tapering baseline until two days post-race. In addition, effect sizes were 
trivial in mean proportional muscle thickness changes over time. Since the SWC (0.2cm) and difference 
in means (-0.6cm) are smaller than the SEM (0.1-1.2o 121), these findings are unlikely to be of 
significance. 
At certain points in time, selected variables were also statistically significant between the two groups. 
The muscle thickness mean was significantly higher in the control group shortly pre-race (p=0.02) as 
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well as two days post-race (p=0.02). The pennation angle mean was also significantly higher (p=0.01) 
in the control group post-race, but not at any of the prior three data collection sessions.  
The control group had statistically significant lower pain ratings in the anterior shin (p=0.03 on right 
and p=0.04 on left) immediately post-race, but this did not persist by two days post-race. In addition, 
the pain ratings improved statistically significantly (p<0.05) more in the right leg with dorsiflexion 
and knee flexion from immediately post-race until two days post-race in the control group compared 
to the experimental group.  
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Discussion 
3.11.1 Introduction 
Compression garments are utilised by numerous runners during training and competitions, despite 
paucity in research in support of a favourable impact11,20. Inconclusive results reported in past studies 
led some authors to suggest that a training period may be necessary to assess the additive impact of 
compression garments41,70. The current study aimed to address this through conducting a randomised 
controlled trial to compare exercise induced muscle damage and performance of ultra-endurance 
runners training and competing with below knee CG compared to those training and competing with 
conventional socks.  
Only limited statistically significant changes over time in measures of exercise induced muscle damage 
and race performance were found between the two groups. Many previous studies also failed to 
detect statistically significant differences in related outcome measures24,61,72–76,78. The ankle 
circumference measurements did, however, increase significantly more in the control group 
compared to the experimental group from immediately post-race until two days post-race, when 
swelling associated with exercise-induced muscle damage is expected to peak4. This was accompanied 
by a large effect size in both proportional and absolute ankle circumference change over this period. 
Medial gastrocnemius parameters (pennation angles and muscle thickness) were also statistically 
significantly larger in the control group compared to the experimental group two days post-race, but 
as these changes were not significant in comparison to pre-race measures, interpretation is 
challenging and this may relate to pre-existing differences in muscle strength. Medium effect sizes 
were detected with proportionately worse performance immediately-post race in countermovement 
jump peak power output in the experimental compared to the control group. However, the 
experimental group had a proportionately greater improvement with a medium effect size in CMJ PPO 
by two days post-race compared to the control group. Since the difference in means is less than the 
standard error of measurement for peak power output, this is unlikely to be of practical significance.  
The findings of each outcome measure as well as descriptive data will be discussed in more depth in 
the sections that follow. Each study objective will be considered and over-all findings presented. 
3.11.2 Research Participants 
The sample size of 41 participants in the current study was somewhat larger than previous studies 
identified in the literature, with numbers ranging from 9 to 40 participants18,28,41,61–78,80,84.  The majority 
of these studies had less than 20 participants in total. Most previous studies included exclusively or 
predominantly males subjects with a low percentage of female participants in the literature. In the 
current study, 29% of the participants were female. Although this is still a relatively low value, it is 
exactly in proportion to the 3287 female entrants out of a total of 11264 entries (i.e. 29% of total 
entries constituted females), thus it can be considered representative of the gender proportion based 
on OMTOM 56km entries. There is a trend for proportionally lower female to male participation rates 
particularly in ultra-endurance events world-wide, although both male and female participation rates 
are increasing170. The paucity of prior research in female subjects regarding compression garment 
utilisation illustrates the importance of their inclusion in the current and future research studies.  
There were no statistically significant differences in age, weight, height or PB marathon times between 
groups, indicating that the groups were similar at the onset of the study in terms of their 
characteristics. A previous study at the OMTOM 56km race included only males (n=40), with the 
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average age (42 ± 8 years; range 27-57 years) almost a decade greater than in the current study.  The 
age limits set at 20 to 45 years, which would explain the lower age group (34 ± 6 years; range 23-45 
years) of the current study, was implemented to help control for age related variability in muscle 
responses and recovery52,156. Similar statures and body masses were reported in the two studies41.  
Training history was quite varied among individuals in both groups in the current study, but the 
majority in each group reported running between four and six times per week (ranging from three to 
more than eight)  with a total distance of 50-79km (ranging from under 50km to over 100km) reported 
in the six week training period. A training distance of 60-110km/week41 with no record of other 
training types were reported in the prior comparable OMTOM 56km study to test CG41. In the current 
study, almost half of each group reported weekly strength training sessions in addition to running. 
This study seems to be the first to provide details regarding additional exercise forms used in training 
in addition to endurance running. This may be as it is the first, to our knowledge, to include a significant 
training period with the compression garments prior to the main testing period (in this case preceding 
the OMTOM 56km race). 
A few participants in each group utilised other recovery modalities in the week prior to the race, during 
1the race and post-race, which may have impacted on results. However, utilisation was very similar 
between the groups with no statistically significant differences in utilisation detected between groups. 
Most previous studies did not provide records of possible other recovery modalities. In addition, it 
may be more difficult to control for utilisation during a field experiment such as in the current study. 
Notwithstanding, the setting of training for and participation in an actual ultramarathon may provide 
a more realistic depiction of natural running conditions, making it more likely that results can be 
appropriately transferred to a real-life running environment. 
During the race, most participants in each group reported drinking between one and six sachets of 
water and between one and four sachets of other fluids per hour. Other nutritional strategies included 
energy gels, energy bars, bananas, potatoes and others in both groups. There were no statistically 
significant differences in fluid and nutrition strategies between groups. 
The menstrual history was non-significantly different between the two groups, although reports on 
regularity could be confounded by the use of various contraceptive methods. In addition, the number 
of females per group were relatively low so it is difficult to draw conclusions. It is possible, yet unlikely, 
that these factors may have impacted on results51. 
At 6 week pre-race baseline, circumference measurements, CMJ heights and medial gastrocnemius 
muscle architecture were also not significantly different. The group averages for ankle circumference 
measurements of 54.6cm and 55.3cm at the start of the study are slightly higher compared to previous 
values of 53.6cm and 53.5cm reported in the literature105, although values specific to runners could 
not be found. The 6 week pre-race baseline mid-calf circumference measures of 38.8cm and 39.4cm 
are also slightly higher than in a previous study that reported values of 37.8cm and 38.7cm in ultra-
distance runners41. The 6 week pre-race CMJ heights of 22.5cm and 23.1cm are slightly lower than 
previously reported values of 27.8cm146 and 26.8cm63 reported in long distance runners although 
values over 40cm have been reported in competitive triathlon and distance runners77. Calculated PPO 
values of 2400W and 2684W at tapering baseline are lower than the value of 3659W reported 
previously in highly competitive runners and triathletes77, most likely as the current study included a 
wider performance range of recreational distance runners participating in ultramarathon distances. 
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The medial gastrocnemius muscle thickness values of 1.82cm and 1.7cm are very similar to values 
previously reported in trained runners114. In contrast, the medial gastrocnemius pennation angles of 
approximately 19o and 20o are lower than previous values reported in long distance runners113,114. The 
reason for this is unclear. 
The control group had higher 6 week pre-race baseline values in circumferences, muscle thickness, 
pennation angles and CMJ heights compared to the experimental group but these were not 
statistically significant. Muscle thickness and CMJ heights have both been positively correlated to 
muscle strength115,171, indicating that the control group may have had marginally higher muscle 
strength in the calves and/or lower limb at the onset of the study. These findings were accompanied 
by a medium effect size in both pennation angle and muscle thickness of the medial gastrocnemius at 
baseline. The difference in means were larger than the lowest values for reported standard error of 
measurement121,122 using this method and equal or lower to the highest values for SEM121,122 reported, 
hence this may be of practical significance. The CMJ PPO at tapering baseline had a small effect size, 
which is unlikely to be of significance since the SWC and difference in means are smaller than the 
SEM149 value reported. Small effect sizes for the ankle circumference where the SWC is larger than the 
SEM102 and for the mid-calf circumference where difference in means exceeded the SEM106, may also 
be of significance.  In theory, increased muscle strength may possibly contribute to improved 
performance and possible protection against EIMD. These potential pre-existing differences may 
therefore have had some influence on the subsequent results.  
3.11.3 Main outcome measures related to exercise-induced muscle damage 
3.11.3.1 Circumference measurements 
The over-all trend for ankle and mid-calf measurements in both groups showed an initial decrease 
post-race followed by an increase in the subsequent two days. This is similar to prior studies which 
demonstrated an immediate reduction in lower limb volume following a marathon distance63 and 
subsequently an increased volume until 72 hours following an ultramarathon41. The initial decrease 
coincided with body mass losses, which is likely to be an indication of reduced hydration status which 
is to be expected immediately post-race172. 
There was no main group effect in lower limb circumference measurements in the experimental and 
control group from six weeks prior to the race until two days following the race. However, post-hoc 
analysis revealed a statistically significant (p=0.01) increase and large effect size (Cohen’s d=1.1) in 
figure-of-8 ankle circumference measurements in the control group compared to the experimental 
group from immediately post-race until two days following the race. The difference in proportional 
change in means and SWC is larger than the SEM102 and so this is likely to be of practical significance. 
This implies that the control group may have had a larger degree of swelling related to EIMD4 
compared to the experimental group by two days post-race. 
A prior study detected significantly smaller increases in mid-calf and ankle circumference 
measurements at 24h, 48h and 72hrs post-race when below knee compression garments were utilised 
during the 56km race and during recovery compared to placebo socks41. Ankle circumferences in this 
prior study were measured as the narrowest section adjacent to the malleoli. The figure-of-8 ankle 
measurements in the current study may present a more encompassing presentation of ankle 
swelling103. The current study in contrast to the prior, did not detect any significant changes in mid-
calf circumference measurements from immediately post-race until two days following the race. The 
small effect size differences in mid-calf circumferences are also unlikely to be meaningful (SWC<SEM). 
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Similarly, no significant changes were detected pre- and post-marathon running in lower leg volume 
assessed by water displacement in another study63. In contrast, a further study assessed lower leg 
volume with a perometer following a 10km race and found significant reductions with compression 
garment use immediately after the run, but this effect vanished as soon as 5 minute post-run85. Due 
to the large number of participants tested in the medical tent at the finish line of the current study, it 
was not possible to test each participant immediately as they finished, and some would have had a 
short waiting period. Considering reduced measurements in a prior study had disappeared by five 
minutes post-race85, even a short waiting period could potentially have impacted on the different 
results obtained. Ideally, if more individuals were able to collect data at once, with high inter-rater 
reliability established, it would be easier to ensure no waiting period for data collection in future 
studies. 
Based on these findings and that of previous studies, there appears to be some evidence that 
compression garments may help to reduce measures of swelling in the ankle and/or lower leg 
following a running event41,85. 
3.11.3.2 Medial gastrocnemius muscle architecture 
There was no main group effect over time for muscle thickness and pennation angles of the medial 
gastrocnemius for the experimental and control group. However, non-significant changes occurred 
over time in both groups with certain significant between-group differences at particular points in 
time. 
There was a trend for muscle thickness to increase from six weeks pre-race until the tapering baseline 
shortly prior to the race in both the experimental and control group. As muscle thickness is positively 
associated with muscle strength115, this may indicate improved calf muscle strength following the 
training period in both groups. The mean tapering baseline muscle thickness was significantly higher 
in the control group compared to the experimental group. As there was no significant effect over time 
between the two groups, this is unlikely to relate to compression garment utilisation or lack thereof.  
In addition, the change in muscle thickness over the training period had a trivial effect size.  There was 
also a trend toward statistical significance between values at the six-week pre-race baseline data 
collection. This implies that the control group most likely had stronger calf musculature prior to the 
race115. A medium effect size in muscle thickness was detected at tapering baseline, which may be of 
significance with the difference in means larger than the low range, but smaller than the high range 
of SEM reported in the literature122. Although the training history was similar between the two groups, 
a slightly higher percentage of the control group reported higher weekly running distances in the range 
of 80km to over 100km in addition to a slightly higher percentage reporting additional weekly strength 
training sessions. This may account for the higher muscle thickness values on average in this group, 
rather than relating to the lack of compression garment utilisation. 
There was also a mild increase in muscle thickness values from tapering baseline compared to two 
days post-race in both groups with significantly higher values reported in the control group. A previous 
study reported a statistically significant increase in muscle thickness values peaking at 48hours 
following exercise108. However, the latter study induced EIMD in participants who had been sedentary 
for at least two weeks prior to testing, which may have resulted in a greater extent of EIMD compared 
to the highly trained runners who participated in the current study. As there were no significant 
changes over time from pre-race to post-race in muscle thickness values, it is not clear if the higher 
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value is simply due to the pre-existing difference between the groups or perhaps indicative of a greater 
severity of EIMD in the control group. 
Medial gastrocnemius pennation angle means increased steadily over time in the control group, 
whereas the values in the experimental group remained unchanged following the training period 
where after it increased to post-race. These changes were not significant over time, although a prior 
study detected a statistically significant increase in pennation angles by 48 hours following DOMS 
induction108. As discussed for muscle thickness, the current study involved highly trained runners, thus 
the extent of EIMD may have been attenuated. Post-race pennation angles were significantly higher 
in the control group compared to the experimental group. This could possibly indicate a higher degree 
of EIMD in the control group. However, as for the muscle thickness values, there was a trend toward 
statistical significance at both pre-race sessions, accompanied by medium (6 weeks baseline) and large 
(tapering baseline) effect size which may be indicative of a pre-existing difference rather than an effect 
related to compression garment use or lack thereof. The difference in means exceeds the SEM at 
tapering baseline and two days post-race, hence it may be of practical significance at these points in 
time. However, proportional percentage and absolute change in muscle thickness and pennation 
angles from tapering baseline until post-race had trivial effect sizes. Therefore, the underlying reason 
for this finding is not clear. 
Interpretation of the muscle architecture parameters considered is further complicated as this study 
was the first to our knowledge to test the extent of EIMD with ultrasound in trained endurance runners 
making comparisons difficult. However, this study may set the grounds for future comparisons. In the 
past, ultrasound has, however, been utilised in other sports environments with different parameters 
considered. For instance, ultrasound measured swelling was found to be significantly lower post-
exercise in a group utilising whole body compression garments during recovery from resistance 
training compared to controls95, whereas the use of upper limb sleeves during resistance training did 
not alter ultrasound echo intensity compared to a control group89. 
Both groups showed a trend for improvement in medial gastrocnemius strength over time due to 
increased muscle thickness and pennation angles detected. This is in line with the expectation that 
most runners will perform peak training volumes followed by a lower volume tapering period in 
preparation for the ultramarathon in the final six weeks pre-race. Although there were significant 
differences in muscle thickness at the tapering baseline and post-race and in pennation angle post-
race only, it is unlikely that this relates to compression garment utilisation or lack thereof. It is more 
probable that this reflects pre-existing differences in medial gastrocnemius muscle architecture 
between the two groups as there was a tendency towards statistical significance and medium effect 
size differences with higher muscle thickness in the control group compared to the experimental 
group at the onset of the study. 
3.11.3.3 CMJ test  
As would be anticipated following a long distance race63,172, both groups showed a reduction in CMJ 
heights and estimated PPO from tapering baseline to immediately post-race. Reduced muscle power 
is one of the indications of EIMD4 and fatigue172. Both groups improved on average by two days post-
race, but did not regain pre-race jumping height and PPO. The deterioration in performance of CMJ 
immediately and two days post-race is indicative of EIMD related reductions in muscle strength and 
lower limb power4,36,37 due to the OMTOM 56km race. Neither the CMJ height nor the PPO changes 
were statistically significant over time between the two groups. However, a medium effect size in CMJ 
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PPO indicates that the experimental group performed proportionally worse than the control group 
immediately post-race. In contrast, by two days post-race, a medium effect size in PPO indicates that 
the experimental group improved proportionally more than the control group.  This may indicate that 
the experimental group made a quicker recovery in lower limb muscle power in the two days post-
race. However, the absolute change in PPO over this period is below the SEM153 reported in the 
literature, therefore it is unlikely to be of practical significance. 
These results are similar to those reported in previous studies. No statistically significant changes in 
jumping height or estimated PPO were detected in competitive long distance runners in the 48hours 
following treadmill running when using no, light or high pressure below knee CG77. Another study did 
not find any significant differences in CMJ height and PPO following a marathon in a group utilising 
below knee CG compared to controls (conventional socks) during exercise63. In addition, calf 
compression sleeves appeared to have no impact when worn during a middle-distance trail run 
compared to controls in terms of CMJ height76. In contrast, one study found improved maintenance 
of CMJ height following a 10km time trial when low and medium pressure level below knee CG were 
utilised compared to controls with no significant changes when high level CG were utilised62. This study 
unfortunately had a small sample size (n=12), thus results may not be generalizable to a wider running 
population. 
Based on the current study and reinforced by similar results in previous studies, it seems unlikely that 
CG utilisation or lack thereof had a significant impact on performance in CMJ testing following long 
distance running. However, the medium effect size improvement in CMJ PPO may indicate a faster 
recovery in muscle power by two days following a race. Based on a previous study, it is also possible 
that CG may improve CMJ performance following shorter distances of running (10km and under)62. 
3.11.3.4 Subjective pain ratings 
The current study found significantly lower VAS ratings in the anterior lower leg immediately post-
race compared to the experimental group, but this effect disappeared by two days following the race. 
In addition, the control group showed statistically significant improvements in pain ratings from 
immediately post-race until two days post-race during right leg dorsiflexion and knee extension 
compared to the experimental group. No further significant changes in pain ratings were detected 
between groups. 
These results are different to the majority of prior studies that reported improved VAS pain ratings 
following various running events when compression garments were utilised compared to conventional 
clothing. For example, runners utilising CG during exercise reported lower VAS pain ratings in the 
lower leg compared to control group runners both shortly after and 24 hours following a 10km race61 
and a 5km race69. 
Another study conducted in marathon runners detected lower VAS ratings at 24 hours post-race63,84. 
However, this no longer applied at 48 hours post-race63. This may be due to the higher training status 
of endurance runners, such as in the current study – quicker recovery may thus occur with subsequent 
reductions in pain ratings. Another study found reduced pain ratings at 24h, 48h and 72hr post-
ultramarathon, when CG were utilised during the race as well as for the subsequent three days41.  It 
may be suggested that pain reductions are only maintained when CG are utilised post-exercise in 
addition to during long distance running. 
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In contrast, higher ratings of discomfort have been reported in general in runners utilising high and 
medium level compression garments compared to low pressure CG and conventional socks62,77. It is 
possible that the higher pain ratings in the shins at rest in the current study could relate to discomfort 
caused by the socks, rather than being an indication of DOMS. Moreover, this did not coincide with 
differences in pain ratings in the posterior lower leg, which constitutes the bulk of lower limb muscle 
mass with DOMS anticipated to be worse in this region. The significant improvements with selected 
movements (dorsiflexion and knee flexion) was not accompanied by significant improvements in the 
left leg, nor with any other movements. As the below knee garments were worn on both sides in the 
experimental group and not on either side in the control group, it seems unlikely that the one sided 
change is due to compression garment use or lack thereof. Instead, it could perhaps relate to 
additional issues reported on race day, with a greater number of unrelated (to CG) complaints 
reported in the experimental group compared to the control group.  
Considering the isolated nature of the significant changes, it is unlikely to be cause for concern. 
However, the current findings challenge those of previous research (which generally consisted of 
much smaller sample sizes) that suggested subjectively reduced pain ratings with CG use during 
running compared to conventional clothing. 
3.11.4 Performance measures 
3.11.4.1 Race performance 
As anticipated, both groups had a slower pace on average during the final 14km (i.e. the final 25%) of 
the race. There were no statistically significant differences and trivial effect sizes in race pace to the 
marathon distance and in the final section of the race between the groups. The lack of significant 
changes in the over-all pace and finish times, is similar to a previous RCT testing compression garments 
conducted at the OMTOM 56km, with no significant changes detected41. The average over-all race 
pace and finish times reported were also similar, although somewhat slower in both groups in the 
current study compared to the previous study41. This may be due to the inclusion of females in the 
prior as opposed to only males in the latter. Unfortunately, a break-down of running times in different 
sections of the race was not available for comparison. 
Only one prior study could be found that analysed pace over time in a running event. This study, 
conducted at a marathon, also found a trend for decreased pace towards the end of the race, with no 
significant differences in race pace at any stage during the 42.2km in a group utilising below knee CG 
compared to a group wearing conventional socks63. Likewise, many other studies failed to detect any 
significant changes in running performance over a range of distances and terrains (from 400m track 
to a 15km trail run) when utilising compression garments compared to control conditions61,69,76,78. The 
current study reinforced previous findings that it is unlikely that compression garments have any 
impact on running performance, including in ultra-endurance events.  
3.11.5 Further possible contributing factors 
The use of additional recovery aids reported were similar between the two groups. Ideally, no 
additional recovery methods should have been utilised to avoid confounding factors. It appears to be 
common-practice in long distance running to utilise various recovery modalities particularly analgesics 
and NSAIDs173. For this reason, this study may be a more realistic depiction of normal running 
conditions as opposed to laboratory conditions. Frequencies of utilisation of other recovery modalities 
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is not clear in the available literature. Nonetheless, the similarity of utilisation with no significant 
differences between groups means it is unlikely to have impacted results. 
Nutrition and fluid strategies were similar with no significant differences during the race. The 
menstrual history was non-significantly different between the two groups, and may have been 
confounded by contraceptive use. It is thus not clear if these differences may account for different 
severity of EIMD and performance in female participants in each group51. 
In addition, a number of participants in each group reported additional issues on race-day such as 
dizziness, cramping and falls, which may have impacted on results obtained. However, none of these 
complaints were likely to be related to CG use or lack thereof. 
The drop-out rate of participants following baseline measurements was the same in each group, with 
two participants not completing the study per group. Only one of these were related to CG use with 
the concerned participant complaining that it caused thermal discomfort during training. The average 
temperatures during the six week training period was 20oC and 19oC on average, ranging from 
minimum values of 11oC and 9oC and maximum values of 36oC and 38oC in the two months of testing, 
respectively174. Interestingly, a prior study found significantly increased skin temperatures with CG use 
compared to controls in a controlled environment of 10oC but no such difference in a 32oC 
enviroment66 – the latter being closer to peak temperatures reached during the testing period. In 
addition, there was no significant association between these changes and running performance66. 
Another study found no difference in ratings of thermal discomfort in participants utilising CG 
compared to controls64. It seems unlikely that thermal discomfort would be a problem for the majority 
of participants, although individual preferences apply. Other reasons for discontinuing the study were 
of a personal nature (illness and lack of time) and apparently unrelated to CG use or lack thereof. 
3.11.6 External Conditions 
The OMTOM occurred on a reasonably hot day with a maximum temperature of 26oC. It is possible 
that when compression garments are tested in cooler conditions such as 18oC more typical of 
laboratory temperatures, the impact may be different. Thermal clothing have been suggested as a 
possible preventative measure against muscle strains175. Compression garment utilisation in cooler 
conditions may thus potentially work more efficiently by keeping the muscles warmer. This may also 
partly explain the differences observed in comparison to the previous study conducted at the OMTOM 
56km where testing was performed at 18-20oC41.  
3.11.7 Training period 
This study pioneered the inclusion of a six week training period prior to competition to allow for 
familiarisation with the product in addition to assessing if the impact changed following routine 
utilisation. All prior studies identified tested participants within a shorter period of time, often without 
accounting for prior routine utilisation or lack thereof and without a formal period of routine 
utilisation or lack thereof.  
During the training period, it was unfortunately difficult to control aspects of training as well as 
specifics regarding compression garments utilisation. The training histories over the six week period 
was varied between individuals and the minimum running distance was not maintained in a few 
participants in each group. Although most experimental participants reported using the garments 
during three to four runs, small percentages reported above and below these rates. To avoid 
introducing a confounding variable, participants were instructed to continue their usual training 
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regimes, rather than implementing a standardised programme for all runners. Although this would 
have been easier to control, it may have caused differences in muscle responses and performance 
related to the training programme rather than the CG. 
No statistically significant changes were detected from six weeks pre-race until shortly pre-race, 
except in terms of muscle thickness of the medial gastrocnemius muscle. As discussed previously, this 
more likely relates to training history and a pre-existing underlying increased muscle strength in the 
control group, and is unlikely to relate to lack of CG use. Based on these findings, it appears that 
routine utilisation of CG did not results in any obvious changes over time compared to the control 
conditions in preparation for an ultramarathon. 
3.11.8 Study limitations and future directions 
Recovery modalities were utilised by a few participants in both groups pre-race, during the race and 
post-race and although there were no statistically significant difference between groups, it may 
confound results obtained. More stringent restriction of alternative recovery modalities should be 
implemented in future studies. However, it is also possible that some previous studies assumed that 
other recovery modalities were not utilised without specifically asking participants to report on 
utilisation. 
This study included both genders due to the relative paucity of prior studies involving females. 
However, the percentage of females was still much lower than males. This could possibly relate to the 
higher numbers of male participants in long distance events. It is recommended that future studies 
include females to increase the research basis relating to compression garments use in this gender in 
addition to males. 
This study pioneered the use of ultrasound to help detect EIMD related changes in muscle architecture 
in long distance endurance runners in relation to CG use. Muscle architecture parameters considered 
presents a suitable alternative to assess EIMD changes, but more extensive measurements such as 
anatomical cross sectional areas may add value to future studies. Furthermore, subtle differences may 
have occurred if the tested leg was selected based on dominance (rather than standardising to the 
right leg only) and this may be improved upon in subsequent studies. 
The current study was the first to our knowledge to include a significant training period to assess for 
an additive impact of compression garments in endurance running. However, it was difficult to control 
the training history and frequency of compression garment utilisation during this period as previously 
discussed. It may be beneficial to include stricter entrance criteria in follow up studies specifying 
number of weekly runs, minimum and maximum running distances, additional training components 
and personal best marathon times within a more narrow range to allow more control over the training 
period. Furthermore, although six weeks should allow sufficient time for muscle adaptation, a longer 
training period with compression garment utilisation may add value to future studies. Closer 
monitoring of CG use and providing more pairs of garments (for practical purposes) should also be 
beneficial. 
Ideally, participants and data collectors should be blinded to group allocation. Unfortunately, for 
practical reasons as discussed in the literature review (Section 2.2.3), it is very difficult to blind 
participants and even when placebo socks were utilised, the majority of participants accurately 
assumed their group allocation. An external, blinded examiner to perform data collection in future 
studies would reduce the risk of any unintentional observer bias.  
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Commercially available compression garments were utilised in this study as this is more likely to be 
accessible to a greater proportion of the socio-economic groups in South Africa, a developing nation. 
As discussed in Section 3.4, it was unfortunately not possible to determine the exact pressure level 
exerted by the garments, thereby limiting reproducibility. In addition, individually-tailored graduated 
compression garments would be preferable in ideal conditions where it would be socio-economically 
accessible to more runners in developed nations and this should be assessed in future studies. 
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CHAPTER 4 
Summary & Conclusion 
Compression garments are commonly utilised in endurance runners, despite paucity in the literature 
regarding its impact17,20. A randomised controlled field experimental study was conducted to assess 
the impact of below knee compression garments on exercise induced muscle damage and 
performance in endurance runners. The results of the study detected limited indications of any impact 
of below knee compression garment utilisation during training for and participation in an 
ultramarathon running event compared to control conditions. Selected measurements suggest a 
possible protective impact with a reduction in ankle circumferences (both with statistical significance 
and a large effect size), possibly related to attenuated swelling, detected over time following the race. 
However, this was not the case for mid-calf measurements with no impact detected. Some differences 
were detected at certain points in time for medial gastrocnemius muscle architecture values, although 
this is more likely to be due to pre-existing group differences than reflecting an impact due to CG use 
or lack thereof. Although statistically significant changes were not detected, a medium effect size 
indicated that the experimental group regained lower limb muscle power better (with improved 
countermovement jump peak power output) in the two days following the race than the control 
group. In addition, it appears that the compression garments may be associated with some discomfort 
in the shins at rest, and smaller improvements in pain ratings with dorsiflexion on the right were 
detected over time. However, these effects seem to be transient and minor. Moreover, compression 
garments appear to have no impact on running pace and performance at any stage during an 
ultramarathon. 
The majority of EIMD related measures considered showed no or minimal statistically significant 
differences between groups indicating a relative lack of effect. More specifically, it seems unlikely that 
below knee CG utilisation or lack thereof during training and competing in an ultramarathon had a 
significant impact over time on mid-calf swelling (i.e. circumference measures), muscle architecture 
of medial gastrocnemius (i.e. pennation angles and muscle thickness) determined by ultrasound scans, 
lower limb power (i.e. countermovement jump heights) or in ultramarathon race performance. 
However, a medium effect size in CMJ PPO indicates greater improvement in lower limb muscle power 
in the experimental group compared to the control group in the two days post-race. Conversely, 
compression garments may be associated with more discomfort in the shins than control conditions. 
Herewith the objectives described in Section 1.2 is answered.  
Currently, there appears to be limited evidence to support the utilisation of commercially available 
below knee compression garments during training and participation in long distance running events 
with mild improvements in isolated measures of exercise induced muscle damage. Moreover, the only 
improvements detected occurred in the 48 hours following the race, with no significant impact 
detected during training and the race itself. Furthermore, it seems extremely unlikely that 
compression garments can be considered an effective ergogenic aid. It is possible that individually 
tailored compression garments may have a different impact. In addition, it is likely that utilising CG 
both during running and the subsequent recovery period may yield greater benefits for muscle 
recovery based on previous research17,20,41. 
There is relatively limited evidence to support the utilisation of below knee compression garments 
during long distance running events for the purpose of muscle recovery and it is not recommended as 
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a performance enhancer. The popularity of commercially available below knee compression garments 
utilised during running should be revisited.  
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Appendix B: Example of recruitment advertisement 
Department of Health and Rehabilitation Sciences    
 
Faculty of Health Sciences       
  
Divisions of Communications Sciences and Disorders,    
Nursing and Midwifery, Occupational Therapy, Physiotherapy   
                                                                                      F45 Old Main Building, Groote Schuur Hospital 
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Appendix C: Nordic Musculoskeletal Questionnaire 
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Appendix D: Physical Activity Readiness-Questionnaire+ 
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Appendix E: Screening tool 
 
                                                                                           
Department of Health and Rehabilitation Sciences    
 
Faculty of Health Sciences       
  
Divisions of Communications Sciences and Disorders,    
   Nursing and Midwifery, Occupational Therapy, Physiotherapy   
                                                                                      F45 Old Main Building, Groote Schuur Hospital 
 
Name of Participant: __________________________   
To assess if you are eligible to participate in the research study: “The impact of below knee compression 
garments on endurance running performance and lower leg muscular responses in endurance runners”, please 
complete the following survey. 
A) Please tick the appropriate statement with an “X”. 
Do the following statements 
apply to you? 
Yes No 
1. Are you 20 and 45 years 
of age? 
  
2. Have you completed 1 or 
more marathons or 
longer distances in the 
past 18 months? 
  
3. Is your average weekly 
training mileage 50km or 
more? 
  
4. Have you entered and 
are you planning to run 
the Two Oceans Ultra-
Marathon in 2017? 
  
5. Would you be willing to 
have data collection 
performed on four 
occasions (6 weeks and 
2-3 days prior to, at the 
finish line and 2 days 
following the Two 
Oceans)? 
  
 
If you have answered “Yes” to all of the above statements, please proceed to the next section to confirm that 
none of the following statements apply to you. 
 
A) Please tick the appropriate statement with an “X”. 
Do the following statements 
apply to you? 
Yes No 
Have you experienced aching, 
discomfort, pain or abnormal 
sensations in your legs that 
necessitated a medical, 
physiotherapy or health 
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professional consultation over 
the past 3 months?  
Have you been diagnosed 
and/or received treatment for 
any injuries or have known 
damage to your muscles, 
bones or nerves that that 
necessitated a medical 
consultation and/or 
physiotherapy and/or other 
health professional in the past 
3 months? 
  
Do you have any previous 
injuries to your muscles, bones 
or nerves in your legs that still 
bothers you (e.g. causes pain 
regularly) and has required 
medical attention within the 
past 3 months? 
  
Do you suffer from any known 
medical conditions or 
complications relating to your 
nervous system, muscles, 
skeleton, heart or hormones that 
would inhibits safe participation 
and that may impact on your 
running performance?  
  
Are current routinely using 
compression garments or would 
you be opposed to 
training/competing with/without 
compression garments provided 
depending on group allocation? 
  
If you have answered “No” to all of the above statements, you may be eligible to participate in this study. 
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Appendix F: Informed consent 
                                                                                                         
                                Department of Health and Rehabilitation Sciences    
 
Faculty of Health Sciences       
  
Divisions of Communications Sciences and Disorders,    
   Nursing and Midwifery, Occupational Therapy, Physiotherapy   
                                                                                      F45 Old Main Building, Groote Schuur Hospital  
 
Informed Consent Form 
Consent to participate in a research study: 
 
A research study to assess the effectiveness of compression socks on ultra-marathon running 
performance and leg muscles in endurance runners 
 
Dear participant 
 
Who is performing the study? 
I am a Master’s student in the Faculty of Health Sciences, Department of Human Biology, Division of 
Exercise Science and Sports Medicine, at the University of Cape Town. I am conducting a study to be 
written up as a mini-dissertation in partial fulfilment of the Master of Science in Sports 
Physiotherapy Degree. The study will be performed under the supervision of Professor Andrew 
Bosch.  
 
Purpose and scope of the research  
You will have noticed that wearing of compression garments has become very popular among 
runners. Unfortunately, the research to support the usefulness of this is inconclusive at present. The 
purpose of this study is to test the effect of compression socks on performance and leg muscles 
during long distance running. 
 
The study will be performed in runners training for and participating in the Old Mutual Two Ocean’s 
56km ultramarathon. It will therefore provide valuable information regarding the possible role of 
compression socks in aiding recovery and improving performance. We hope that this will help with 
decision-making regarding the continued use of compression garments in the running community. 
 
Who can take part in this study? 
To participate in this study, you must: 
a) Be entered for the 2017 Two Oceans Ultra 
b) Be 20-45 years of age 
c) Have completed at least 1 marathon or ultra-marathon in the past 18 months 
d) Have a minimum average training distance of 50km per week. 
 
You cannot take part in this study if you:  
a) Have had one or more running injuries in the past 3 months or have pain or other symptoms 
from older injuries 
b) Have any medical or physical conditions that may impact on safety or performance 
c) Are currently routinely using compression garments and would be unwilling to train and 
compete with or without compression socks based on which group to which you will be 
randomly assigned. 
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What will the study involve?  
For this study, if you decide to participate, you will be randomly allocated (i.e. each person has an 
equal chance of being selected for each group) to one of two groups. If you are allocated to Group 1, 
you will be required to train for 6 weeks and participate in the 56km race with compression socks 
that will be provided to you. If you are allocated to Group 2, you will be required to train and 
participate in the event without compression garments. In this case, you will receive compression 
socks after the completion of the study. 
 
You will be required to perform four visits for data collection. The first visit will take place 6 weeks 
before the Two Ocean Ultra-marathon. Basic measurements of your weight and height will be taken 
as well as measures of the circumference of your legs. An ultrasound scan will also be done to assess 
your leg muscles. These measurements will be repeated at the second visit 2-3 days before the race 
along with a questionnaire relating to compression socks usage and your training schedule. In 
addition, you can choose to participate in another test involving a jumping movement on a force 
plate. This involves standing with your legs together, then bending at the knees, and jumping as high 
as you can. Both of these visits will be at the Sport Science Institute of South Africa. At the finish line 
of the Two Oceans these tests will be repeated along with a questionnaire, with questions on muscle 
pain levels, food and fluid intake, and muscle recovery strategies. In addition, a jumping test can be 
completed. The ultrasound scan, circumference measures and questionnaire will finally be repeated 
at the Sport Science Institute two days after the race. In addition, the jumping test can be completed 
on a force plate. Information regarding your finish times and race pace will also be accessed from 
RaceTec, the official timing device for the race. 
 
What will happen to the collected data? 
All the information gathered will be kept strictly confidential. It will only to be seen by the 
researchers and your identity will not be associated with the information that appears in the report. 
To protect your privacy, we will replace your name with a code on all of the measurements. We will 
only use this code on information about you. We will do our best to keep the code private. It is 
however always possible that someone could find out your name but this is very unlikely to happen. 
Hard copies of data will be locked away and all electronic data will be password protected. Data will 
be analysed by the researchers to establish if there are any significant difference between the two 
groups.  
 
Voluntary participation and the right to withdraw  
Participation in this study is completely voluntary. In other words it is your personal decision 
whether you want to take part in the study. If you decide to participate, you are free to withdraw 
from the study at any point and this decision will not affect you or your current or future health or 
well-being in any way, or your participation in the race. If you do decide to withdraw, please let us 
know and we will destroy your information.  
 
Potential risks associated with the research 
To date, no negative effects have been reported with the use of compression socks, so the usual 
running risk profile will remain unchanged (or may be improved by compression socks). None of the 
measurement procedures poses any known risks.   
 
How will your privacy will be protected? 
Your personal information will be kept on a secure computer with hard copies locked in a secure 
cabinet. It is always possible that someone may find out that you participated in this study. 
However, it is very unlikely that this will happen and we will do our very best to ensure that it will 
not. 
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What happens if I get hurt taking part in this study? 
Although there are no risks involved in this study, should you suffer a bodily injury because of taking 
part in the study, the study is covered by an insurance policy taken out by the University of Cape 
Town (i.e. the UCT No Fault Insurance Clause).  
 
The insurer will pay for all reasonable medical costs required to treat your bodily injury, according to 
the South African Good Clinical Practice Guidelines 2006, which are based on the Association of the 
British Pharmaceutical Industry Guidelines. The insurer will pay without you having to prove that the 
research was responsible for your bodily injury. 
 
If you are harmed and the insurer pays for the necessary medical costs, usually you will be asked to 
accept the insurance payment as full settlement of the claim for medical costs. However, accepting 
this offer of insurance cover does not mean you give up your right to make a separate claim for 
other losses based on negligence, in a South African court.  
 
The University will not be liable for any loss, injuries and/or harm that you may sustain where the 
loss is caused by 
 The use of unauthorised medicine or substances during the study 
 Any injury that results from you not following the protocol requirements or the 
instructions that the study researcher may give you 
 An injury that results from negligence on your part 
It is important to follow the study researcher’s instructions and to report straightaway if you have a 
side effect from the study procedure. 
 
Potential benefits associated with the research  
This research will help us to understand the impact of compression garments on performance in 
endurance runners as well as the impact on muscles while training for and participating in a long-
distance event. This information can be used to aid both individual athletes and health professionals 
with decision making and advice regarding the use of these garments. If you decide to participate, 
you will receive cost-free compression garments during (Group 1) or following (Group 2) the study. 
Please be advised and understand that you will not be paid for your participation in this study.  
 
Return of results 
You will receive a report of your test results as well as general findings in the study. This may take 
approximately 3-6 months. 
 
Questions 
Please direct any questions, concerns or comments at myself or my supervisor. You are assured that 
all inquiries will remain confidential. 
Yours faithfully  
Grethe Geldenhuys 
BSc Physiotherapy (UCT)  
Email: GLDALD001@myuct.ac.za 
Phone: 0722686887 
Research Supervisor:  
Prof Andrew Bosch 
Email: andrew.bosch@uct.ac.za 
Phone: 0216504578 
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__________________________________________________________________________________ 
 
If you have any questions or concerns about your rights or welfare as a research participant, you can 
contact the Human Research Ethics Committee as listed below. 
 
Chairperson of Faculty of Health Sciences Human Research Ethics Committee:  
Professor Marc Blockman 
Telephone number: 021 406 6492 
E-mail address: marc.blockman@uct.ac.za 
 
__________________________________________________________________________________ 
Informed Consent Signature sheet 
 
I, ________________________________________________________have read the above and am 
satisfied with my understanding of the study, the possible benefits, risks and alternatives. My 
questions about the study have been answered. I hereby voluntarily consent to participate in the 
research study as described.  
 
                                  
 
_____________________  _____________________  ___________ 
  
Signature of Participant   Name (Please Print)   Date 
 
_____________________  _____________________  ____________ 
  
Signature of Investigator  Name (Please Print)   Date 
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Appendix G: Operational Definitions and protocol 
Operational definitions: 
Ultrasound imaging 
Testing procedure: 
Participant must be positioned in prone on a plinth with ankle maintained at 90o plantarflexion by a 
firm footplate. Participants should be instructed to relax the muscle while ultrasound imaging is 
performed.  
1) Determine aponeuroses and musculotendinous junctions. 
2) Find midpoint between musculotendinous junctions and mark clearly. 
3) Perform U/S scan here. 
Pennation Angle of medial gastrocnemius 
(degree) 
angle formed between the muscle fascicles and 
the deep aponeurosis 
Muscle thickness of medial gastrocnemius 
(mm) 
distance between the superficial and deep 
aponeuroses 
Perform each scan twice and use average values. 
Circumference measures 
Mid-calf circumference 
Testing procedure: 
Participants must be sitting over the edge a plinth and be instructed to relax the muscles during 
testing. 
Mid-calf measurement (mm) Measured at widest girth section of calf 
Perform each measurement twice and use average. 
Ankle circumference 
Testing procedure 
Participants must be sitting over the edge a plinth and be instructed to relax the muscles during 
testing. 
1) Start midway between tibialis anterior tendon and lateral malleolus 
2) Move tape medially towards tuberosity of navicular 
3) Pull tape upwards across arch and proximal to base of 5th metatarsal 
4) Pull tape across tibialis anterior 
5) Pull tape around ankle joint to distal tip of medial malleolus 
6) Pull tape across the calf/ Achilles tendon 
7) Continue with tape to distal tip of lateral malleolus 
8) Continue until starting point of measurement 
Ankle measurement (mm) Defined by Figure of 8 method (Tatro-Adam, et 
al., 1995)103 
Perform each measurement twice and use average. 
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Appendix H: Visit 3 - Adapted Visual Analogue Scale and Self-developed Questionnaire 
Name of Participant: ___________________________                  Group number:     1       2         
To assess your pain level, please circle the appropriate number. 
Adapted Visual Analogue Scale 
1) While sitting comfortably on a chair, what are your pain levels in the front of your lower leg? 
2) While sitting comfortably on a chair, what are your pain levels in the back of your lower leg? 
 
3) While sitting comfortably on a chair, what are your pain levels in the front of your upper leg? 
 
4) While sitting comfortably on a chair, what are your pain levels in the back of your upper leg? 
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5) What are your pain levels when you point your toes downwards while lying on your back? 
 
6) What are your pain levels when you point your toes up while lying on your back? 
 
7) What are you pain levels when you straighten your knee while sitting? 
 
8) What are your pain levels when you bend your knee while lying on your tummy? 
 
 
9) Did you experience any other issues during the race such as a fall or feeling unwell? Please 
circle the appropriate answer. If yes, please explain further below (Visit 3 only). 
YES 
 
NO 
 
__________________________________________________________________________________
__________________________________________________________________________________ 
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Records of Nutrition and Fluid Intake 
1) Please indicate approximately how many units (sachets) of water you consumed during the race? 
Please tick most appropriate answer. 
0 units/hr  
1-2 units/hr  
3-4 units/hr  
5-6 units/hr  
7-8 units/hr  
9-10 units/hr  
More than 10 
units/hr 
 
 
2) Please indicate approximately how many units (sachets) of other fluids (e.g. energy drinks, soft drinks, 
juice) you consumed during the race? Please tick most appropriate answer. 
0 units/hr  
1-2 units/hr  
3-4 units/hr  
5-6 units/hr  
7-8 units/hr  
9-10 units/hr  
More than 10 
units/hr 
 
 
3) Please indicate which, if any, of the following items were consumed during the race. Please tick all 
appropriate responses and indicate the number consumed. 
Energy bar  
Energy gel  
Other (Please 
specify) 
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Record of recovery strategies 
1) Please indicate if any of the following recovery strategies were employed during the last 
week. Where applicable, indicate when and how frequently the recovery modality was 
utilised. 
Type Please tick 
if utilised 
Please indicate date(s) of utilisation and frequency 
Pain medication   
Anti-inflammatory medication   
Massage   
Stretching   
Ice   
Taping   
Foam rolling   
Nutritional supplements   
Electrical therapy (e.g. 
ultrasound) 
  
Other (Please specify)   
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Menstrual Cycle (to be completed by females only) 
Menstrual Cycle (to be completed by females only) 
Participant Code: 
 
1.1) Are you currently menstruating regularly (at least once every one to two months)? 
YES NO Prefer not to answer 
 
 
1.2) If yes, please indicate how long ago (weeks and days) was the onset of your last menses? 
           _______________________________________________________________________ 
 
1.3) If no, please indicate when was your last menses (month and year)? 
            __________________________________________________________________________ 
 
2.1) Are you currently taking a contraceptive pill? 
YES NO Prefer not to answer 
 
2.2) If yes, please indicate brand name. 
_________________________________________________________________________ 
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Appendix I: Visit 4 - Adapted Visual Analogue Scale and Self-developed Questionnaire 
Name of Participant: ___________________________                  Group number:     1       2         
To assess your pain level, please circle the appropriate number. 
Adapted Visual Analogue Scale 
1) While sitting comfortably on a chair, what are your pain levels in the front of your lower leg? 
2) While sitting comfortably on a chair, what are your pain levels in the back of your lower leg? 
 
10) While sitting comfortably on a chair, what are your pain levels in the front of your upper leg? 
 
11) While sitting comfortably on a chair, what are your pain levels in the back of your upper leg? 
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12) What are your pain levels when you point your toes downwards while lying on your back? 
 
13) What are your pain levels when you point your toes up while lying on your back? 
 
14) What are you pain levels when you straighten your knee while sitting? 
 
15) What are your pain levels when you bend your knee while lying on your tummy? 
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Record of recovery strategies 
Please indicate if any of the following recovery strategies were employed over the past two days. 
Where applicable, indicate when and how frequently the recovery modality was utilised. 
Type Please tick 
if utilised 
Please indicate date(s) of utilisation and frequency 
Pain medication   
Anti-inflammatory medication   
Massage   
Stretching   
Ice   
Taping   
Foam rolling   
Nutritional supplements   
Electrical therapy (e.g. 
ultrasound) 
  
Other (Please specify)   
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Appendix J: Training history questionnaire 
Training and compression garment usage records 
Please tick the appropriate answers: 
1) Please select all of the appropriate statements regarding your compression garment usage over the 
last 6 weeks (more than one may apply). 
 I did not wear compression garments at all during training. 
 I used the compression garments occasionally during my runs. 
 I used the compression garments for half of my runs. 
 I used the compression garments for most of my runs. 
 I used the compression garments for all of my runs. 
 I used the compression garments only during my long runs. 
 I did not use the compression garments during my long runs. 
 I used the compression garments for one or two runs per week. 
 I used the compression garments for three or four runs per week. 
 I used the compression garments five or six times per week. 
 I used the compression garments seven or more times per week. 
 
2) Please select the number of runs you generally performed per week over the past 6 weeks. 
 0 
 1 
 2 
 3 
 4 
 6 
 7 
 8 
 More than 8 
 
3) Please select the approximate average range of mileage you performed per week over the past 6 
weeks.  
 0-49km 
 50-60km 
 60-70km 
 70-80km 
 80-90km 
 90-100km 
 More than 100km 
 
4) Do you perform any other training in addition to running regularly every week? 
YES NO 
If yes, please indicate the type and frequency. 
Type: Participation: Frequency: 
Strength training (e.g. weight training, 
crossfit) 
YES NO  
Flexibility Training (e.g. stretch classes, yoga) YES NO  
Cycling YES NO  
Swimming YES NO  
Team sports (e.g. football, cricket, tennis, 
netball) 
YES NO  
Skill specific training (e.g. agility classes, 
balance training) 
YES NO  
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Other (Please specify) 
__________________________________ 
__________________________________ 
 
YES NO  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
139 | P a g e  
 
Appendix K: Summary of Data Collection 
Visit 1 Initial Baseline Data Collection 
Time 6 weeks prior to event 
Location Division of Exercise Science and Sports Medicine (ESSM), Department of Human 
Biology, University of Cape Town (UCT), Sport Science Institute South Africa 
(SSISA) 
Outcome 
measures 
• Height, weight (BMI)  
• Pre-race medial gastrocnemius pennation angles and muscle thickness 
• Pre-race mid-calf and figure-of-8 ankle circumference 
Duration  Approximately 30 minutes per participant  
 
Visit 2 Second Baseline Data Collection 
Time 2-3 days prior to event 
Location  ESSM, SSISA 
Outcome 
measures 
• Pre-race mid-calf and figure of 8 ankle circumference 
• Pre-race medial gastrocnemius pennation angles and muscle thickness 
• Tapering baseline countermovement jump (CMJ) 
Duration  Approximately 15-20 minutes per participant 
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Visit 3 Event Data Collection 
Time During and at the finish line of the event 
Location Old Mutual Two Oceans Marathon finish line at the Green Mile, University of 
Cape Town 
Outcome 
measures 
• Immediately post-race mid-calf and figure of 8 ankle circumference 
• Immediately post-race VAS pain ratings 
• RaceTec finish times and split at 42km (average race pace)  
• Immediately post-race CMJ  
Duration  Approximately 10 minutes per participant 
 
Visit 4 Post-Event Data Collection 
Time 2 days following the race 
Location ESSM, SSISA 
Outcome 
measures 
• 2 days post-race medial gastrocnemius pennation angles and muscle 
thickness 
 
• 2 days post-race mid-calf and figure of 8 ankle circumference 
 
• 2 days post-race VAS pain ratings 
 
• 2 days post-race CMJ 
Duration  Approximately 15-20 minutes per participant 
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Appendix L: Individual Results Template 
Provisional Individual Results For Mr XY 
Descriptive measures: 
  Measurment:    Intepretation: 
Baseline weight: 
Baseline height: 
Baseline body mass index: (normal range: 18.5-25.0; 
Please note that this does not 
discriminate between lean 
tissue and adipose/fat tissue, 
therefore higher ranges may 
be normal in athletes due to 
higher muscle bulk). 
Tapering baseline weight: 
Immediately post-race weight: 
2 days post-race weight: 
Circumference measures: 
Ankle measures: 
6 weeks baseline: 
Tapering baseline: 
Immediately post-race: 
2 days post-race: 
Mid-calf measures: 
6 weeks baseline: 
Tapering baseline: 
Immediately post-race: 
2 days post-race: 
Ultrasound measures: 
6 weeks baseline: *Disclaimer: Please note
measures were taken
specifically for research
purposes and should not be
considered diagnostic i.e. it
does not replace the need for a
radiography report if there are
concerns regarding calf
complaints/injuries.
Tapering baseline: 
2 days post-race: 
Countermovement jump test: 
Tapering baseline jump height: 
Immediately post-race jump 
height: 
2 days post-race jump height: 
Average Race pace: 
To 42km: 
Final 14 km: 
Over-all race pace: 
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Appendix M: Data Capturing 
Name of Participant: ___________________________                  Group number:     1       2         
To be completed by examiner: 
1) Personal Best Marathon Time (past 18 months):___________________ 
a) Calculated average pace:___________________ 
b) If unavailable, use ultra-marathon time:___________________  
 
2) Anthropometric information 
a) Height (cm) :___________________ 
b) Weight (kg) :___________________ 
c) Calculated BMI :___________________ 
 
3) Ultrasound imaging 
 Visit 1 Visit 2 Visit 3 Visit 4 
Pennation angle 
(o) 
    
Muscle thickness 
(mm) 
    
4) Circumference measures 
 Visit 1 Visit 2 Visit 3 Visit 4 
Mid-calf 
Circumference 
(cm) 
    
Figure of 8 ankle 
circumference 
(cm) 
    
 
5) RaceTec timing results 
a) Time to 42km:_____________ 
b) Time to 56km:_____________ 
c) Calculated race pace: 
-Over-all:  __________ 
-First 75%:__________ 
-Final 25%:__________ 
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Appendix M: Timing of Data Collection  
Example of proposed timing schedule for first data collection 
Visit 1 
Number Name of Participant Group 
Number 
Date & 
Time 
Completed 
 
1 X Y 1 2 March 
8:00 
X 
2 B N 1 2 March 
8:30 
 
3  1   
4  1   
5  1   
6  1   
7  1   
8  1   
9  1   
10  1   
11  1   
12  1   
13  1   
14  1   
15  2   
16  2   
17  2   
18  2   
19  2   
20  2   
21  2   
22  2   
23  2   
24  2   
25  2   
26  2   
27  2   
28  2   
29  3   
30  3   
31  3   
32  3   
33  3   
34  3   
35  3   
36  3   
37  3   
38  3   
39  3   
40  3   
41  3   
42  3   
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Appendix N: Example of follow up email correspondence during recruitment 
Follow up email following initial interest 
Dear Potential Participant  
  
Thank you to everyone who indicated an interest in the research study.   
 
Please find attached an informed consent form which contains further information regarding 
the study procedure and regulations. If anything is unclear or if you have any questions 
regarding this, please do not hesitate to ask. If you decide to participate, you will be asked to 
complete the bottom section of the form at the first data collection session (see below). 
Please note that participation is voluntary and if you should decide at a later stage that you 
no longer wish to participate, you will be free to do so. We do ask, however, that you 
carefully look at the schedule below and consider in advance if you would be able to attend 
the data collection sessions. This will occur on four occasions: 
Duration Dates Locations 
Visit 1 
(Approximately 20-30 min) 
Between 2-5 March 2017 Sport Science Institute of 
South Africa, Newlands 
Visit 2 
(Approximately 15 minutes) 
Between 12-14 April 2017 Sport Science Institute of 
South Africa, Newlands 
Visit 3 
(Approximately 5-10min) 
15 April 2017 Medical tent, finish line of 
Old Mutual Two Oceans 
Visit 4 
(Approximately 10-15min) 
17 April 2017 Sport Science Institute of 
South Africa, Newlands 
  
If you would like to participate, please answer the questions on the screening tool (attached), 
which will help to determine if you meet the preliminary inclusion and exclusion criteria. 
Further screening will be performed at the first data collection session (visit 1).  If you would 
be willing and able to participate, please let us know by the 20th of February. After this date 
or once we have reached our maximum capacity for the study, we will unfortunately no 
longer be able to include further participants. 
 
We look forward to hearing from you! 
 
Yours sincerely 
Grethe Geldenhuys 
 
*If you would like to opt out of receiving further correspondence regarding the research study, 
please let me know so I can remove you from the mailing list. 
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Example of email correspondence regarding for Visit 1 
Dear Participant 
Thank you for your willingness to commit to the study. Based on the preliminary criteria, you are 
eligible to participate. This will be verified with further screening during your first visit. 
The first visit will take place at the Sport Science Institute of South Africa. Further details have been 
attached. In addition, a time schedule is included. Please select and send through three possible 
slots (e.g 8:00 on 2nd of March; 18:15 on 3rd of March, etc) when you would be available to come in 
for data collection. We will then do our best to accommodate you in one of these slots. A 
confirmation email with the time of your appointment will be sent.  
If you have any further questions, please let me know.  
Please send your responses to gldald001@myuct.ac.za. 
Kind regards 
Grethe 
*A map with directions to the Sport Science Institute of South Africa is also attached.
VISIT 1 
Location: 
Physiology Lab 3, Second floor, Sport Science Institute of South Africa 
Address: Boundary Road, Newlands, Cape Town, 7725 
Duration and description: 
The first visit will take approximately of 30 minutes. It will involve screening questionnaires, height 
and weight measurements, an ultrasound imaging scan of your calves and leg circumference 
measures. 
Please come in comfortable clothing and preferably in shorts to expose the calf for ultrasound 
imaging and circumference measures. 
Parking 
Please note that there is secure parking available at the Sport Science Institute of South Africa. 
Please sign in at security at the Visitors section. 
Time table: 
2 March (Thursday) 3 March (Friday) 4 March 
(Saturday) 
5 March 
(Sunday) 
7:30 7:30 7:30 7:30 
8:00 8:00 8:00 8:00 
8:30 8:30 8:30 8:30 
9:00 9:00 9:00 9:00 
9:30 9:30 9:30 9:30 
10:00 10:00 10:00 10:00 
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10:30 
 
10:30 
 
10:30 
 
10:30 
11:00 
  
11:00 11:00 
 
11:00 
  
11:30 
  
11:30 
 
11:30 
  
11:30 
 
12:00 
  
12:00 
 
12:00 
 
12:00 
  
12:30 
 
12:30 
 
12:30 
 
12:30 
 
13:15 
 
13:15 
 
13:15 
 
13:15 
13:45 13:45 13:45 
  
13:45 
14:15 14:15 14:15 
 
14:15 
 
14:45 14:45 
 
14:45 
  
14:45 
15:15 
 
15:15 
 
15:15 
 
15:15 
15:45  
 
15:45 
 
15:45 
 
15:45 
16:15 
  
16:15 
 
16:15 
 
16:15 
16:45 
 
16:45 
  
16:45 16:45 
17:15 
 
17:15 
  
17:15 
 
17:15 
 
17:45 
 
17:45 
  
17:45 17:45 
18:15 
 
18:15 
 
18:15 18:15 
Available slots:___; Unavailable slots:___ 
Please provide a possible time slots when you would be available for data collection. Please note 
that we operate on a first come, first serve basis with the allocation of time slots. You will receive a 
confirmation email of your allocated time slot in due course. 
We kindly request that you arrive 10 minutes before the start of your time slot to allow for timely 
data collection of each participant. 
We look forward to seeing you there! 
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Example of email correspondence prior to visit 2-4 
Dear participant 
I hope this email finds you well. 
Thank you to each one of you who performed the baseline testing and has become involved in the 
study. Your participation is greatly appreciated.  
Just a reminder that the next visit (visit 2) will take place on the 12-14 April at the Sport Science 
Institute of South Africa. The venue will be at the Biomechanics lab on the first floor. The third visit 
will be at the medical tent following completion of the OMTOM 56km and the fourth and final visit 
will take place on Monday the 17th of April, again at the Biomechanics Lab, Sport Science Institute of 
South Africa. Further information regarding the data collection sessions as well as a time schedule 
for visit 2 has been attached. Please could you send through three possible time slots and I will do 
my best to accommodate each one of you in one of these slots. 
Furthermore, there is also the opportunity to add an additional test courtesy of a visiting masters 
student from the University of Jyväskylä in Finland. For those who are interested and willing, 
following a repeat of the ultrasound and circumference measure testing as previously, an additional 
test to estimate muscle power by means of a simple jumping movement on a force plate can be 
performed at the next three visits. There are minimal risks associated with this test. This may add 
approximately 10-15minutes to the duration of testing at each visit. As with the other testing, this is 
completely voluntary and all the same principles apply. You can indicate on the day of testing if you 
would be willing to take part in this additional test without affecting participation in any of the other 
tests. 
Please let me know if you have experienced any issues related to either using or not using the 
compression garments or if you have any other questions. In addition, could everyone in group 2 
(that is, those of you who were asked to run without compression garments) please send me your 
shoe size as we will be providing a pair of compression socks to you once the study is completed.  
In addition, we kindly request that runners try to refrain from using other recovery modalities (such 
as pain or anti-inflammatory medication, massage, foam rolling, stretching classes, electrotherapy 
modalities and so forth) as this may impact on results. However, if it is utilised, we ask that a record 
is kept and disclosed to the researcher at your discretion. 
All the best with the final weeks of training! 
Kind regards 
Grethe 
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VISIT 2 
Location and directions to venue:  
Biomechanics Lab, First floor, Sport Science Institute of South Africa 
Address: Boundary Road, Newlands, Cape Town, 7725 
 
Upon arrival at the Sport Science Institute of SA, please sign in at reception. Walk straight through 
the cafeteria to the lifts/stairs to go up to the first floor. Walk across the blue floor to the 
Biomechanics Lab on the left hand side.  
 
Duration and description: 
The second visit will take approximately of 15 minutes.  
 
It will involve an ultrasound imaging scan of your calves and leg circumference measures.  
 
Please come dressed in shorts to expose the calf for ultrasound imaging and circumference 
measures.  
 
Parking 
Please note that there is secure parking available at the Sport Science Institute of South Africa. 
Please sign in at security at the Visitors section.  
 
Time table: 
12 April  (Wednesday) 13 April (Thursday) 14 April (Friday) 
7:30  7:30  7:30  
7:50 7:50 7:50 
8:10 8:10 8:10 
8:30 8:30 8:30 
8:50 8:50 8:50 
9:10 9:10 9:10 
9:30 9:30 9:30 
9:50 9:50 9:50 
10:10 10:10 10:10 
10:30 10:30 10:30 
10:50 10:50 10:50 
11:10 11:10 11:10 
11:30 11:30 11:30 
11:50 11:50 11:50 
12:10 12:10 12:10 
12:30 12:30 12:30 
12:50 12:50 12:50 
13:30 13:30 13:30 
13:50 13:50 13:50 
14:10 14:10 14:10 
14:30 14:30 14:30 
14:50 14:50 14:50 
15:10 15:10 15:10 
15:30 15:30 15:30 
15:50 15:50 15:50 
16:10 16:10 16:10 
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16:30 16:30 16:30 
16:50 16:50 16:50 
17:10 17:10 ___ 
17:30 17:30 ___ 
17:50 17:50 ___ 
18:10 18:10 ___ 
Available slots:___; Unavailable slots:___ 
Please provide 3 possible time slots when you would be available for data collection. Please note that 
we operate on a first come, first serve basis with the allocation of time slots. You will receive a 
confirmation email of your allocated time slot in due course. 
We kindly request that you arrive a few minutes before the start of your time slot to allow for timely 
data collection of each participant. 
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Visit 3 
Location:  
Medical tent at the finish line of the Old Mutual Two Oceans, Green Mile, University of Cape Town. 
 
Duration and description: 
The third visit will take approximately 5 minutes. It will involve leg circumference measures and a 
questionnaire.  
At this visit, we will ask you to confirm the time slot for the final data collection. As we will need to 
test a large volume of individuals in a limited period of time for the fourth and final visit, we kindly 
request that you keep strictly to the time schedule. A guide for the time schedule can be found 
below. If you have special requests for times, please let me know in advance. 
VISIT 4 
Location:  
Biomechanics Lab, First floor, Sport Science Institute of South Africa 
Address: Boundary Road, Newlands, Cape Town, 7725 
 
Upon arrival at the Sport Science Institute of SA, please sign in at reception. Walk straight through 
the cafeteria to the lifts/stairs to go up to the first floor. Walk across the blue floor to the 
Biomechanics Lab on the left hand side.  
 
Duration and description: 
The final visit will take approximately of 10-15 minutes.  
 
It will involve an ultrasound imaging scan of your calves and leg circumference measures and a 
questionnaire. You will receive the questionnaire after completing your race. We kindly request that 
you complete this questionnaire shortly before coming in for your data collection to allow us to 
perform testing within the time frames.  
 
Parking 
Please note that there is secure parking available at the Sport Science Institute of South Africa. 
Please sign in at security at the Visitors section.  
 
Time table: 
17 April (Monday) 
6:45 
7:00 
7:15 
7:30 
7:45 
8:00 
8:15 
8:30 
8:45 
9:00 
9:15 
9:30 
9:45 
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10:00 
10:15 
10:30 
10:45 
11:00 
11:15 
11:30 
11:45 
12:00 
12:30 
12:45 
13:00 
13:15 
13:30 
13:45 
14:00 
14:15 
14:30 
14:45 
15:00 
15:15 
15:30 
15:45 
16:00 
16:15 
16:30 
16:45 
17:00 
17:15 
17:30 
17:45 
18:00 
18:15 
18:30 
18:45 
19:00 
Available slots:___; Unavailable slots:___ 
